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Summary
Summary.
This thesis reports two immuno-epidemiologicai studies of cellular immune responses 
to Schistosoma haematobium infection in humans. The first study was a cross 
sectional infection study. The study cohort consisted of 59 Gambians made up of two 
distinct age groups: children (12-16 years old) and adults (25-88 years old). The 
study examined three hypotheses: 1) protection against infection is associated with a 
Th2-type immune response, 2) Thl and Th2 responses are dichotomous options in 
individuals and 3) cytokine production is affected by cross-reactive antigen.
The second, a re-infection study, was based in Zimbabwe. The study cohort 
consisted of 83 Zimbabwean children (6 to 15 years) recruited from two separate 
villages. One site had significantly lower prevalence of infection than the other, 
conferring an opportunity to examine the effects of transmission dynamics on the 
development of a protective immune response. The study addressed two major 
hypotheses: 1) an appropriate protective type of immune response develops faster in 
the high prevalence area compared to the low prevalence area and 2) individuals 
produce either IL-4 or IL-5 but not both.
PBMC from Gambian children produced more IFNy on stimulation with antigen 
compared to PBMC from adults, whereas PBMC from Gambian adults had greater 
overall cellular immunological responses in response to PHA. Assuming that the 
adults have had past and continuing exposure to infection these observations could 
support the hypothesis that Thl-type responses are associated with susceptibility to 
infection.
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Summary
To investigate the cytokine profiles that may be associated with protection or 
susceptibility to infection, peripheral blood mononuclear cells (PBMC) from the 
study cohort were isolated and cultured in the presence of schistosome egg antigen 
(SEA), whole adult worm homogenate (WWH) or phytohaemagglutinin (PHA). The 
levels of Interleukin (IL)-2, IL- 4, IL-5, IFNy, TNFa, and GM-CSF released into the 
culture supernatants were measured. The statistically significant differences between 
the cellular responses of PBMC from infected and uninfected individuals when they 
were cultured with either PHA, WWH or SEA, minus the equivalent values for 
culture of PBMC without stimulant (net data) were as follows. Infected individuals, 
irrespective of age, had higher peripheral blood eosinophil counts (p<0.003) and 
produced more IFNy on stimulation with SEA (p<0.02) and WWH (p<0.02) than 
uninfected individuals. PBMC from uninfected individuals produced more IL- 4 on 
stimulation with PHA (p<0.001) than infected individuals. No significant differences 
in levels of net IL-2, GM-CSF, IL-5, TNFa or cell proliferation were found between 
PBMC of infected and uninfected individuals.
Thl and Th2 responses, as indicated by levels of IFNy and IL-4 respectively, were 
not found to be dichotomous options. Although as a group, infected individuals and 
children produced more IFNy and less IL-4 than uninfected individuals and adults, on 
a personal level high IFNy production did not necessitate low IL-4 production.
Cross-reactive antigen was found to affect cell proliferative responses (p<0.001), 
GM-CSF, (p<0.001), IFNy (p<0.001), IL-2 (p<0.001), IL-4, (p<0.001) and TNFa, 
(p<0.001). These results confirm that cytokine producing cells can be antigen-
XV
Summary
specific and have the ability to recognise similar epitopes on different stages of the 
parasite.
If it is assumed that a degree of resistance to S.haematobium infection is associated 
with Th2-type responses, a number of results might have been expected from the re­
infection study in Zimbabwe. Children from the high prevalence area might produce 
more Th2-type cytokines, and less Th-1 type cytokines than children from the low 
prevalence area. Since older children had been exposed for longer, it could be 
expected that they would produce more Th2-type cytokine than their younger 
colleagues. If resistance to infection was acquired faster in the high prevalence area, 
it might be expected that a difference between cytokine production might be 
expected in one area but not the other.
To investigate the cytokine profiles that may be associated with protection or 
susceptibility to infection, whole heparinised blood from the study cohort was cultured in 
the presence of SEA, WWH, Cercarial antigen (CERC) or phytohaemagglutinin (PHA). 
The levels of IL-4, IL-5, IL-10, IFNy, TNFa, and GM-CSF released into the culture 
supernatants were measured.
On stimulation with PHA, children from the low prevalence area produced more IL-4, 
(p<0.001) IFNy, (p<0.0005) and GM-CSF, (p<0.0005) than children from the high 
prevalence area. On stimulation with SEA, children from the high prevalence area 
produced more GM-CSF, (p<0.05) and IL-10, (p<0.05) than children from the low 
prevalence area. More children who were infected before treatment produced IL-5, 
(p<0.05) on stimulation with PHA than children who were uninfected. On stimulation
XVI
Summary
with SEA, production of IL-4, (p<0.05) was associated with lack on infection before 
treatment whereas production of IFNy, (p<0.05) on stimulation with WWH was 
associated with protection from re-infection.
Area was the dominant factor in determining cytokine profile. I would speculate that 
the cytokine production was of a ThO type in the low prevalence area, compared to 
the high prevalence area, whereas in the high prevalence area, a pattern that could be 
described as either macrophage or Th2 type predominated.
Analysis of IL-4 and IL-5 production in the Zimbabwean study gave some support to 
the hypothesis that there is a subdivision of the Th2 subset in humans. When blood is 
incubated in the presence of antigen or mitogen, for 24 or 48 hours, the majority o f 
people will produce either IL-4 or IL-5 but not both.
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Chapter 1.
General Introduction.
Chapter 1: General Introduction
1.1 Biology of Schistosomes.
Schistosoma spp., are digenean trematodes of the order Sirigeata. Several species 
of the family Schistosomatidae can infect humans, but only six have been found to 
be capable of maturation and oviposition (Mahmoud, 1992). Of these species, 
Schistosoma haematobium, S.mansoni and S.japonicum are considered to be of 
international public health significance. S.mattheei, S.intercalatum and S.mekongi 
also infect humans and are of public health significance in more restricted foci 
(Schmidt e/a/., 1989).
S.haematobium, S.japonicum and S.mansoni have distinct life cycles and cause 
different symptoms, mainly because of the different preferred sites of development 
in the mammalian host of each type of adult worm. Adult S.haematobium can be 
found primarily in the veins of the urinary bladder plexus, whereas S.mansoni 
adults live principally in the portal veins draining the large intestine and 
S.japonicum inhabit the veins of the small intestine. The female worm lies within 
the gynaecophoric canal of the male worm (Schmidt et al, 1989).
S.haematobium lay their eggs in the small venules surrounding the bladder, 
whereas S.mansoni, and S.japonicum lay their eggs in the venules surrounding the 
intestine. In order to continue the life cycle, the eggs must be excreted in either 
urine or faeces. Some eggs successfully pass through intervening tissue from 
venule to the lumen of the bladder or intestine, but many remain lodged in gut or 
bladder mucosae, or are swept away in the bloodstream and become lodged 
elsewhere in the body. The eggs induce a granulomatous response; comprised of 
an aggregate of inflammatory immune cells, primarily macrophages, eosinophils
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and lymphocytes. Eggs which become trapped in the tissue die and the granuloma 
is replaced by scar tissue (Mahmoud, 1992). In cases of chronic infection, the gut 
or bladder wall can become thickened by scar tissue with large numbers of eggs 
lodged in the tissues (Mahmoud, 1992).
On excretion into water, the eggs hatch and the larval miracidia which are 
released, infect an appropriate species of snail; Bulinus sp. are intermediate hosts 
for S.haematobium. After a number of larval stages, the cercariae emerge from the 
snail. Humans become infected when they contact water-containing cercariae. The 
cercariae penetrate the skin shedding their tails in the process. Within 24 hours the 
schistosomula, as they are now called, are moved by the peripheral circulation to 
the heart. Larval worms migrate through the pulmonary capillaries to the left side 
of the heart and on to the liver sinusoids, where they undergo a three week period 
of development before migrating to the definitive site. A schematic representation 
of the life cycle of S.haematobium, S.mansoni and S.japonicum is in figure 1.1.
In recent times, schistosomiasis has become an increasingly important problem 
because of the proliferation of hydrological development schemes that have 
provided additional environments for the snail intermediate hosts. Mortality due to 
schistosomiasis is difficult to quantify because death certificates rarely identify 
schistosomiasis as the underlying cause of death. However, Koroltchouk and 
colleagues (1987) estimated mortality at 1 in 1000 infected adults. Morbidity 
caused by chronic schistosomiasis constitutes a major public health problem in 
affected areas. S.haematobium infection can lead to inflammation of the bladder, 
haematuria and pain on urination. In some cases this can lead to more severe
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pathology in the urinary tract and bladder, including fibrosis and calcification 
resulting in functional abnormalities. In the most serious cases, renal failure may 
also result. S.haematobium infection has also been linked to bladder cancer; it has 
been estimated that primary prevention of urinary schistosomiasis could reduce 
the global rate of carcinoma of the bladder by 5000-10,000 cases per year 
(Koreoltchouk a/., 1987).
A number of methods have been used to control schistosomiasis, including 
chemotherapy, sanitation, health education and vector elimination. Effective drug 
treatments are available: praziquantel and oxamniquine reduce intensity of 
infection and allow improvement in clinical status of patients with severe 
schistosomiasis (Cline et ai, 1982; Mott, 1982; Sleigh et al, 1986). Population 
based chemotherapy has been the most successful method of control over large 
areas (Cline et al, 1982; Mott, 1982; Sleigh et al, 1986) but re-infection occurs 
quickly and regular treatment programs are expensive, difficult to sustain, and in 
danger of producing drug-resistant strains of schistosome. For these reasons; drug 
treatment has been considered unsuitable for long-term control (Cline et al, 1982; 
Butterworth et al, 1987; Liese, 1987; United Nations Development 
ProgrammeAVorld BankAVorld Health Organistaion Special Programme for 
Research and Training in Tropical Diseases, 1990).
1.2 Epidemiology of schistosomiasis.
The distribution of schistosomiasis differs from species to species and is linked to 
the distribution of suitable intermediate hosts (Schmidt et al, 1989; Mahmoud,
1992). S.japonicum is found predominantly in Japan and China, whereas
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S.haematobium and S.mansoni are prevalent in Africa and in parts of the Middle 
East. S.mansoni, but not S.haematobium, can be found in parts of Central and 
South America (Schmidt et al, 1989; Mahmoud, 1992).
Humans resident in an endemic area are often exposed early in life. Prevalence and 
intensity of infection, as measured by urinary or stool egg counts, increase slowly, 
normally peaking in the 10-20 age group. During adult life, prevalence of infection 
drops and there is a large decrease in intensity of infection (Bradley et al, 1973; 
Mahmoud, 1992). Worm burden within a community exhibits a negative binomial 
distribution pattern - most infected individuals harbour low intensity infection, but 
a few people are heavily infected - a feature common to many helminth infections 
(Mahmoud, 1992).
The differences among individuals and age-related differences in the prevalence 
and intensity of infection undoubtedly arise from several sources. Amongst these 
sources are genetic susceptibility, exposure to infected water and immunity to 
infection. Each of these is discussed below.
Host genetic factors probably influence an individual’s capacity to control worm 
burden. Family studies in Brazil have indicated that intensity of infection with 
S.mansoni is associated with a single gene locus (Abel et al, 1991). The same 
research group subsequently mapped this locus: 'SMI' (Marquet et al, 1996), 
which their analysis indicated could account for 66% of the residual variation in 
infection intensity after controlling for water contact, age and sex. This 
observation may explain why some individuals appear to be predisposed to high
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intensities of infection, but it does not explain why prevalence of infection in a 
community is lower in adults than in children in endemic areas.
The genetic region that contains SMI, contains several loci (CSFIR, D55393 and 
5q31-q33) that encode for components of the immune system and could thus be 
candidates for determining resistance or susceptibility to infection (Marquet et al, 
1996). CSFIR mediates colony stimulating factor 1 (CSFl) which modulates cell 
survival, proliferation and differentiation, and has a primary role in regulating 
mononuclear phagocyte production. D55393 denotes a region that includes genes 
coding for GM-CSF, IL-3, IL-4, IL-5, immune regulatory factor 1 and IL-13. 
5q31-q33 is linked with a locus regulating IgE levels and a locus that controls 
bronchial hyper-responsiveness in asthma. The results of Marquet et al. (1996) 
were generated assuming that genetic predisposition to resistance/ susceptibility to 
infection with S.mansoni was linked to a single gene. Marquet and colleagues 
(1996) pointed out that the actual genetic picture could be more complicated 
implying that a 'resistant' or 'susceptible' phenotype may involve all or any of the 
previously listed factors, and may also include factors not encoded by SM I. It is 
reassuring that some of the factors possibly encoded by SMI coincide with factors 
implicated by other areas of research, discussed in section 1.3. However, SMI will 
be of only limited utility in identifying which phenotype might be associated with 
resistance or susceptibility to schistosomiasis, until the physical region of the 
genome to which it is associated is more tightly defined. Even so, genetic factors 
can only be useful in identifying factors that affect predisposition of an individual 
to infection, they cannot explain the drop in prevalence of infection that occurs 
around puberty in populations.
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The relationship between age and intensity of infection could be explained by a 
slow attrition of adult worms from earlier infections in older people, at the same 
time as a gradually acquired resistance to subsequent infection (Clarke, 1966).
Alternatively, a slow reduction in exposure to infection with age at the same time 
as the gradual death of an existing adult worm population could result in the same
1
pattern (Butterworth et al, 1992).
Whilst changing levels of exposure is certainly a factor in determining levels of 
infection (Wilkins et al, 1987), Butterworth and colleagues (1992) reviewed 
evidence from several studies and concluded that exposure alone does not explain 
the drop in intensity of infection that occurs with age. The key evidence 
supporting this conclusion is that, following treatment, re-infection rates are 
strongly dependent on age. For example, in a study of S.haematobium infection in 
The Gambia (Wilkins et al, 1987; Hagan et al, 1991a; Hagan, 1992a) adult 
women were as intensely exposed as children who became heavily infected after 
treatment, despite having significantly lower re-infection intensities of infection.
Further evidence resulted from a study of an S.mansoni endemic area in Kenya, 
where the level of re-infection was highest in children aged between 8 and 12 
years whereas, greatest exposure to infected water did not occur until the ages of 
16 to 24 years. Even when water contact rates were taken into account, they did 
not explain the large differences in infection intensities between the different age 
groups (Butterworth et al, 1988b).
Evidence from re-infection studies therefore indicates that exposure to infection 
alone cannot account for the relationship between age and infection. This suggests
Chapter 1: General Introduction
that other factors, perhaps including an increase in the effectiveness of the immune 
response may be responsible for the observed reduction in prevalence and intensity 
of infection with age.
An immunological response could result in the death of larvae or adult worms. It 
might also affect the measurement of worm burden by egg counts in urine or 
faeces by altering female worm fecundity or the number of eggs that successfully 
traverse the tissue between the venule and bladder or intestine, dependent on 
species. The extent and type of immune response could depend on a number of 
factors. These include: current infection (Smithers et al, 1965; Smithers et al, 
1967), genetic predisposition to infection (discussed above), age dependent 
physiological features and immunity acquired as a result of experience of infection.
There are some data to support the hypothesis that immunity might reduce worm 
fecundity. S.bovis and S.haematobium adult worm pairs in immuno-competent 
mice produced significantly less eggs than the same number of pairs in T-cell 
depleted mice (Agnew et al, 1992). This anti-fecundity immunity could be 
transferred to a different animal by transfer of serum. This phenomena was not 
observed in similar experiments using S.mansoni (Agnew et al, 1992; Wynn et 
al, 1996). Adult S.japonicum worm pairs produced less eggs per day in mice 
immunised with recombinant 261cDa glutathione-S-transferase (GST), a vaccine 
candidate (Liu et al, 1995a). Similar observations have been reported when pigs 
were vaccinated with either purified recombinant S.japonicum 26 glutathione-S- 
transferase (rSj26GST) or rSj26GST from S.japonicum using alum as an adjuvant 
(Liu et al, 1995b). Agnew and colleagues (1996) considered the relationships
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between both S.mansoni and S.haematobium parasite density in humans and levels
of circulating parasite antigen, egg excretion and host age. They found that whilst 
S.mansoni egg output remained stable irrespective of host age or infection 
intensity, S.haematobium egg production was reduced with host age compared to 
infection intensity as measured by circulating antigen (Agnew et al, 1996). Since 
most pathology is egg induced (Mahmoud, 1992;) a reduction in fecundity could 
be a valid objective of a future vaccine since it could significantly reduce disease.
These interesting results notwithstanding, most attention in immunity to 
schistosomes has focused on killing of larvae and adult worms. The classic dogma 
within this field is that of concomitant immunity, an idea first introduced by 
Smithers and Terry (1967). The essential evidence for this theory was that when 
adult schistosomes were implanted into Rhesus monkeys with no history of 
schistosome infection, the hosts had the same capacity to kill schistosomula as 
those in a control group that had become immune through repeated exposure to 
infection. Concomitant immunity, as originally proposed, has not been universally 
accepted (as reviewed (Hagan, 1992a)), because not all of the data are in 
accordance with it. For example, observations of young children (under 10 years 
old), showed that despite a net increase in worm burden, some adult worms still 
died (Wilkins et al, 1978). Wilkins and colleagues (1984) suggested therefore 
that worm burdens in humans are in a dynamic state and that ‘concomitant 
immunity’ represents a balance between gain and loss of worms, mediated by the 
immune response. They showed that when they halted transmission by killing the 
snail intermediate host with molluscicides, intensity of infection in the study 
population dropped, implying that adult worms were gradually dying and that the
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acquisition of new infections was necessary to maintain a stable adult worm 
population (Wilkins et al, 1984). Concomitant immunity could not, therefore, be 
completely effective in killing new larval invasions.
Further evidence from re-infection studies indicates that adults from an endemic 
area did not lose their partial immunity to schistosome infection after they have 
lost their adult worm populations as a result of treatment (Hagan et al, 1991). 
This result suggests that concomitant immunity could be at most a minor factor in 
a protective immune response in adults although it does not rule out concomitant 
immunity entirely. Hagan and colleagues (1993) proposed that TNFa could 
facilitate concomitant immunity. TNFa is produced by macrophages, which can be 
found in granulomas surrounding schistosome eggs. There is some evidence to 
suggest that it can enhance adult worm fecundity, whilst having direct toxic 
effects on schistosomula (Hagan et al, 1993b).
It is possible that, instead of removing the source of immunity, treatment with 
praziquantel could result in an enhanced immune response. The death of adult 
worms could result in the exposure to the immune system of large amounts of 
adult antigen, which could effectively be considered equivalent to vaccination. 
Thus the treatment intervention not only removes the worm burden but could also 
be immunising individuals to different degrees, dependent on the level of the 
worm burden before treatment. Acquired immunity after treatment, could 
therefore be affected by history of exposure, number of treatments and by worm 
burden at the time of treatment.
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Hope for a future vaccine is based on the assumption that immunity can be 
synthetically induced at an early age by vaccination. If resistance is intrinsically 
age rather than exposure related, the development of a vaccine might face 
unforeseen difficulties. Kloetzel and Da Silva (1967) provided evidence that egg 
count patterns were attributable to duration of infection rather than age. They 
studied a group of men in Brazil, who had recently moved into an area endemic 
for S.mansoni. Although the data lacked any statistical analysis, they did show 
clearly that egg counts declined after twenty years of exposure. Gryseels (1994a), 
however, had a number of criticisms of this work. The conclusions relied on 
fourteen immigrants, who had moved into the area more than twenty years 
previously and had a higher average age than more recent immigrants. Gryseels 
(1994a) also pointed out that past and current exposure patterns and socio­
economic status were not documented and variation in either could have 
confounded interpretation o f the data.
More recent studies to investigate the separate effects of age and history of 
exposure/ immunity on worm burdens in Burundi, (Gryseels et al., 1987; Gryseels 
et al, 1988; Gryseels et al, 1989; Gryseels, 1991a; Gryseels et al, 1991b) and in 
Senegal (Talla et al, 1990b; Gryseels et al, 1994b) have considered new foci of 
infection. In Senegal, (Talla et al, 1990b; Gryseels et al, 1994b) prevalence of 
infection was 100% in every age group over five years of age. However, intensity 
of infection, as measured by both egg counts and circulating antigen followed a 
typical age-related pattern, with peak intensities in the 10-15 year old age group 
suggesting that age was dominant over history of exposure in determining the 
shape of the age-intensity of infection curve. Supporting evidence came from
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epidemiological studies in Burundi (Gryseels et al, 1987; Gryseels et al, 1988). 
In these studies, both prevalence and infection levels rose to a peak in older 
children and then declined in adults. In subsequent re-infection studies in Burundi 
(Gryseels et al, 1989; Gryseels, 1991a; Gryseels et al, 1991b), children were 
observed to return to pre-treatment levels of intensity of infection one to two 
years after treatment. In contrast, adults had very low re-infection intensities 
despite continued exposure.
Woolhouse (1995) commented that immunity in the new foci in Senegal studied 
by Gryseels and colleagues (Talla et al, 1990b; Gryseels et al, 1994b) may have 
developed at an accelerated speed because of high rates of transmission. The 
immune responses observed, might not therefore reflect those of a naive 
population. Gryseels (1995) replied that this hypothesis was not consistent with 
the observed convex age-egg count patterns in Senegal. If exposure to high levels 
of antigen hastened development of immunity, children would be the first to 
develop a protective immunity because children generally have the highest levels 
of water contact and would be exposed to the most antigen (Gryseels, 1995), 
suggesting that immunity to infection may be strongly age- rather than experience 
of infection- dependent. Water contact observations for the new foci in Senegal, 
however, are yet to be published.
Mathematical models have also been used in an attempt to examine the various 
factors that might contribute to the age-intensity of infection curve. If acquired 
immunity is a significant factor in determining the distribution of worm burden in a 
community, it could be predicted that immunity would develop faster in areas of
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intense transmission (Fisher, 1934; Clarke, 1966). This idea has been explored 
using an age-structured immigration-death model (Woolhouse et ai, 1991). This 
model considered changes in the mean intensity of infection with age, as a 
function of rate of infection and parasite mortality. It predicted changes in the 
shape of the age-intensity of infection curve; an increase in the maximum intensity 
of infection and a decrease in the age of peak intensity of infection in areas of 
intense transmission, compared to areas of less intense transmission. This latter 
characteristic has been called 'peak shift' (Woolhouse, 1994) and has been 
observed in a comparative analysis of seventeen data sets of prevalence of 
S.haematobium infection in Zimbabwean school children, suggesting, in contrast 
to the results from new foci of infection, that acquired immunity to infection as a 
result of history of exposure is a significant factor in limiting schistosome 
infections in endemic areas.
There is therefore evidence for both immunity due to age (Gryseels et al, 1987; 
Gryseels e/a/., 1988; Gryseels a/., 1989; Talla a/., 1990b; Gryseels, 1991a; 
Gryseels et al, 1991b; Gryseels et al, 1994b) and due to history of exposure 
(Woolhouse, 1994). I would like to speculate that both factors may act 
concurrently in the development of resistance but that the evidence from the new 
foci of schistosomiasis (Gryseels et al, 1987; Gryseels et al, 1988; Gryseels et 
al, 1989; Talla et al, 1990b; Gryseels, 1991a; Gryseels et al, 1991b; Gryseels et 
al, 1994b) would suggest that age is the dominant factor.
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1.3 Immune responses to Schistosome infection.
Evidence from epidemiological studies would suggest that at least a partial 
immunity to schistosomiasis is attained by adults in endemic areas. The relative 
proportions of immunity attributable to age-dependent physiological changes and 
to history of exposure to infection are difficult to quantify. However, it is 
reasonable to assume that some type of immunity accounts for the observed 
reduction in prevalence and intensity of infection amongst adults in endemic areas.
It was the generally held view until relatively recently, that schistosomes were 
most vulnerable to an effective attack from the immune response during the three 
hour transformation (McLaren, 1980) from cercariae to schistosomula (Smithers 
et al, 1976; Butterworth et al, 1992), because many of the defence mechanisms 
employed by the adult worm were not active in newly invading larvae. The surface 
membrane of the adult is composed of two closely opposed bilayers (McLaren et 
al, 1977) which can be repaired and replaced with the rest of the outer tegument 
(Perez et al, 1973; Kusel et al, 1975). In contrast, schistosomula immediately 
after invasion of a host, have one lipid bilayer (McLaren et al, 1977; McLaren, 
1980; McLaren et al, 1982). Adult worms can acquire a coating of host 
molecules (Smithers et al, 1969; Clegg et al, 1971; Goldring et al, 1976) and 
their own surface antigens may resemble those of the host (Damian, 1967) 
whereas early schistosomula have yet to acquire this protective cloak (McLaren, 
1980). Despite the adult's apparently superior protection, and the persistent 
survival of the adult worm in experimental hosts that are immune from infection 
with larvae (Smithers et al, 1967) it has become increasingly clear from in vitro 
(McLaren, 1980; McLaren, 1989; Wilson et al, 1989; Agnew et al, 1993) and in
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vivo (Agnew et al, 1992; Wynn et al, 1996) studies that all stages of parasite can 
be subject to immune attack. Immune responses to antigens derived from a 
number of life cycle stages have therefore been considered in immuno- 
epidemiological studies.
The types of immune response that protect adults/experienced individuals against 
schistosomiasis have been investigated using infection and re-infection studies 
which relate human immune responses to schistosome antigen. This approach has 
a number of advantages over the use of animal models. The human situation is 
difficult to reproduce in an animal. Although S.mansoni and S.haematobium can 
infect laboratory animals, they are parasites of humans, so the host-parasite 
combination in animals is artificial. In addition, inbred laboratory animals, 
although convenient, may not adequately reflect the immune response in a human 
population with a large genetic polymorphism (Demeure et al, 1993). 
Mechanisms of protection also differ in quality and quantity in different 
experimental models (Butterworth et al, 1988b; Demeure et al, 1993) making it 
difficult to ascertain which, if any, of the mechanisms reported from animal studies 
might be applicable to humans (Butterworth et al, 1988b).
However, many types of investigation that cannot be carried out in humans are 
possible using animals. For example, it is possible to investigate the immune 
responses of laboratory animals using cells removed from the definitive site; the 
granuloma, or an appropriate draining lymph node; animals can be experimentally 
infected in controlled conditions without concurrent infections; and pathology can 
be directly observed. Quantifying intensity of infection, by directly counting
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numbers of adult worms, not possible in a human, can be carried out using an 
animal. The use of genetically altered animals, such as 'knock-out mice' could also 
be extremely useful in an investigation of the main factors contributing to 
resistance or susceptibility to schistosomiasis. Mechanisms shown to work in 
animals, can be tested subsequently using human cells and serum, to ascertain if 
the response found in animals adequately reflects that of humans.
Human studies also have disadvantages. Infection or re-infection studies 
demonstrate potential immune effector mechanisms using in vitro techniques and 
then correlate results with observed immunity to infection or re-infection. This 
methodology could potentially result in significant but non-causative associations. 
Butterworth and colleagues (1988b) suggest that this possibility could be avoided 
by first establishing a meaningful pattern of correlations and using them to devise 
new assays that are predictive of immunity to schistosomiasis. Although an 
awareness of the limitations of correlative results is useful, it would seem there 
would also be a danger of designing a study for which the results have already 
been ascertained, and by circular logic ascribing a positive result as evidence that 
the original correlation was causative and not just associative. Despite these 
limitations it is encouraging that a number of immuno-epidemiological studies 
have arrived at similar conclusions, despite difference with the details of the 
experimental design, and studying quite genetically different populations, from 
The Gambia (Hagan et al, 1991), Kenya (Dunne et al, 1992), and Brazil 
(Demeure era/., 1993).
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1.3.1 Humoral Immunity.
Accumulated evidence suggests that resistance to schistosomiasis is associated 
with IgE. Low levels of IgE that recognised either S.haematobium adult worm 
antigen or S.haematobium egg antigen in The Gambia was predictive of re­
infection one year after treatment (Hagan et al, 1991). A positive correlation was 
also reported between resistance and anti-larval IgE (Rihet et al, 1991; Demeure 
et al, 1993) and between specific anti-adult S.mansoni IgE and resistance in 
Kenya (Dunne et al, 1992). In the Kenyan study, other IgE responses were not 
correlated with resistance. For example, ?iX\\\-S.mansoni egg antigen IgE 
antibodies were present at high levels in young children, who were susceptible to 
infection (Dunne et al, 1992). The presence in western blots of IgE antibodies 
that recognise Sm22 (a 22kDa molecule and S.mansoni vaccine candidate), 
correlated with resistance to re-infection (Dunne et al, 1992). IgE that recognised 
both the native molecule and recombinant peptide correlated with resistance to re­
infection (Butterworth, 1994).
IgE levels can explain variation in levels of resistance that remain after age has 
been taken into account using either multiple linear or logistic regression analysis 
(Hagan et al, 1991; Dunne et al, 1992; Demeure et al, 1993). This result would 
suggest that these studies are observing a component of resistance to 
schistosomiasis that is experience rather than age dependent.
IgE could mediate the immunity to schistosomiasis via antibody-dependent cell- 
mediated cytotoxicity (ADCC) (Butterworth, 1994; Capron et al, 1994). Hagan 
and colleagues (1991) suggested that cross-linking of IgE bound to the surface of
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mast cells resulting in the release of chemotactic agents such as leukotriene-B/^, 
platelet-activating factor and cytokines would allow a rapid amplification of a 
cellular effector response. Support for this hypothesis comes from the 
demonstration that inflammatory cells with IgE receptors such as eosinophils, 
macrophages and platelets can kill larval schistosomes in vitro (Capron et al, 
1989).
Butterworth and colleagues (1992) speculated that IgA rather than IgE might 
mediate the marked immunity seen in adults because anti-parasite IgA has been 
observed to increase more during adult life, from 25 years onwards (Butterworth, 
1994), rather than during late childhood as observed in the case of IgE responses 
(Butterworth et al, 1992). A protective role for IgA is supported by studies of 
immune responses to the vaccine candidate, P28 glutathione-S-transferase. Serum 
IgA levels that recognised P28 were higher in serum from children considered to 
be resistant to S.mansoni than in serum from susceptible children (Auriault et al, 
1990; Grzych et al, 1993).
Resistance to re-infection with S.mansoni has been reported to be associated with 
IgG reactivity to the 37 kDa antigen, schistosome gIyceraldehyde-3P- 
dehydrogenase, which is present in both larva and adult worms (Dessein et al, 
1988; Goudot-Crouzel et al, 1989). IgGl and IgG3 purified from serum from 
children have demonstrated the ability to mediate eosinophil killing of 
schistosomula in vitro (Khalife et al, 1986), but in a re-infection study in The 
Gambia, the ability of IgG from children's sera to recognise S.haematobium
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antigens appeared to be unrelated to resistance or susceptibility to infection 
(Hagan a/., 1987).
Antibodies specific to schistosome antigens have been found in the blood of young 
children (Butterworth et al, 1992), so the susceptibility of young children to 
schistosomiasis cannot be due to a low overall immune response, such as might be 
expected of a totally naive population. Instead, a number of studies have observed 
correlations of IgG4 (Auriault et al, 1990; Hagan et al, 1991; Dunne et al, 
1992; Demeure et al, 1993), IgG2 (Butterworth et al, 1988a; Demeure et al,
1993) and IgM (King et al, 1989a; Butterworth et al, 1992) with susceptibility 
to infection or re-infection. These observations have lead to the hypothesis that 
some antibody isotypes share antigenic specificity and compete for epitopes with 
effector antibodies such as IgE and IgA without sharing the ability to mediate 
anti-parasite effector mechanisms (Butterworth et al, 1992).
Butterworth (1994) speculated that the balance between 'blocking' isotypes and 
effector antibodies might be more important in the development and achievement 
of immunity to schistosomiasis than the absolute presence or absence of particular 
antibody isotypes. Blocking antibody activity had previously been demonstrated in 
the rat model of schistosomiasis. Grzych and colleagues (1984) observed in vitro 
and in vivo that rat IgG2c monoclonal antibodies could block the effect of an 
IgG2a monoclonal antibody, with specificity for the same antigen.
Production of non-specific IgE as well as parasite-specific IgE may be up- 
regulated as a result of infection (Hagi et al, 1990a; Hagan, 1993a). Some
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authors have suggested that non-specific IgE could favour parasite survival by 
competing with specific IgE for Fc-receptors on effector cells such as mast cells, 
macrophages, eosinophils (Capron et al., 1984; Pritchard, 1993a), platelets 
(Joseph et al, 1983) and phagocytes (Joseph et al, 1978). However, in an area 
endemic for S.haematobium in Somalia, total IgE levels were high in all age 
groups but patterns of specific IgE were consistent with acquisition of resistance 
to infection (Hagi et al, 1990), suggesting that the effects of the specific antibody 
are dominant over any blocking by non-specific antibody.
Anti-parasite IgM antibodies have been observed to be high in young children 
from endemic areas and decline with age (Butterworth et al, 1992), and 
resistance to infection has been associated with IgM that recognises SmW68, a 
68Kd antigen derived from S.mansoni (King et al, 1989a). IgM purified from 
children's serum could block eosinophil-dependent killing of schistosomula, 
mediated by IgG antibodies from the same sera (Khalife et al, 1986).
Specific IgG4 has been correlated with a high intensity of infection before 
treatment (Dunne et al, 1988; Dunne et al, 1992) or with re-infection after 
treatment (Hagan et al, 1991; Demeure et al, 1993). From a study in an area 
endemic for S.mansoni in Kenya, Auriault and colleagues (1990) reported that 
IgG4 specific to the vaccine candidate, recombinant glutathione-S-transferase 
(P28) was higher in susceptible than in resistant groups. In this study, (Auriault et 
al, 1990) a susceptible individual was defined as having a high intensity of 
infection and low level of exposure, and a resistant individual had a low intensity 
of infection and a high level of exposure. A similar pattern was also observed for
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IgG4 that recognised two out of three synthetic peptides derived from the primary 
sequence ofP28 (amino acids 115-131 and 140-153).
Hagan and colleagues (1991) suggested that the slow development of immunity to 
S.haematobium could be due to a slow maturation of the protective specific IgE 
response and the early production of anti-adult worm and anti-egg IgG4. Similar 
mechanisms have also been suggested in a number of other studies in which IgG4 
could be interpreted as blocking the activity of both anti-larval and anti-adult 
S.mansoni (Rihet et al, 1991; Dessein et al, 1992; Dunne et al, 1992; Demeure 
et al, 1993). Evidence for competition between IgG4 and IgE has been reported 
in studies of allergic patients (Stanworth et al, 1973; Aalberse et al, 1983; 
Hussain et al, 1992; Lambin et al, 1993) and there is some evidence that specific 
IgG4 is competing for the same epitopes as specific IgE that recognise either 
S.mansoni schistosomula or adult worm antigens (Rihet eta l, 1992).
Rihet and colleagues (1992) measured anti-parasite IgE in both unfractionated 
serum and in a sample in which the IgE had been separated from other isotypes by 
immunopurification. They reported that specific IgG4 and IgE from 
immunopurified sera were significant explanatory variables for levels of specific 
IgE measured by ELISA in unfractionated sera. IgG4 correlated negatively and 
immunopurified IgE correlated positively with IgE in unfractionated sera. The 
authors suggested that the specificity spectra of IgE and IgG4 overlap, and further 
speculated on this basis that IgE and IgG4 could be produced by progeny of the 
same B-cell clones, possibly during clonal expansion by switching from IgM to 
either IgE or IgG4 as a result of IL-4 and helper T-cell control (Devey et al.
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1976; Ortolani et al, 1984). Since IgE would presumably interfere with the IgG4 
assay in this experiment, it would have been interesting to see whether using 
immunopurified IgG4 as well as immunopurified IgE would have increased their 
joint ability to predict unpurified IgE levels.
The same group subsequently observed that the opposing effects of IgE and IgG4 
as predictive factors of re-infection were undissociable in the analyses (Demeure 
et al, 1993). The strong correlation between IgE and IgG4 meant that the 
variation in infection re-intensities could not be explained by one or other isotype 
alone, but could when both were taken into account. A resistant person therefore 
had a high IgE titre, and a low IgG4 titre.
Three mechanisms for IgG4 blocking of IgE mediated immunity have been 
suggested (Demeure eta l, 1993). First, IgG4 could block the development either 
of hypersensitivity reactions, locally in the skin in the case of an anti- 
schistosomula response, or in the blood. Second, IgG4 could inhibit mast cell or 
basophil activation, or inhibit IgE-dependent cell cytotoxicity mediated by 
monocytes, eosinophils or platelets. There is some evidence for IgG4 interference 
with IgE-mediated mast cell degranulation (Hagan et al, 1992b), possibly as a 
result of competition with specific IgE (Stanworth et al, 1973; Iskander et al, 
1981; Hussain et al, 1986) and IgG4 blocking of basophil activation in studies of 
schistosomiasis (Hofstetter et al, 1982) and filariasis (Ottesen et al, 1981), 
Third, IgG4 could block IgGl- and IgG3- mediated eosinophil killing of 
schistosomula as demonstrated by Khalife and colleagues (1986), although, since
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there is very little evidence to support a role for IgGl or IgG3 in vivo, this 
mechanism could well be an in vitro phenomenon only.
1.3.2 Mechanisms of immune killing.
A range of human immune responses have been found capable of killing 
schistosomula in vitro (Butterworth et al, 1992). Antibodies and complement 
were found to effect some damage on schistosomula (Clegg et al, 1972). 
Cytotoxic lymphocytes were generally considered to be inactive (Butterworth et 
al, 1979) although there were some reports of lymphocyte-mediated killing 
(Ellner et al, 1982). Effective killing of schistosomula was mediated by ADCC 
reactions by macrophages and platelets in the presence of IgE (Capron et al, 
1975), and neutrophils (McKean et al, 1981). The most important effector cells, 
however, were considered to be eosinophils: highly active in killing schistosomula 
in the presence of antisera (Butterworth et al, 1975; Butterworth et al, 1977; 
Vadas et al, 1979) and IgE (Capron et al, 1984). An ability to kill schistosomula 
in vitro does not necessarily signify an active role in vivo but, there is considerable 
correlative evidence from immuno-epidemiological studies that eosinophils do 
have an in vivo role.
Numbers of circulating eosinophils in blood measured before treatment from 
people resident in areas endemic for S.mansoni (Sturrock et al, 1983) and 
S.haematobium (Hagan et al, 1985a; Hagan et al, 1987a; Hagan, 1992a) 
correlated with expressions of immunity in re-infection studies. There is also 
evidence that antibody-dependent killing of schistosomula by human eosinophils 
was more effective when the eosinophils were recovered from people with
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eosinophilia induced by a helminth infection, or other condition. (David et al, 
1980). These cells were considered to be in an activated state (Butterworth et al, 
1988b). Despite the association between pre-treatment eosinophilia and lack of re­
infection (Sturrock et al, 1983a; Hagan et al, 1985; Hagan et al, 1987; Hagan, 
1992a), there is less evidence to support an ADCC mechanism of eosinophil 
action in vivo. Hagan and colleagues (1985) attempted to correlate ADCC killing 
o f S.haematohium schistosomula in vitro with immunity to re-infection. They 
reported that when using eosinophils from children, levels of killing were 'barely 
detectable' and did not differ between re-infected and non-re-infected groups.
1.3.3 Cytokine responses to schistosome infection.
The work reported in this thesis is primarily concerned with the role of cytokines 
in immune responses to human schistosomiasis. Cytokines, as defined by Vilcek 
and colleagues (1994) are,
"regulatory proteins that are secreted by white blood cells and a 
variety of other cells in the body, the pleiotropic actions of cytokines 
include numerous effects on the cells of the immune system and 
modulation of inflammatory responses."
Cytokine production may be transient and often, as implied in their role in 
inflammation, within a short action radius. The actions of cytokines can usually be 
attributed to an alteration of the pattern of gene expression in target cells. These 
alterations could result in a change in the rate o f cell proliferation, alteration in cell 
differentiation state, or in a change in their function (Vilcek et al, 1994). For 
example, a B-cell may be induced to change the antibody isotype it expresses.
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The nature of the immune response to an antigen is therefore dependent to a large 
extent on the modulating influence of cytokines (Del Prete et al, 1994). It is the 
opinion of these authors, that it is largely the preferential activation of one sub- 
population of CD4+ helper T-cells over another that determines the profile of 
cytokines released on stimulation with antigen and therefore the nature of the 
ensuing immune response. Two subpopulations of helper T-cells, type 1 (Thl) and 
type 2 (Th2) were identified from studies of murine CD4+ T cell clones 
(Mosmann et al, 1986; Mosmann et al, 1989b). The two subpopulations 
produced a different range of cytokines (Mosmann et al, 1986; Mosmann, 1987). 
Cytokines produced by Thl-type clones include IL-2, ÏL-12, TNpp and IFNy and 
those produced by Th2 clones include IL-4, IL-5, IL-6, IL-9, XL-10 and IL-13. 
Both Thl and Th2 cells produce IL-3, TNFa and GM-CSF (Vilcek et al, 1994; 
Locksley, 1997). A further T cell type ThO, considered to be a precursor of Thl 
and Th2 types is capable of producing both Thl and Th2-type cytokines (Del 
Prete era/., 1994).
There is some evidence that T-helper cells occur as two subpopulations in humans 
as well as in mice. Cytokine profiles of a series of antigen- specific T-cell clones 
taken from the peripheral blood of healthy people showed that stimulation of 
blood with different antigens resulted in T-cell clones of either one type or another 
(Del Prete et al, 1994). For example, T-cell clones specific for the purified 
protein derivative (PPD) of Mycobacterium tuberculosis secreted IL-2 and IFNy 
but not IL-4 or IL-5 and were therefore considered to be equivalent to murine 
Thl cells. Conversely, Toxocara ca/i/^-specific clones secreted IL-4 and IL-5, but
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not IL-2 and IFNy and therefore resembled murine Th2 cells. (Del Prete et al,
1991).
It is likely, however, that the Thl/Th2 model of cytokine production is an over­
simplification of the in vivo situation since it is now clear that many cells other 
than T-helper cells produce a wide spectrum of cytokines in abundant quantity 
(Gordon et al, 1990). For example the cell types capable of expressing GM-CSF 
include helper T-cells, B lymphocytes, macrophages, mésothélial cells, 
kératinocytes, osteoblasts, uterine epithelial cells, synoviocytes, mast cells, 
fibroblasts, stromal cells, endothelial cells and various solid tumours (Rasko et al, 
1994). In vivo, it would seem likely that cytokines are produced by a number of 
cell types. However, the Thl/Th2 model has persisted as a conceptual framework, 
even in situations where the cellular source of the cytokines has not been 
determined, because the two ranges of cytokines tend to be detected together and 
have different and often antagonistic modulatory effects on the immune system 
(Cox et al, 1992).
In mice, the Thl/Th2 dichotomy has become more than simply a useful conceptual 
framework. Studies have shown that it is possible to manipulate the immune 
response of a host and therefore its ability to expel gut helminth infections by 
application of cytokine or cytokine neutralising antibody (Urban et al, 1991; 
Urban et al, 1993; Else et al, 1994; Locksley, 1997), possibly as a result of 
influencing the development of ThO cells (Locksley, 1997). Such findings suggest 
the possibility of cytokine-profile influencing therapies or vaccines.
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Generally, in mice, intracellular pathogens, such as Leishmania major (Cox et al,
1992), viruses, bacteria, and yeast (Locksley, 1997) are controlled or killed by a 
Thl type immune response. Cytokines produced by Thl cells stimulate 
macrophage activation, immunoglobulin selection for XgG2a and IgG3, both 
isotypes that mediate ADCC and complement activation. A Th2 type response has 
been shown to be deleterious to these intracellular pathogens, since IL-4, IL-10 
and IL-13 can down-regulate macrophage activation, even when IFNy is present 
(Sher et al, 1992).
Cytokines produced by Th2 cells, favour production and activation of mast cells 
and eosinophils, stimulate B-cell growth and differentiation, and induce isotype 
switching to IgE and IgGl. These are features associated with infection with 
helminths (Finkelman et al, 1992; Locksley, 1997), so it might be expected that 
the human immune response to schistosome infection would be of a Th2-type. 
However, since the Thl/Th2 model of immunity is likely to be an 
oversimplification, it might be useful to consider what cytokines are likely to be 
involved in the regulation of those components of an immune response, currently 
considered to be important in schistosomiasis in humans: IgE, IgA, IgM, IgG2, 
IgG4 and eosinophilia.
IgE production (Finkelman et al, 1990) and up-regulation of IgE receptor 
expression (Defiance et al, 1987b) are induced primarily by IL-4, although IL-13 
(Cocks et al, 1993;) and IL-5 (Coffman et al, 1987) are also involved in the 
promotion of the IgE response. These responses are inhibited by IFNy (Snapper et 
al, 1987) and to a lesser extent IFNa (Mond et al, 1986; Rabin et al, 1986). IgE
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secretion from murine (Vilcek et al, 1994) and human (Snapper et al, 1987) cells 
is enhanced by IL-4 in vitro and IL-4 neutralising antibody or antibody that binds 
to the IL-4 receptor can inhibit polyclonal and antigen-specific primary and 
secondary IgE responses (King et al, 1990). IL-4 dependent isotype switching to 
IgE may depend on the type of antigen that activated the B-cells. For example, IL- 
4 can induce IgE in an enriched B-cell population that contains T-cells, but when 
purified B-cells are pre-activated with Staphylococcus aureus IL-4 induces IgM 
production and switching to IgG instead of IgE (Yokota et al, 1988). Since IgM 
may block an effective response to schistosomiasis, this may be an important 
subtlety to consider. IL-13 can induce IgE synthesis independently of IL-4 (Cocks 
et al, 1993), although IL-4 and IL-13 may share the same signalling pathways 
(Punnonen et al, 1993). IL-5 can synergise with IL-4 to promote IgE production 
(Coffman et al, 1987), although EL-5 alone does not appear to be involved in the 
production of IgE antibodies (Sanderson, 1994).
IL-4 dependent IgE synthesis is inhibited by IFNy (Snapper et al, 1987). This 
attribute of IFNy has been observed in vivo: preliminary clinical trials using hyper- 
IgE patients have indicated that IFNa or IFNy can result in decreased levels of 
circulating IgE (King et al, 1989b; Souillet et al, 1989). IgE bound to the low 
affinity receptor for IgE, CD23, on B-cells, can present antigen to T-cells. Since 
CD23 expression is enhanced by IL-4 (Defrance et al, 1987b) and IL-13 
(McKenzie et al, 1993; Punnonen et al, 1993) antigen presentation is also 
enhanced. IFNa and IFNy can block the IL-4 enhancement of CD23, (Mond et 
al, 1986; Rabin et al, 1986) thus limiting antigen presentation through this 
mechanism.
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IgA levels can be increased by TGF(3, IL-2, IL-5, IL-10 (Mosmann, 1994) and EL- 
6 (Beagley et ai, 1989). TGFp can selectively augment IgA synthesis (Lehman et 
al, 1990), presumably by inducing isotype switching since it generally inhibits 
secretion of all immunoglobulins, including IgA by cells that have already 
switched (Mosmann, 1994). IL-2 and IL-5 can enhance TGFp induced IgA 
production by LPS stimulated B-cells (Sonoda et al, 1989; Lehman et al, 1990) 
and IL-10 synergises with TGFp in inducing IgA secretion by anti-CD40 activated 
B-cells (Defrance et al, 1992). Although IL-5 has been considered to be of 
primary importance in enhancing IgA levels (Sanderson, 1994), some studies have 
suggested that IL-6 (Beagley et al, 1989) and IL-2 (Sonoda et al, 1989) may be 
of greater importance than IL-5.
Production of the putative blocking antibodies, IgM, IgG2 and IgG4, may be 
determined by a number of cytokines. IL-2 (Matsui et al, 1989) and IL-5 
(Takatsu et al, 1988; Matsui et al, 1989) can together, but not separately, up- 
regulate IgM secretion (Matsui et al, 1989). IL-5 can however, in the absence of 
EL-2, enhance numbers of murine IgM-producing B-cells (O'Garra et al, 1989). 
EL-4 and IL-10 can independently induce activated B-cells to produce larger 
amounts of IgM (Rousset et al, 1992). IgG4 synthesis can be induced by either 
IL-4 or IL-13 (Rothman et al, 1988; Zurawski et al, 1994). The cytokines that 
modulate IgG2 are less clearly defined, because most studies have concentrated 
on murine IgG subclasses and these may not be entirely equivalent to human 
IgG2. However, murine IgG2b is down modulated by IL-4 and IFNy and 
upmodulated by TGFp (Vilcek et al, 1994).
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Eosinophilia is a T-cell-dependent phenomenon (Sanderson et al, 1985) 
controlled primarily by IL-5 (Sanderson, 1992; Sanderson, 1993). Eosinophil 
levels tend to be independent of the levels of other leukocytes and, in the murine 
model, IL-5 can induce eosinophil production in bone marrow suspension cultures 
without inducing the production of other cell types (Sanderson et al, 1985; 
Sanderson et al, 1988; Sanderson, 1990). IL-3 and GM-CSF, although they can 
produce eosinophils independently of IL-5 (Clutterbuck et al, 1989), also 
stimulate production of other cell types (Campbell et al, 1988). The details o f the 
interactions between IL-3, GM-CSF and IL-5 are not clear from in vitro 
experiments because they appear to depend to a large extent on the precise 
mixture of cells and the culture conditions into which the cytokines were added 
(Sanderson, 1994). In vivo experiments however, provide clear evidence of the 
pivotal role of IL-5. A transient eosinophilia has been observed in mice treated 
with IL-5 (Sanderson, 1994) and mice infected with Trichinella spiralis 
developed eosinophilia, which dropped to levels below that of control animals on 
administration of anti-IL-5 antibody (Coffman et al, 1989).
In summary (table 1), by extrapolation from the humoral responses and effector 
cells considered to be important in the immune response to schistosomiasis, it 
would seem reasonable to predict that IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-13, 
IFNa, IFNy, TGFp and GM-CSF might have some role in modulating the immune 
response during infection. EL-2 can enhance IgA production (Mosmann, 1994) 
and in the presence of IL-5, can up-regulate IgM production (Matsui et al, 1989). 
IL-3 has a role in increasing eosinophil production (Clutterbuck et al, 1989). IL-4 
and IL-13 can both increase levels of IgE (Defrance et al, 1987a; Finkelman et
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al, 1990) and induce IgG4 synthesis (Rothman et al, 1988; Zurawski et al, 
1994). IL-4 can also induce activated B-cells to produce larger amounts of IgM 
(Rousset et al, 1992) and down regulate murine IgG2b production (Vilcek et al, 
1994). IL-5 synergises with IL-4 to promote IgE production (Sanderson, 1994), 
although on its own, it does not appear to be capable of influencing IgE 
production (Sanderson, 1994). IL-5 can enhance IgA secretion (Lehman et al, 
1990; Sanderson, 1994), although it is not clear if it is the dominant cytokine 
controlling the IgA response (Sonoda et al, 1989). IL-5 is considered to be the 
cytokine primarily responsible for the up-regulation of eosinophil production 
(Sanderson, 1992; Sanderson, 1993). It is interesting that both IgA and 
eosinophilia are influenced by the same cytokine, because IgA can induce 
eosinophils to degranulate and eosinophils are frequently found at mucosal 
surfaces where IgA is the most abundant immunoglobulin (Sanderson, 1994). 
Another function of IL-5 is the up-regulation of IgM production, which requires 
the presence of IL-2 (Matsui et al, 1989), although it can independently enhance 
the numbers of murine IgM producing cells (O'Garra et al, 1989). IL-6 can 
enhance IgA production, and may play a more important role than IL-5 in this 
respect (Beagley et al, 1989). IL-10 can also enhance IgA production (Mosmann,
1994), in the presence of TGFP (Defrance et al, 1992) and can induce activated 
B-cells to produce larger amounts of IgM (Rousset et al, 1992). IFNy inhibits 
IgE synthesis (Snapper et al, 1987) and can induce reduced levels of circulating 
IgE in hyper-IgE patients (King et al, 1989b) it can also down regulate 
production of IgG2b (Vilcek et al, 1994). IFNy is a potent inhibitor of IL-4, in 
that it can block the response of resting B-cells to IL-4 (Noelle et al, 1984; Rabin 
et al, 1986). IFNa can also down regulate IgE production (Souillet et al, 1989).
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TGFp is probably responsible for promoting B-cells to switch isotypes and 
produce IgA (Lehman et al, 1990; Mosmann, 1994) and can up regulate 
production of IgG2b (Vilcek et al, 1994). GM-CSF can up-regulate eosinophil 
production (Clutterbuck c/a/., 1989).
Tablel.l: A summary of cytokine modulation of IgA, IgE, IgG2, IgG4, IgM 
and eosinophil production.
IgA IgE IgG2 IgG4 IgM Eosinophils
IL-2 ♦
IL-3
IL-4 4/ T
IL-5 ❖ O
IL-6
IL-10 © t
IL-13
IFNa 4/ sL
IFNy 4/
TGFp
GM-CSF
can act alone to increase level of antibody 
4/ can act alone to decrease levels of antibody 
♦  acts only in the presence of IL-5, ❖ synergises with IL-4,
O acts only in the presence of IL-2, © acts only in the presence of TGFp
It is very difficult to predict from an extrapolation of the results of studies on 
humoral responses and effector cells whether a Thl-type or a Th2-type cytokine
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response would be protective against a schistosome infection. The classic Th2- 
type cytokines; IL-4, IL-5, IL-10 and IL-13 all have a role in up-regulating the 
production of both protective and putative blocking antibodies. IFNy, a Thl-type 
cytokine can reduce the response of B-cells to IL-4 and may down-regulate IgG4 
production, a blocking antibody, at the same time as reducing levels of protective 
IgE and IL-2, can enhance production of both IgA (a protective isotype) and IgM 
(a blocking isotype).
Butterworth (1994) speculated that it might be the balance between different 
antibody isotypes rather than the presence or absence of any particular isotype 
that differentiates between a protective and a non-protective immune response. 
The same may be true of cytokine responses, with the additional complication that 
combinations of cytokines can have very different effects from cytokines on their 
own.
To illustrate this point further, consider a hypothetical population of B-cells and 
T-helper cells stimulated with schistosome antigen, in micro-environments that 
included either IL-2 or IL-5. Evidence from in vitro experiments discussed above, 
suggests that B-cells with the capacity to produce IgA would probably be up- 
regulated. According to Butterworth and colleagues (Auriault et al, 1990; 
Butterworth et al, 1992; Grzych et al, 1993; Butterworth, 1994) this could be 
considered a protective response. Thus, the same protective response could have 
been triggered by either a Thl-type cytokine or a Th2-type cytokine. However, 
some B-cells may be influenced by both IL-2 and IL-5 at the same time. This 
combination of cytokines could up-regulate the production of IgM an antibody
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with blocking potential. Whilst it seems reasonable that the immune response 
would have negative feedback mechanisms, this indicates that whilst the Thl/Th2 
model can be useful in some instances, particularly in mice, it is likely to be an 
over-simplification of the in vivo immune response in humans and it may thus also 
be more appropriate to consider the net effect of a given cytokine or mixture of 
cytokines, rather than attempting to classify a response as either Thl or Th2 type 
per se.
In the murine model, Sher and colleagues (1991) observed that Th2-type 
responses were associated with egg production and pathology. Vaccination with 
IL-12, which up-regulated the Thl response, was shown to inhibit pathology in 
mice infected with S.mansoni (Sher et ai, 1991). Conversely, a Thl-type profile, 
as characterised by IFNy production and macrophage activation was linked to 
host protective responses. Smythies and colleagues (1993) noted a Thl mediated 
protective response in mice. Multiple vaccination with attenuated cercariae, have 
resulted in a protective Th2-type immune response, with the added benefit that a 
protective humoral response was also stimulated using this method (Wynn et al, 
1996). Further protection was achieved by using a multiple vaccination protocol 
using IL-12 as the adjuvant, in which a Thl-type protection with both cellular and 
humoral components was achieved. It would appear therefore that either a strong 
Thl or a Th2 response can protect against challenge infections in mice (Wynn et 
al, 1996). In other helminth infections in mice, Thl responses are not the only 
means of protection. Th2-type responses can also play a role in resistance in for 
example, Heligomosomides polygyrus (Urban et al, 1991), Nippostrongylus
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braziliensis, Trichuris muris and Strongyloides venezuelensis infection 
(Finkelman et al, 1992).
The cellular immune responses to schistosomiasis in humans have been studied 
directly in a number of different ways. Some research groups have concentrated 
on determining the dominant phenotype of parasite-specific T-cell clones 
(Hirayama et al, 1994; Couissinier-Paris et al, 1995), whereas others have 
attempted to correlate cellular parameters, such as cytokine production or cell 
proliferation in vitro on stimulation with parasite antigen with either, infection 
(Araujo et al, 1994), re-infection (Roberts et al, 1993) or pathology (Williams et 
al, 1994). Another approach has attempted to measure schistosome-modulated 
cellular responses by comparing cellular parameters before and after treatment 
(Abdel-Salam e/a/., 1981; Grogan c/a/., 1996).
Couissiner-Paris and Dessein (1995) measured IL-2, IL-4 and IFNy produced by 
T-cell clones from three adult Brazilian men considered to be resistant to infection 
with S.mansoni and one adult European man, considered susceptible to infection. 
T-cell clones from the susceptible individual produced more IFNy and less IL-4 
than T-cell clones from the resistant individuals, although all of the clones 
produced some IL-2, IL-4 and IFNy. The authors concluded that a ThO/2 
phenotype characterised resistance whereas a ThO/1 phenotype characterised 
susceptibility. All of the T-cell clones produced IL-4 and IFNy and therefore 
technically had a ThO phenotype, however, this should not detract from the main 
conclusion that cells from resistant individuals presented a more Th2-biased 
cytokine profile then the susceptible individual.
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From one individual, Hirayama et al (1994) produced four CD4+ T-cell clones, 
specific to S.mansoni antigen. Each of the four clones produced a different range 
of cytokines. One was considered to have a ThO phenotype, because it produced 
all o f the cytokines measured: IL-2, IL-4, IL-5, IFNy, GM-CSF and TNFa. The 
second clone was considered to have a Thl phenotype because it produced GM- 
CSF, IFNy and TNFa. It also produced very small amounts of IL-5, but no EL-2 
or IL-4. The third clone was characterised as a Th-2 cell type because it produced 
high levels of IL-4, IL-5 and GM-CSF but low levels of IFNy and TNFa. The 
authors classified their fourth clone as 'Th3', because it produced IL-2, EL-5, GM- 
CSF, IFNy and TNFa but no detectable IL-4. Cytokine levels were measured by 
sandwich ELISA and the presence of cytokine mRNA was verified using a reverse 
transcriptase polymerase chain reaction (RT-PCR).
T-cell cloning experiments have an advantage over in vitro stimulation of 
heterogeneous cell populations, in that it is possible to classify individual cell- 
types. It could be argued, however, that the phenotype of individual cells is less 
important than the overall balance of cytokines produced by all cell types since the 
function of a cytokine is not dependent on the type of cell that produced it. It is 
possible to interpret the results from Couissiner-Paris and Dessein (1995), in 
terms of a Thl/Th2 dichotomy. However since Hirayama and colleagues (1994) 
could not identify a dominant T-cell phenotype, and one of their clones did not 
conform to Thl, Th2 or ThO phenotypes, this study could be considered further 
evidence that the Thl/Th2 model (which can be considered to include the ThO 
phenotype) has limited utility in explaining human immunity to schistosomiasis.
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In a study in an S.mansoni endemic area in Kenya, Roberts and colleagues (1993), 
measured cell proliferation, IL-2, IL-4, IL-5 and IFNy production by PBMC on 
stimulation with S.mansoni antigen and mitogen and compared the results with 
resistance to re-infection. IL-5 and cell proliferation were significant determinant 
factors for post-treatment re-infection intensities. After controlling for age, sex 
and exposure to infection in a multiple linear regression model, proliferation of 
PBMC taken from 14-35 year old residents of the endemic area, was negatively 
correlated with re-infection intensity (this was not reported to be log 
transformed). This relationship was statistically significant when PBMC were 
stimulated with either adult or schistosomulum antigen. They also reported that on 
stimulation with adult and schistosomulum antigens, cell proliferations were 
higher 3 months after treatment than before treatment, and had dropped to pre­
treatment levels again one year post treatment. IL-5 was measured in the culture 
supernatants of PBMC taken three months post-treatment and stimulated with egg 
antigen. In this one instance, IL-5 correlated positively with age (p<0.02), and 
associated with low intensity of infection (p<0.05). However, analysis of a repeat 
assay set, did not confirm the latter association, and a multiple linear regression 
analysis did not dissociate the effects of age, infection and IL-5.
In order to elucidate the interactions between cytokines, Roberts and colleagues 
(1993) correlated different cytokines measured in culture supernatants. They 
reported negative correlation co-efficients between levels of IFNy (a Thl-type 
cytokine) and IL-5 (a Th2-type cytokine) detected in both 2- and 4- day culture 
supernatants from cells stimulated with adult worm antigens, schistosomula and 
egg antigens. These correlations were observed pre-treatment, three months after
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treatment and one year after treatment. These observations imply a cross- 
regulatory relationship between Thl and Th2 helper T-cell subsets. Although only 
the data for the three months post-treatment were presented, from this data it is 
possible to see that any combination of cytokine and time at which culture 
supernatants were harvested were correlated. For example, any combination of 
IFNy and IL-5 measured in culture supernatants harvested at either two or four 
days post incubation was considered acceptable for analysis. In this study, peak 
levels of both cytokines occurred at four days post incubation. There were 
therefore four opportunities at each bleed and for each antigenic stimulation for 
IFNy to negatively correlate with IL-5, however there is no record of correction 
for multiple tests. Since significant results are reported at 95% confidence limits, 
one would expect one in twenty correlations to be significant by simple chance 
and thus the possibility of Type I errors cannot be entirely ruled out.
Williams and colleagues (1994), compared cellular responses of Brazilian patients 
presenting with different manifestations of disease caused by S.mansoni, They 
concluded that patients with iS'.wawsom-related pathology produce more Th2-type 
cytokines on stimulation with poke weed mitogen and ionomycin or egg antigens, 
but produce more IL-5 and IFNy on stimulation with worm antigens and therefore 
have a ThO-like profile.
Their rational for these conclusions was as follows. In vitro stimulation of PBMC 
with mitogen indicated that the Th2 cell population was expanded as a result of 
schistosome infection. PBMC from acutely infected (p<0.001), and hepatosplenic 
patients (p<0.005), produced significantly more IL-4 than uninfected controls.
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More IL-5 was produced by PBMC from ‘acute’ patients (p<0.01) and those with 
intestinal disease (p<0.001) than by PBMC from the control group. These results 
were linked to an expansion of numbers of IL-4 producing cells. The percentage 
of IL-4 producing cells was higher in acutely infected patients (p<0.05) and 
hepatosplenic patients (p<0.005) than in uninfected controls, although the 
absolute difference in percentage was small (»1.5%). These authors reported that 
while both egg and adult worm antigens could induce Th2-type responses, egg 
antigen failed to trigger Thl cytokine production, except during the acute stages 
of infection. It is difficult to interpret the results of stimulation with antigen, 
because the authors were unable to detect any cytokine in culture supernatants. 
The results rely entirely on cytokine mRNA measured RT-PCR. Although, in 
most cases, mRNA does correlate with secreted protein, RT-PCR is semi- 
quantitative at best and cannot distinguish between cells that are producing 
cytokine and those that are synthesising cytokine without secreting it (Mosmann 
et al, 1989a). Given this qualification, PBMC from acute patients produced more 
mRNA encoding for IL-5 (p<0.01) and IFNy (p<0.02) on stimulation with adult 
worm antigen, and more mRNA encoding for IL-2 (p<0.05) on stimulation with 
egg antigen. PBMC from hepatosplenic patients produced more mRNA encoding 
for IL-4 (p<0.02) on stimulation with egg antigen and IFNy (p<0.02) on 
stimulation with adult worm antigen. Only background levels of cytokine mRNA 
was produced by patients with intestinal schistosomiasis.
Although this study produced some interesting results, an analysis of their 
conclusions should be qualified by some consideration of the methodology. The 
authors reported that their control group of uninfected volunteers were from
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endemic areas and from North America. This could mean two things: either that 
the control group was a mixture of people who had been exposed but remained 
uninfected (i.e. uninfected volunteers from an endemic area), and people who 
were uninfected and had never been exposed i.e. uninfected volunteers from North 
America; or the control group was comprised entirely of individuals who had 
never been exposed to schistosomiasis.
Assuming the control group consists entirely of people with no history of infection 
or exposure, the paper states that PBMC from these people have lower Th2 type 
responses, on stimulation with mitogen, than people with a current infection or 
schistosomiasis related pathology. One interpretation of this finding could be that 
adults with experience of disease have a higher Th2 response than adults with no 
experience of disease. This interpretation suggests that a Th2 response is related 
to experience rather than necessarily to pathology. Indeed, Williams and 
colleagues (1994) report that acutely infected patients produced more IL-4 on 
stimulation with a mitogen than patients with intestinal disease. This implies that 
as the disease progresses, from acute to chronic, the Th2 response, as 
characterised by IL-4 produced on stimulation with mitogen, is reduced. This 
result is only significant to within 95% confidence limits and given the limited 
method of statistical analysis used, there may be an unacceptable risk that this 
observation could have occurred by chance.
Although patients and controls were classified into four groups, the authors did 
not use a test suitable for multiple groups such as parametric, or Kruskal-Wallis 
ANOVA (Siegel et al, 1988a) and made no attempt to correct for the probability
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that an apparently significant result had occurred by chance due to the number of 
tests carried out (Rice, 1989). The difference in absolute terms ranged from 0 to 
1.5% and is reliant on 2 out of 5 patients. In such a case, a more stringent analysis 
might require a value of p<0.01 before the results are considered to be statistically 
significant.
Grogan and colleagues (1996), investigated the changes in cellular immune 
parameters that occurred with treatment for S.haematohium. Proliferation of 
PBMC stimulated with adult worm antigen and IL-4 produced on stimulation with 
both adult worm and egg antigen were significantly greater five weeks post 
treatment compared to pre-treatment levels (p<0.001 in each case). Cultures of 
PBMC were depleted of either CD4+ or CD8+ T-cells. IL-4 production was 
reduced to below the cut off level of the IL-4 assay in CD4+ depleted cells, but 
was not affected by removal of CD8+ cells. Levels of IL-4 increased after 
treatment, but levels of IL-5 did not (Grogan et al, 1996). The authors 
interpreted this as implying that distinct cells produced these cytokines. There is 
some evidence from other studies to support this conclusion (Jung et al, 1995; 
Sewell e/a/., 1996).
Grogan and colleagues (1996) interpret their results as implying that chronic 
infection with S.haematohium was associated with a reversible down-regulation of 
T-cell proliferative responses and IL-4 release, and that CD4+ T-cells were the 
target of this down-modulation. They also discuss the possibility that antigen 
released by treatment, could have up-regulated the IL-4 and proliferative 
responses. They reject this second possibility because egg antigen-specific
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responses were up-regulated, despite the eggs remaining intact after treatment. 
Although this could be due to worm antigen cross-reacting with egg antigen, T- 
cell responses to egg antigen, unlike adult worm antigen, were non-proliferative. 
As fiirther evidence for rejecting the possibility that the release of adult worm 
antigen on treatment could up-regulate cellular responses, the authors note that T- 
cell proliferative responses to schistosomal antigen can be sustained for up to one 
year post treatment (Barsoum et al., 1982). However, if people are effectively 
vaccinated by treatment, could the effect equally last for up to one year post 
treatment?
Barsoum and colleagues (1982), also report that people who had been treated a 
year and a half prior to the start of the study, did not show as much of an elevated 
response one month after re-infection, compared to patients who were treated for 
the first time. Therefore, whilst down-regulation of responsiveness as suggested 
by Grogan and colleagues (1996) is possible, their justification for rejecting 
possible up-regulation of responses by drug treatment is deficient. I consider it 
reasonable to propose that antigen release might contribute, at least in part, to the 
effect of treatment on cellular immune responses.
Grogan and colleagues (1996) also conclude that a deficiency in IFNy and IL-2 
release was not restored by chemotherapy, because no detectable IL-2 production 
was observed pre-treatment, and IFNy production to parasite antigens was only 
detectable in 21% of people and these levels did not rise after treatment. 
However, an alternative interpretation might imply that the lack of significant 
difference between IL-2 and IFNy before and after treatment is not evidence for
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Thl cell deficiency, but simply that production of these cytokines is not the 
dominant effect of stimulation with schistosome antigen.
In summary, cell proliferation on stimulation with either adult or schistosomulum 
antigen was negatively correlated with re-infection intensity (Roberts et al, 1993) 
and the Th2 cell population, as characterised by IL-4 and IL-5 production on 
stimulation with mitogen expanded as a result of schistosomiasis infection 
(Williams et al, 1994). Proliferation of PBMC stimulated with adult worm 
antigen and IL-4 produced on stimulation with both adult worm and egg antigen 
increased after treatment either as a result o f release from down-modulation by 
adult worms, (Grogan et al, 1996) or as a result of release of antigen at 
treatment. Cellular immunity to schistosomiasis is therefore not as clearly 
understood as the humoral response. The primary aim of this thesis is to attempt 
to elucidate further the role of cytokines in the immune response to 
schistosomiasis, by associating cytokines produced on in vitro stimulation with 
mitogen and S.haematohium antigens with prevalence of infection (chapter 3) and 
re-infection (chapter 4).
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Figure 1.1
A Schematic representation of the life cycle of S.haematohium^ S.mansoni 
and S.japonicum.
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Development of assays for the analysis of cytokine production 
in human peripheral blood.
Chapter 2: Assay Development
2.1 Introduction.
A variety of methods are available for the measurement of cytokines. The choice of 
a protocol for the investigation of cytokine responses in humans must depend to 
some extent on the hypothesis being tested and on the sample type and quantity. 
Resources and time available in the field are also determining factors.
Cytokine production can be measured in a variety of complex milieu including saliva 
and blood; in supernatants from heterogeneous populations of cells cultured in vitro, 
for example peripheral blood mononuclear cells (PBMC), spleen cells or triturated 
tissue; or in homogeneous cell cultures such as T-cell clones. For practical purposes 
however, in situations where there is a systemic circulation of cytokine producing 
cells, peripheral blood is the preferred source of cells.
Until relatively recently, it was assumed that CD4+ T-cells were the dominant 
cytokine producers (Mosmann, 1987). It is now evident that many populations of 
lymphocytes such as CD8+ T-cells, lymphokine activated killer cells and B- 
lymphocytes, together with other cell types such as mast cells and eosinophils not 
only produce cytokines but do so in quantity (Gordon et al, 1990). It can be argued 
that a clearer insight into in vivo cytokine activity may be obtained by assessing the 
overall cytokine production by heterogeneous cell populations rather than 
homogeneous sub-populations.
In many population-based studies of helminth infections the aim is to investigate the 
immune responses to infection. The immune response is studied in relation to
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resistance to infection rather than to aspects of pathology that may occur at tissue 
sites from which routine sampling for cells would be impossible. Studies of 
pathology can be problematic since cytokines are generally locally acting and have a 
short half-life. Circulating cytokines are usually only detectable in cases of severe 
pathology such as cerebral malaria. The typical action of cytokines is autocrine or 
paracrine rather than endocrine. Bearing these restrictions in mind, the present study 
was designed to allow an assessment of cytokine production in relation to infection, 
rather than pathology. In this context, PBMC or whole peripheral blood was used, 
not only because it is the only practicable source of cells, but because the argument 
that it will yield information about whether an individual is infected or not is 
reasonable, whereas the argument that peripheral blood truly reflects local tissue 
pathology is not. Cellular immune responses that can be detected systemically, as 
reflected by cytokine production by peripheral blood, may be an important factor in 
assessing and designing any vaccine candidates, which will probably also act at a 
systemic rather than local level.
The argument for studying cytokines produced by cells in the peripheral blood is 
further strengthened by a consideration of schistosome biology. Adult worms live in 
the blood, so immune cells in contact with adult worm antigens are likely to move 
freely in the systemic circulation. Likewise, eggs, the principle direct cause of 
pathology, are shed into the bloodstream before lodging in a variety of tissue 
locations, allowing systematically circulating immune cells considerable exposure to 
egg antigens.
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2.2 Detection of cytokines.
Both bioassays and immunoassays can be used for detecting and measuring 
cytokines in complex milieu. The results from either assay type should be qualified 
by a consideration of the method employed. The accuracy of the assays may be 
influenced by a variety of factors including the in vivo or in vitro absorption and 
utilisation of cytokines that are produced.
Neither bioassays nor immunoassays give any indication of the frequency of cytokine 
producing cells nor of the anatomical site of their production in vivo. Investigating 
newly synthesised cytokines at a clonal level or studying individual secreting cells 
could give some insight into these aspects. A number of techniques are available to 
measure cytokine production in single cells. These include the haemolytic plaque 
assay, the cell blot assay and ELIspot (a modification of the enzyme linked immuno- 
sorbant assay (ELISA)). Visualisation of intracellular cytokine markers by flow 
cytometry can also demonstrate the phenotype of cytokine secretion by cells (Lewis, 
1991). These questions were not considered in this study.
Bioassays detect functionally active cytokine. However, they are time consuming 
and rely on the availability of permissive cell lines. They are not necessarily specific 
in that they do not exclusively measure the activity of a single cytokine. Given the 
complexity of the concurrent messages a target cell line may receive, care must be 
taken to ensure that adequate controls are included.
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Ascertaining the concentration of cytokine in a sample using a bioassay can be more 
time consuming than using an ELISA. It is necessary to culture cell lines in the 
presence of sample and neutralising cytokine antibody as well as the sample alone at 
a variety of concentrations. Target cell lines need to be maintained and for assays 
based on cell proliferation therefore appropriate facilities for thymidine use are 
required. Thus several factors make bioassays unsuitable as a field method or for 
screening large numbers of samples.
Immunoassays, whether radio-, fluoro- or enzyme-linked are usually specific to 
individual cytokines. Such assays can be readily performed on large numbers of 
samples; a considerable bonus for population based studies. However, they do not 
necessarily detect biologically functional cytokine since the monoclonal antibodies 
on which they are based may bind fragments of inactive cytokine. It is useful to 
screen large numbers of samples using ELISA and consider results from both ELISA 
and bioassay for a smaller subset of samples. Although sensitive, ELISAs are not as 
sensitive as RT-PCR which detects cytokine mRNA even when relatively few cells 
in the sample are producing the cytokine being studied.
RT-PCR tends to be more sensitive than either bioassay or ELISA because the 
mRNA signal is amplified many times before the detection stage. For example, RT- 
PCR can be used to detect cytokine mRNA in a single cell whereas a minimum of 
1x 10^ cells ml“l are required for short term culture to produce cytokine at 
concentrations measurable by ELISA (Brenner et at., 1991). However, RT-PCR is 
semi-quantitative at best and cannot distinguish between cytokine producing cells
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and cells that are synthesising cytokine mRNA but not secreting cytokine protein. In 
most cases however, transcribed mRNA correlates well with secreted protein 
(Mosmann et al, 1989a).
2.3 Development of cytokine immunoassays.
A sandwich ELISA protocol was received from Pharmingen, on purchase of their 
anti-human cytokine antibody pairs. The protocol gave a range of concentrations for 
the use of capture and detection antibodies. On testing this range of concentrations it 
became clear that there were problems with the protocol. These problems included 
low overall absorbance and a high level of absorbance in wells containing a negative 
control as compared to wells containing cytokine standards. Wells prepared in an 
identical way produced markedly different absorbance readings. Over a series of 
trials, therefore, the method was honed until the results achieved as determined by 
absorbance readings and reproducibility, were considered acceptable. A number of 
changes were made.
Using the original protocol, across a standard curve ranging from 512uml‘^  to 
0.0625uml~^ OD^os ranged from 0.01 to 0 after background was subtracted. Using 
the improved protocol, OD405 ranged from 1.999 to 0 after background was 
subtracted. Overall absorbance was increased by altering ABTS substrate (2,2'azino- 
bis(3-ethyl benzthiazoline-sulfonic acid) concentration until a stronger colour 
reaction was attained thirty minutes after addition of the substrate. By preparing the 
ABTS substrate immediately before use, rather than using substrate prepared in
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advance and stored frozen as suggested by Pharmingen's protocol, optical density 
readings in negative control wells reduced from OD405 0.11-0.14 to 0.066-0.07.
It was important for the cytokine ELISAs to have a low well to well variability 
because replicate tests on each sample were not possible due to the low volume of 
sample supernatants from the field studies. Reproducibility was measured in terms of 
the standard deviation between absorbance levels of 24 wells processed in an 
identical manner. Standard deviation was measured using four concentrations of 
cytokine standard: 8uml"^, 16 umpl, 32 uml"l and 64 uml"l and a mean of these 
standard deviations was considered for each ELISA protocol. A standard deviation 
of <0.03 was considered acceptable, which resulted in the ELISA having a minimum 
accuracy of 0.01 um l'\ Well to well variation was brought to within acceptable 
bounds by increasing the volume of the first antibody from 50p.l to lOOpl and using a 
newly serviced multi-well pipette, (figure 2.1). The acceptable standard deviation 
value (< 0.03) was derived using Equation 2.1.
Equation 2.1
The equation was designed to find the sample size required to find a significant 
difference using an ANOVA (Sokal et al, 1995). It was used to estimate standard 
deviation assuming a sample size of 1. As ANOVA was not used to analyse the data, 
this should be considered an estimate only.
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-where
n = number of replications 
a  = true standard deviation
5 = the smallest true difference that it is desired to detect.
V = degrees of freedom of the sample deviation with a groups and 71 replications per 
groups
P = desired probability that a difference will be found to be significant (if it is as 
small as Ô). This is the intended power of the test.
and t2(i_p)[v] = values from a two tailed t-table with v degrees of freedom and 
corresponding to probabilities of a  and 2(1-P), respectively.
Two types of standard curve have been used (figures 2.2 and 2.3) in this study. For 
The Gambian study (chapter 3), a linear regression was used. This had the 
disadvantage that only the linear portion of the graph could be employed. This 
restricted the practical sensitivity of the assay. For the Zimbabwean study (chapter
4), the standard curve was described using a sigmoidal equation (figure 2.3). This 
allowed the utilisation of all parts of the standard curve, and so effectively improved 
the sensitivity of the assay. The sensitivity of the assays as used in The Gambian 
study was below lumF^ in each case, and in the Zimbabwean study was below 
0.0625 uml“\  Both equations adequately describe the relationship between standard 
concentration and optical density as evidenced by correlation co-efficients of >0.9. 
Standard curves were run on each plate.
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The revised cytokine protocol as used in both field studies (Chapters 3 and 4) 
Primary mAh l)Dilute purified anti-cytokine capture monoclonal antibody 
(mAb) to Ifigml"^ in coating buffer. Add lOOpl to wells of an 
enhanced protein binding ELISA plate (Immulon IV, 
Dynatech).
2)Cover plate and incubate overnight at 4°C.
3)Wash 2x with PBS-Tween. For each wash, fill wells with 
PBS-Tween and allowed to stand for 1 minute prior to 
aspirating or dumping, pound plate on paper towels as a final 
step in the drying process.
Blocking 4)Add 200^ 11 of PBS/10% FCS to each well.
5)Cover plate and incubate at room temperature for 2 hours.
6)Wash 2x with PBS/Tween 20.
Samples 7)Add standards and samples at lOOpl per well (diluted in 
RPMI media/heat inactivated human serum at 10% for the
Gambian study and 50% for the Zimbabwean, as appropriate 
for the different type of sample supernatant). Standards ranging 
from 512 to 0.0625 units ml"l are appropriate.
8)Cover and incubate overnight at 4°C.
9)Wash 4x with PBS/Tween.
Secondary mAh 10)Dilute biotinylated anti-cytokine (detecting) mAb to 
2|igml"^ in PBS/10% FCS. Add lOOpl per well.
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1 l)Cover and incubate at room temperature for 1.5 hours. 
12)Wash at least 6x with PBS/Tween.
Avidin-peroxidase 13)Dilute avidin-peroxidase to 0.4ugml"^ in PBS/10%
FCS. Add lOOpl per well.
14)Cover and incubate at room temperature for 30 minutes.
15)Wash at least 8x with PBS/Tween 20.
Substrate 16)Prepare ABTS substrate immediately prior to use. Protect it 
from light. Add lOfil of Hydrogen peroxidase per 10ml of 
substrate. Immediately add lOOpl per well and allow to 
develop at room temperature in the dark.
17)Stop the colour reaction by adding lOOpI of SDS/DMF.
18)Read the plate at OD 405 nm.
Solutions Coating buffer.
O.IM sodium hydrogen carbonate (NaHCOg) pH8.2
Phosphate Buffered Saline Solution (PBSV 
4.25g sodium chloride (NaCl)
14.48g di-sodium hydrogen orthophosphate (Na^HPO^) 
0.78g anhydrous sodium dihydrogen orthophosphate 
(NaH2P04)
1 L double distilled water (H2O)
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PBS/Tween 20.
Add 0.5ml of polyoxyethlenesorbitan monolaurate (tween-20) 
to IL PBS from above.
Substrate buffer.
Make up a 0.5mgml"l solution of 2,2'Azino-bis (3- 
ethylbenzthiazoline-6-sulfonic acid), in O.IM citric acid in 
ddH20 . Adjust the pH to 4.35 with sodium hydroxide (NaOH) 
pellets. (Add lOpl of 30% hydrogen peroxidase (H2O2) per 
10ml of substrate solution just before use.)
SDS/DMF.
200ml N,N-dimethyl formamide (DMF)
80g sodium dodecyl sulphate (lauryl sulphate ) (SDS)
220ml double distilled water (H2O)
2.4 Comparison of an IL-4 immunoassay and bioassay.
As previously discussed, bioassays detect biologically functional cytokine but 
immunoassays detect the epitopes on the cytokine protein recognised by the 
component antibodies of the ELISA. Therefore ELISAs do not necessarily measure 
biologically active cytokine. Although it was not possible to measure all of the 
samples using a bioassay, IL-4 was measured in a sub-set of samples from The
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Gambian study in order to investigate the hypothesis that the IL-4 measured by the 
ELISA was predominantly biologically active (see figure 2.4a and b).
IL-4 was detected using a sandwich ELISA as previously described (section 2.3), 
and a bioassay. The bioassay was based on the proliferation of the C.Th.4S cell line, 
generously provided by W. E. Paul (Huli et al, 1989) and has been described 
elsewhere (Wadhwa et al, 1995). Briefly, C.Th.4S cells require IL-4 for 
proliferation. Cells were cultured in the presence of IL-4 standard at various 
concentrations, in the presence of sample diluted to 1:8, 1:16, 1:32 and 1:64 or in 
the presence of sample and neutralising IL-4 antibody. The IL-4 international 
standard 88/656 (lOOOiu per ampoule) (NIBSC) was used to calibrate both assays 
(figures 2.4a and 2.4b). Medium alone was included as a negative control. 
Proliferation was measured using thymidine incorporation.
Using Spearman's Rank correlation, the relationship between the results of the
2ELISA and bioassay correlated to a significance of p<0.001 and an r of 75% 
(n=65). When only samples positive for IL-4 were considered, the correlation co­
efficient had a significance of p<0.008 and an r^ of 38% (n=17). Although the 
bioassay and the immunoassay intrinsically measure different attributes of the 
cytokine, the results of one are significantly correlated with the results of the other 
(figure 2.4b).
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2.5 Development of field culture techniques.
The following method was used successfully in The Gambian study (see Chapter 3). 
PBMC were obtained by ficoll-hypaque gradient centrifugation of heparinised 
peripheral blood (Boyum, 1968) under sterile conditions using lymphoprep, 
according to the manufacturer's instructions. Briefly, approximately 20ml of whole 
heparinised blood was gently layered on top of 10ml lymphoprep (Nycomed) in a 
50ml centrifuge tube and centrifuged at 800g for 20 minutes. After centrifugation, 
the PBMC formed a distinct band at the sample/medium interface. PBMC were 
transferred using a plastic pasteur pipette to approximately 10ml of sterile culture 
media and centrifuged at 350g for 15 minutes to wash them. Culture media 
consisted of RPMI 1640, supplemented with 2.4mM sodium hydrogen carbonate, 
2mM glutamine, 50mg L"1 gentamycin, 100 000 units L"1 nystatin, Ix non-essential 
amino acids, ImM sodium pyruvate, 30mM Hepes and 0.5mM 13- mercaptoethanol. 
The resulting pellet of PBMC was re-suspended, washed twice more and used in 
lymphocyte proliferation assays and for short term culture in the presence of various 
stimuli as described in Chapter 3.
For proliferation studies and short term culture, PBMC were adjusted to a 
concentration of 1 x 10^ cells ml"^ in culture media supplemented with 10% heat 
inactivated normal AB plasma generously donated by the West of Scotland Blood 
Donation Service. Cells were incubated for 48 hours in a humidified incubator at 37° 
C and 5% C02 /air .
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2.5.1 Use of Cryopreserved PBMC.
The same method was employed in the Zimbabwean study in 1994. The study site, 
the Burma Valley in the Eastern Highlands of Zimbabwe, was an overnight drive 
away from the laboratory in Harare so PBMC were cryopreserved in culture media 
described above, supplemented with 20% foetal calf plasma and 5% DMSO. Cells 
were frozen at a rate of 1°C per minute in liquid nitrogen vapour until they reached 
-120°C. PBMC were stored in liquid nitrogen, and transferred to Glasgow via 
Harare for subsequent in vitro cell culture.
Sterile conditions in the field were not ideal. Blood was processed in a chipboard 
'hood'. The hood and equipment was swabbed with methylated spirits once an hour 
and bathed in ultra violet light when not in use. Flaming of containers was not 
possible. The equipment for ficol-gradient centrifugation was also less than ideal. 
The purpose bought equipment: 50ml centrifuge tubes and lymphoprep, remained 
impounded by customs for the duration of the field trip in 1994. Leucoprep tubes, 
universal tubes, and lymphoprep (some unfortunately past their sell by date) were 
utilised instead.
2.5.2 Initial Testing of Cell Viability.
Materials and Methods.
On return to Glasgow, 120 vials of stored cells from thirty individuals picked 
randomly from the cohort were defrosted by placing the cryovials in a universal tube 
and standing in a 37°C water bath. Viable cells were identified by trypan blue 
exclusion and counted using a haemocytometer. For each sample 1 x 10  ^ cells were
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cultured in 1 ml cultures in the presence of either Schistosome Egg Antigen, (SEA) 
Whole adult Worm Homogenate (WWH) phytohaemagglutinin (PHA) or without 
stimulant. Supernatants were harvested at 24, 48, 72 and 96 hours post culture and 
tested for IL-4, IL-5, IL-10, GM-CSF, IFNy, and TNFa using sandwich ELISAs.
S.haematobium antigens were purchased in freeze dried form from the Schistosome 
Biological Supply Programme, Theodore Bilharz Research Institute, Giza, Egypt. 
They were reconstituted in sterile phosphate buffered saline. Some preparations did 
not arrive pre-homogenised. In these cases, antigen was ground in a homogeniser 
with a «lOOjj.1 of PBS. Dissolved antigen was separated from undissolved antigen by 
centrifuging the sample at centrifugation for 10 minutes at 800g. This process was 
repeated three times. The final concentrations were measured using a BCA Protein 
Assay Kit (Pierce), according to the manufacturer's instructions.
As outlined below, difficulties were encountered in detecting cytokines from the 
cryopreserved cells in view of which a number of pilot experiments were constructed 
in an attempt to isolate the source of the problem. Viability of stored cells from 
Zimbabwe was tested under a variety of culture conditions. The media recipe, 
concentration of cells, fungicide and semm supplement were altered.
In Glasgow, PBMC separated by ficol gradient centrifugation from blood taken from 
two volunteers were used as positive controls for the effects of cell preparation with 
out-of-date reagents and cryopreservation. These were prepared as described above. 
Briefly, cells were washed three times in RPMI 1640 and re-suspended at a
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concentration of 1x10^ cellsmkV They were cultured for 48 hours with either 10 % 
heat inactivated human AB plasma, foetal calf serum (FCS) batch number 228 
(Labtech) or Lot number 40Q7354F (Gibco). They were either stimulated with PHA 
at a variety of concentrations or cultured without stimulant.
Two different recipes for the culture medium were tested: one as described 
previously used without nystatin, and the other as described by Williams and 
colleagues (1994). It consisted of RPMI 1640 supplemented as before except 
lOOuml'  ^ Penicillin and lOOugmb^ Streptomycin were used instead of Gentamycin, 
and the 2-mercaptoethanol concentration was reduced from 0.5mM to 50|aM. One 
set of cells was prepared and cultured using each recipe. Neither preparation 
contained ftmgicide.
Two concentrations of PBMC were compared. Cells were cultured at 1x10^ or 
1x10^ ml'Tor 48 hours, stimulated with 10|igml-^ PHA or not stimulated. Half of the 
supernatant from cultures initiated at 1x 10  ^ cellmh^ was tested at the original 
concentration. The other half was concentrated by freeze drying and reconstituting 
at ten times the original concentration in an attempt to detect very low 
concentrations of cytokine. All supernatants were tested for IL-4, IL-5, IL-10, IFNy, 
GM-CSF and TNFa.
The possibility that fungicide in the medium might have affected cell growth in 
cytokine products was investigated. Culture media was supplemented with either 
nystatin, fungizone or left without fungicide.
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Results.
When cryopreserved cells from Zimbabwe were defrosted, cell death as measured by 
trypan blue exclusion ranged from 40% to 100%. When live cells were cultured with 
either variant of culture medium, at either concentration of cells, with or without 
ftingicide or with any serum supplement no measurable cytokine was produced, even 
in response to PHA.
Cytokines were produced by fresh PBMC (figure 2.5). IL-4 and IFNy were detected 
in supernatants from cultures supplemented with FCS, but not in supernatants from 
cultures supplemented with hAB plasma. IL-5 was detected in only one supernatant 
which was taken from a culture of PBMC supplemented with FCS supplied by 
GIBCO and stimulated with lOpgml’ l of PHA. IL-10 was not detected in 
supernatants from cultures supplemented with FCS, but was detected in 
supernatants from cultures supplemented with hAB plasma. GM-CSF was detected 
in all supernatants. TNFa was detected in some cultures supplemented by each type 
of FCS and some cultured with hAB plasma.
Discussion.
This series of trials suggests that either culture media would be acceptable, and that 
1x 10'  ^ is a reasonable density at which to culture cells but that although some cells 
were alive, as defined by ability to exclude trypan blue, they no longer had the ability 
to produce cytokine under the conditions tested here. Preferential death of antigen 
presenting cells, which are larger and more delicate than T-cells is one possible 
explanation, although it is surprising that PHA stimulation, which does not depend
61
Chapter 2: Assay Development
on antigen presentation should fail to illicit a cytokine response. The fungicides, 
necessary for culture in The Gambia, could be removed when culturing in the 
laboratory in Glasgow.
The presence and amount of detectable cytokine produced by fresh PBMC from 
volunteers in Glasgow, was influenced by the culture conditions. For example IL-10, 
a Th2-type cytokine was produced when the fresh PBMC were cultured with human 
AB plasma, but was not produced when they were cultured with either batch of 
FCS. Conversely, IFNy, a Thl-type cytokine, was produced when PBMC were 
cultured with FCS, but not produced when cultured with Human AB plasma. 
Different types of heterologous plasma can therefore bias cytokine production, 
making it difficult to compare studies in which PBMC are cultured in heterologous 
plasma.
2.5.3 Development of a Whole Blood Stimulation Method.
The limitations identified during the field trip in 1994 indicated that ficol gradient 
centrifugation of blood was not a practicable method to use under the field 
conditions in Zimbabwe, because under the conditions used here cryo-preserved 
cells produced no cytokine.
Field conditions placed a number of restrictions on any new methods. Cell culture 
equipment such as a sterile hood and incubator were available only in Harare, but 
blood could be transported to Harare overnight. The method had to be carried out 
by one operator, processing up to 80 samples per day. A maximum of lOmls of
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blood was available per person. A whole blood stimulation method was therefore 
developed for use in the field trip in 1995 because it involved less manipulation of 
sample, was a faster technique, did not require serum supplements and was a more 
economical use of blood. Whole blood stimulation has been successfully used in 
other studies (Kirchner et ai, 1982; Elsasser-Beile et al, 1991).
In advance of the 1995 field session, the whole blood stimulation method was 
established in Glasgow, using heparinised blood taken from four volunteers. From 
each individual 2ml of blood was diluted in culture media (using the recipe of 
Williams and colleagues (1994)) at dilutions of 1/2, 1/4, 1/5, 1/8, and 1/10, Blood 
was cultured in the presence of either lOugml”! PHA or without stimulation. Blood 
was removed 24, 48, 72, and 96 hours post incubation and cells and debris were 
separated by centrifugation for 10 minutes at 800g. The supernatants were removed 
and stored at -20°C. Supernatants were then tested for IL-10, GM-CSF, IFNy and 
TNFa production using sandwich ELISAs (see section 2.3).
The results for cytokine production with time and at different concentrations of 
whole blood for GM-CSF, IFNy, IL-10 and TNFa are shown in figures 2.6, 2.7, 
2.8, 2.9. In each case more cytokine was produced by cultures containing PHA than 
blood cultures without stimulant.
Markedly more GM-CSF was produced at 48 hours than at other time points and 
the culture that contained blood diluted to 1/4 with culture media produced the most 
GM-CSF with dilutions of 1/5 and 1/8 also producing acceptable levels, but cultures
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containing blood diluted to 1/2 and 1/10 produced negligible amounts of cytokine 
(figure 2.6). The low concentrations of GM-CSF produced by blood cultured at a 
dilution of 1/2 could be due to an inhibitory factor produced at an effective 
concentration at this level of dilution or alternatively high levels of cytokine 
consumption.
IFNy production ranged at 24 hours from 5 umk^ in the case of the 1/8 dilution to 
VOumf^ in the case of the 1/2 diluted culture. The 1/2 dilution produced ISOumf^ 
by 48 hours, rising to 200uml'^ by 72 hours before reducing to 160uml  ^ by 96 
hours. Cytokine produced by other dilutions peaked at 72 hours. The 1/4 dilution 
produced about half the amount of IFNy compared with the 1/2 diluted culture at 48 
hours reached the same level as the 1/2 dilution by the 72 hour time point and then 
reduced to a lower level (figure 2.7).
IL-10 production remained fairly stable across the four time points. The 1/2 dilution 
produced between 7 and 11 uml"\ the 1/4 between 3 and 6 uml'^ with cultures of 
blood at 1/5, 1/8 and 1/10 dilutions producing very low levels of cytokine (figure 
2 .8).
TNFa production was highest at 24 hours. Blood cultured at a 1/2 dilution 
produced 79um f\ at least double the amount produced in other cultures (figure 
2.9).
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Discussion.
These data clearly demonstrate that a whole blood stimulation assay was a 
practicable method of assessing cytokine production. A 1/2 dilution of blood was 
chosen because in most cases, this produced the largest amount of cytokine. Antigen 
stimulated cultures tend to produce less cytokine than mitogen stimulated culture, so 
a high concentration was considered desirable. High dose inhibition factors were 
thought to be less likely to be a problem in an antigen-driven system. Supernatants 
were harvested at 24, 48 and 72 hours post culture because peak production of 
cytokine was passed by 72 hours and no additional information could be gleaned by 
taking an additional sample after 96 hours.
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Figure 2.1. A comparison of the accuracy of two protocols for cytokine 
sandwich ELISAs.
0.16 
0.14 
_ 0.12 
eg 0.10I
0.04 ^  H  0.02
0.00
0.08
0.06
C/3 ■ ■ l i btm#
IL-4 IL-5 IL-10 GM-CSF 
Cytokine
IFNy TNFa
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A standard 
deviation 
of 0.03 was 
considered 
acceptable.
The standard deviation between wells was measured using either the original or the 
revised protocol. In each case, standard deviation was measured using 24 wells 
containing one of four concentrations of cytokine standard: 8uml'% 16uml'\
32umf^ and 64umf\ A mean of these standard deviations was considered for each 
ELISA protocol. All cytokines were measured using sandwich ELISAs using 
Pharmingen antibody pairs.
Standard deviation is not shown for IL-4, IL-5 or IL-10 using the original protocol. 
Optical density readings for IL-4 and IL-5 were so low as to render accurate 
reading impossible using the original protocol. An IL-10 ELISA was standardised 
later than the others, so the improved protocol was tested in the first instance and 
found to be acceptable.
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Figure 2.2. Typical standard curves as produced in the Gambian study 
(Chapter 3).
The best fit line was fitted using a linear regression described by the equation 
y = A + Bx
where x = log (concentration + 1), y = log (Optical Density +1), A & B = 
constants.
The sensitivity for each assay was < luml'^ (approximately lOOpg ml'^) and the 
accuracy was within O.Oluml'* (approximately Ipg mf^).
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Figure 2.3 Typical standard curve as produced in the Zimbabwean study 
(Chapter 4)
A sigmoid curve expressed by equation of the form; 
where x = log (concentration), y ^ D ^
y = log (Optical Density),
A, B, C & D = constants.
-was used to describe the relationship between optical density and concentration of 
cytokine. The sensitivity for each assay was below 0.0625uml‘  ^ (approximately 62.5 
pgrnl'^) and the accuracy was within O.Oluml"  ^ (approximately Ipg ml'^).
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Figure 2.4a. Standard curve for a CTh4s proliferation assay for the 
measurement of IL-4.
A standard curve for an IL-4 bioassay. The graph also demonstrates its specificity 
for IL-4 by means of a neutralising antibody.
Figure 2.4b. IL-4 measured by bioassay correlated with IL-4 measured by 
sandwich ELISA.
A comparison of IL-4 measured using a sandwich ELISA as described in section 
2.3 and a bioassay based on the proliferation of the C.Th.4S cell line described in 
section 2.4. IL-4 was produced by PBMC collected before treatment from Gambian 
individuals and cultured at a concentration of 1 x 10  ^ cellsml"^ in 1ml aliquots, for 
48 hours in the presence of lOpgml'^ PHA SEA or WWH. IL-4 measured by 
bioassay correlated with IL-4 measured by sandwich ELISA using a Spearman’s 
Rank correlation. p<0.001, r  ^=75%, n=65
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Figure 2.4a
Standard curve for a CTh4s proliferation assay for 
the measurement of IL-4.
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Figure 2,5. The influence on cytokine production by PBMC of different 
plasma supplements in RPMI.
Cytokines were produced by fresh PBMC cultured 
in RPMI at a concentration of I x lO^cellsml'^ 
supplemented with either FCS or hAB plasma and 
stimulated with PHA at a variety of concentrations.
Six different cytokines were measured in culture 
supernatants using sandwich ELISAs as described in 
section 2.3
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Figure 2.6. Net production of GM-CSF by whole blood at different dilutions 
and time points.
A comparison of net GM-CSF produced by whole blood collected from volunteers 
(n = 4 for each point) from the University of Glasgow and cultured in 1ml aliquots, 
for 24, 48, 72 or 96 hours in the presence of lOpgml'^ PHA. GM-CSF concentration 
was determined using a sandwich ELISA as described in section 2.3, which has a 
sensitivity of 0.0625 umL^ and an accuracy of O.Oluml'V Net data are the amount 
of cytokine produced by blood when cultured with PHA minus levels produced by 
blood cultured without stimulant. These background levels were always <1.30umr^ 
(median control value = 0.00 uml’ )^.
Figure 2.7. Net production of IFNy by whole blood at different dilutions and 
time points.
A comparison of net XFNy produced by whole blood collected from volunteers (n = 
4 for each point) from the University of Glasgow and cultured in 1ml aliquots, for 
24, 48, 72 or 96 hours in the presence of lOpgml'^ PHA. IFNy concentration was 
determined using a sandwich ELISA as described in section 2.3, which has a 
sensitivity of 0.0625 umL^ and an accuracy of 0.01uml'\ Net data are the amount 
of cytokine produced by blood when cultured with PHA minus levels produced by 
blood cultured without stimulant. These background levels were always <9,3umr^ 
(median control value = 0.00 uml'^).
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Figure 2,6. Net production of GM-CSF by whole blood at different dilutions 
and time points.
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Figure 2,7. Net production of IFNy by whole blood at different dilutions and 
time points.
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Figure 2.8. Net production of IL-10 by whole blood at different dilutions and 
time points.
A comparison of net IL-10 produced by whole blood collected from volunteers 
(n = 4 for each point) from the University of Glasgow and cultured in 1ml aliquots, 
for 24, 48, 72 or 96 hours in the presence of lO^gml'^ PHA. IL-10 concentration 
was determined using a sandwich ELISA as described in section 2.3, which has a 
sensitivity o f 0.0625 umL^ and an accuracy of 0.01u m f\ Net data are the amount of 
cytokine produced by blood when cultured with PHA minus levels produced by 
blood cultured without stimulant. These background levels were always <1.9uml'^ 
(median control value = 0.00 uml" )^.
Figure 2.9. Net production of TNFa by whole blood at different dilutions and 
time points.
A comparison of net TNFa produced by whole blood collected from volunteers 
(n = 4 for each point) from the University of Glasgow and cultured in 1ml aliquots, 
for 24, 48, 72 or 96 hours in the presence of lOjagmf^ PHA. TNFa concentration 
was determined using a sandwich ELISA as described in section 2.3, which has a 
sensitivity o f 0.0625 umL^ and an accuracy o f O.OlumfV Net data are the amount 
of cytokine produced by blood when cultured with PHA minus levels produced by 
blood cultured without stimulant. These background levels were always <34.48uml" 
 ^ (median control value = 0.00 umf*).
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Figure 2.8. Net production of IL-10 by whole blood at different dilutions and 
time points.
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Figure 2.9. Net production of TNFa by whole blood at different dilutions and 
time points.
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Chapter 3.
Cytokine production in response to Schistosoma 
haematobium infection in Gambian individuals.
Chapter 3: Cytokine Production in Gambian Individuals
3.1 Introduction.
Despite the progress which has been reported on attempts to develop a vaccine 
which would protect against schistosome infection (Dunne et al, 1995; Wynn et 
al, 1995), there is still some controversy regarding the particular types of immune 
responses that will need to be induced when any vaccine candidates are used in 
humans. Studies on murine schistosomiasis indicate that Thl-type responses with 
the production of IFNy and macrophage activation, but no humoral component to 
the immune response, are associated with protection in animals which have been 
immunised once with attenuated cercariae (Wynn et al, 1996) and with some 
vaccine candidates such as glutathione-S-transferase and triose-phosphate 
isomerase (Dunne et al, 1995). Responses of the Th-2 type appear to be a feature 
of egg-induced pathology in mice (Sher et al, 1991). Triple vaccination of mice 
with attenuated cercariae however improved protection and changed the nature of 
the protective response from a Thl to a Th2 type (Wynn et al, 1996). 
Furthermore, protection has been observed to improve if IL-12 is administered as 
an adjuvant along with radiation attenuated cercariae in the triple vaccination 
model. Mice vaccinated three times with cercariae and IL-12, display 
predominantly Thl type cytokines and although they retain a humoral response, the 
antibodies produced are also associated with a Thl-type pattern of immunity.
Studies of reinfection after chemotherapy in humans have demonstrated that 
resistance is associated with eosinophilia (Sturrock et al, 1983; Hagan et al, 
1985; Hagan et al, 1987; Hagan, 1992) and with the production of parasite- 
specific IgE (Hagan et al, 1991; Rihet et al, 1991; Dunne et al, 1992; Demeure 
et al, 1993). The production of eosinophils is largely dependent on IL-5
74
Chapter 3: Cytokine Production in Gambian Individuals
(Sanderson, 1992; Sanderson, 1993), and the production of IgE is largely 
dependent on IL-4 (Defrance et ah, 1987a; Finkelman et al, 1990). IL-4 and 
IL-5 are cytokines classically associated with Th2-type responses (Vilcek et al, 
1994). The protective effects of IgE may be influenced by the presence of IgG4 
(Hagan et al, 1991; Dunne et al, 1992; Demeure et al, 1993), IgM (King et al, 
1989a; Butterworth et al, 1992) and IgG2 (Butterworth et al, 1988a; Demeure et 
al, 1993) antibodies which appear to have the capacity to block the activities of 
protective antibody classes. IgG4 production is up-regulated by both IL-4 and IL~ 
13 (Lehman et al, 1988; Rothman et al, 1988; Zurawski et al, 1994). IgM is 
largely modulated by IL-5 (O'Garra et al, 1989), DL-2 (Matsui et al, 1989), IL-4 
and IL-10 (Rousset et al, 1992) and IgG2 may be down modulated by IL-4 and 
IFNy and upmodulated by TGFP (Vilcek et al, 1994).
There have been relatively few studies of human cytokine responses to 
schistosomiasis, and a clear picture has yet to emerge. Cell proliferation on 
stimulation with either adult worm or schistosomulum antigens has been negatively 
correlated with re-infection intensity whereas IL-5 was associated with low 
intensity of infection (Roberts et al, 1993). More IL-4 and IL-5 mRNA was 
measured in patients with greater degrees of pathology attributed to S. mansoni 
infection (Williams et al, 1994). Proliferation of PBMC stimulated with adult 
worm antigens and IL-4 production on stimulation with both adult worm and egg 
antigens increased after treatment either as a result o f release from down- 
modulation by adult worms, or as a result of boosted immune reactivity due to 
release of antigen at treatment (Grogan et al, 1996).
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In the light of evidence from the murine model that suggests that either Thl or 
Th2"type responses (Wynn et al, 1996) could provide protection, it is important to 
clarify this issue in humans. In this chapter, results are reported from studies of the 
production of cytokines in response to stimulation with schistosome antigens and 
mitogen by peripheral blood mononuclear cells from 59 Gambians, resident in an 
area where S. haematobium is endemic. Three hypotheses have been examined:
1. that protection against infection is associated with a Th2-type immune response.
2. that Thl and Th2 responses are dichotomous options in individuals.
3. that cross reactive antigens in Whole adult Worm Homogenate (WWH) and 
Soluble Egg Antigens (SEA) result in related secretion of cytokine to the two 
antigenic types.
3.2 Methods.
59 subjects, 32 children (12 to 16 years) and 27 adults (25 to 88 years) were 
recruited from the villages of Misera and Diabugu Basillah in the Upper River 
Division, The Gambia. Forteen adults were male and 13 were female. Of the 
children, 27 were male and 5 female. A comprehensive re-infection study, including 
water contact observations, has been previously carried out in the village of 
Madina which is also in the upper river division of The Gambia (Wilkins et al 
1987). The area is endemic for S.haematobium infection, but S,mansoni is rare 
(Hagan, pers. communication). Transmission for S.haematobium is restricted to 
the wet season, which is between June and November. Water contact is 
predominantly from water holes. The area is also endemic for malaria 
(predominantly falciparum malaria), although again transmission is principally 
restricted to the wet season. The study was carried out in April 1994, during the
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dry season so the prevalence of infection with malaria was likely to be low.
Intestinal helminth infections, including Ascaris spp. are also endemic. Urine and 
blood samples were obtained from all participants. All were offered treatment with 
40mg k g 'l praziquantel.
Intensity of infection was determined by counting S. haematobium eggs stained 
with Lugol’s iodine in 10ml of urine after filtration through 20pm pore 25mm 
diameter polycarbonate filters (Nucleopore Corporation). Lugol’s iodine consists 
of 5g Iodine, Ig Potassium iodide in 100ml water. Absolute eosinophil counts were 
determined in a Fuchs-Rosenthal cytometer, after dilution of blood in a Phloxin B- 
based stain (Speirs, 1952). Peripheral blood mononuclear cells (PBMC) from the 
study population were obtained by Ficoll-hypaque gradient centrifugation of total 
heparinised peripheral blood (section 2.5) (Boyum, 1968). People were transported 
from the village to the MRC laboratories in Basse, where samples were taken.
PBMC were then used in lymphocyte proliferation assays and for short term ?
culture in the presence of various stimuli as described in section 2.1.
Proliferation Studies.
For proliferation studies, 1 x 10^ cells m l'l in 0.1ml aliquots were incubated with
S.haematobium antigens: soluble egg antigen (SEA), whole adult worm 
homogenate (WWH) or phytohaemagglutinin (PHA) at a final concentration of 
lOpg ml"l or without stimulant (see section 2.1.2). At 5 days, 6 hours post 
incubation, proliferative responses were assayed using a commercially available kit 
(Promega) according to the manufacturers instructions. Briefly, plates were pulsed 
with 15jil dye (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
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(MTT). Four hours later a lOOp.1 solublisatlon agent (proprietary recipe) was 
added. Plates were incubated at 37°C overnight and optical densities were read at 
570nm.
Short Term Culture for the production of cytokines.
1ml volumes o f PBMC at a concentration o f 1 x 10^ cells ml" I were stimulated 
with SEA, WWH or PHA at a concentration of lOpg ml"l in culture, or without 
stimulant. Forty-eight hours post incubation, culture supernatants were removed, 
and centrifuged for 5 minutes at 12 000 gravity to ensure removal of all cell 
fragments and nystatin and stored at -20^C for use in ELISAs or bioassays.
Detection of Cytokine.
The concentrations of IL-4, IFNy, TNFa, IL-5 and GM-CSF were each measured 
using a sandwich ELISA. Genzyme kits were used for IFNy and IL-4 Pharmingen 
antibodies were used to measure TNFa, IL-5 and GM-CSF concentrations using 
protocols described in section 2.3. In addition, IL-4 produced on stimulation with 
SEA was also measured using a sandwich ELISA using Pharmingen antibodies as 
described in section 2.3. IL-2 concentration was measured using a bioassay based 
on proliferation of the CTLL cell line (Gillis et al, 1978; Wadhwa et al, 1995). 
The international standards (I S.) or reference reagents (R.R.) from National 
Institute for Biological Standards and Control (NIBSC) were used to calibrate the 
cytokine assays. The following standards were used : IL-4: NIBSC 88/656 I S. 
(1000 international units (iu) per ampoule), IL-5: NIBSC 90/586 R.R. (5000 units 
(u) per ampoule), TNFa: NIBSC 87/650 I S. (40 OOOiu per ampoule), GM-CSF:
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NTBSC 88/646 I S. (10 OOOiu per ampoule), IL-2: NIBSC 86/502 I S. (13203iu 
per ampoule), IFNy: Genzyme kit standard.
Data analysis.
Data were analysed using non-parametric statistics on SPSS for Windows version
6. The two-tailed Mann-Whitney U Rank Comparison was applied to comparisons 
of two groups. Statistical analyses were based on mean rank data because mean 
values are inappropriate for non-parametric data and log+x transformation failed to 
normalise the data.
The results refer to net and gross levels of cytokine or proliferation. Net levels of 
cytokine or proliferation refer to cytokine or proliferation produced as a result of 
culture in the presence of a stimulant, such as antigen or mitogen, minus cytokine 
or proliferation produced with no stimulation. This allows the influence of 
individual variations in baseline cytokine or proliferation levels to be minimised. 
Gross levels of cytokine or proliferation refer to total proliferation or cytokine 
produced.
Examination of the three hypotheses.
Hypothesis 1: protection against infection is associated with a Th2 type 
immune response.
This hypothesis was examined by comparing differences in levels of cytokine 
produced by PBMC from either infected and uninfected individuals or children and 
adults using a Mann-Whitney U test.
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Hypothesis 2: Thl and Th2 responses are dichotomous options in individuals.
If Thl and Th2 responses are dichotomous options, one would expect to find 
relatively low amounts of IFNy in individuals with relatively high amounts of IL-4, 
and vice versa. It follows that the relative amounts of IL-4 and IFNy, may be 
responsible for driving an immune response in a particular direction, rather than the 
absolute amount of cytokine. If this is the case it might be expected that ratios 
between IL-4 and IFNy might fall into two distinct clusters, hypothetically depicted 
in figure 3.1, or be negatively correlated.
Hypothesis 3: Cytokine responses to WWH are related to the cytokine 
responses to SEA and vice versa, as a result of cross-reactive antigen.
Cross-reactive antigens in SEA and WWH may result in the cytokines produced in 
response to one life-cycle stage being associated with the cytokine produced in 
response to another as cells specifically sensitised to antigens jfrom one life cycle 
stage may also respond to shared or similar epitopes in the antigens from another 
life cycle stage. WWH and SEA will have cross-reactive antigen, because WWH 
will contain female worms with eggs. However it is useful to test the hypothesis in 
this instance when the answer is already clear, to test the methodology for potential 
future use with larval and adult antigen and for testing stage-specificity of effect of 
possible recombinant vaccine candidates. Cross reactive antigens have been 
suggested as a possible medium for effecting concomitant immunity (Hagan et al, 
1993).
In order to investigate this hypothesis potential correlations between cellular 
responses produced on stimulation with SEA and cellular responses produced on
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stimulation with WWH were sought. A positive correlation between the cellular 
response produced on stimulation with the two antigens would suggest that cross 
reactive antigens may affect the production of cytokine. However, an alternative 
interpretation of such a result, would be that PBMC from some individuals 
produce more cytokine than others, irrespective of the stimulant used. If this 
second possibility was correct, cytokine produced on stimulation with antigen 
would be expected to correlate not only with cytokine production to the other 
antigen, but also with cytokine production to the non specific mitogen PHA. 
Therefore, to test the hypothesis, cytokine produced in response to the SEA was 
partially correlated with cytokine produced on stimulation with WWH controlling 
for cytokine produced on stimulation with PHA using a Kendall non-parametric 
correlation coefficient.
A minimum sample size of 10 was accepted as a valid comparison. Where a large 
proportion of the individuals produced no cytokine in response to one or both 
antigens, a significant positive correlation could be the result of one or two 
outlying data points. For this reason, a correlation was only accepted as supporting 
the hypothesis if a simple majority of data points were non-zero um l'l for both 
antigens.
3.3 Results.
Intensity of infection.
Children (16 years and less) had a higher intensity of infection than adults (over 25 
years) (figure 3.2)f 1 adult and 29 children were positive for S.haematobium
1 p < 0.0001, n =59: 32 children, 27 adults, U =  50.0, W =  428.0, Z =  -6.1912
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infection. 26 adults and 3 children were negative for S.haematobium infection. The 
burden of infection was therefore predominantly in the children. Peak infections 
were in those aged 13 to 14 years.
3.3.1 Hypothesis I: protection against infection is associated with a Th2 type 
immune response.
A summary of statistical comparisons between two groups for proliferative 
responses and the production of six cytokines is shown in tables 3.1 and 3,2. 
Eosinophil levels were higher in children than in adults^ and higher in infected than 
uninfected individuals (figure 3.3)^.
Cytokines produced by PBMC on stimulation with PHA.
PBMC from adults produced more IFNy on stimulation with PHA than PBMC 
from children when nef^ and gross data were analysed^. However, when infected 
and uninfected individuals were compared, this difference was no longer 
significant.
PBMC from adults and uninfected individuals produced more IL-4 on stimulation 
with PHA than PBMC from children and infected individuals respectively when net 
data were analysed (figure 3.4)^. These observations were significant when IL-4 
was measured using the Genzyme Kit ELISA. When gross data were analysed 
PBMC from adults and uninfected individuals produced more IL-4 on stimulation
2 p < 0 .0 0 0 4 , n = 59: 32 children, 27 adults, U = 2 0 0 .5 , W = 5 7 8 .5 , Z = -3 .5222
3 p < 0.003, n = 59: 29 uninfected, 30 infected, U = 2 3 8 .5 , W = 673 .5 , Z = -2 .9 7 9 4
4 p < 0 .0 5 , n = 45: 21 children, 24 adults, U =  165.0, W = 396 .0 , Z =  -1.9794  
^ p < 0.05 , n = 4 5 , 24 adults and 21 children, U =  166.0, W = 397 .0 , Z =  -1.9567
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with PHA than PBMC from children and infected individuals when IL-4 was 
measured with either the Genzyme Kit ELISA or Pharmingen antibody pairs as 
described in section 2.3^
PBMC from adults and uninfected individuals produced more IL-2 on stimulation 
with PHA than PBMC from children^® or infected individuals^ * respectively when 
gross, but not when net data were analysed.
There was no significant difference between IL-5, TNFa or GM-CSF production 
by PBMC from adults compared to children or infected individuals compared to 
uninfected individuals when cultured with PHA for 48 hours.
Cytokines produced by PBMC on stimulation with SEA or WWH.
PBMC from children showed increased IFNy production compared to adults 
following stimulation with SEA and WWH. These observations were unchanged 
whether net (SEA^^, WWH^^) or gross (SEA '^*, WWH*^) data were analysed. 
PBMC from infected individuals had produced more IFNy on stimulation with
 ^ adults vs. children: p<0.0001, n=45, 21 children and 24 adults, U=85.0, W =316.0, Z=-3.7994 
and uninfected vs. infected p<0.0007, n=45, 23 uninfected, 22 infected, U= 103.0, W =356.0, Z=- 
3.4059
^adults vs. children: p<0.0002, n=45, 24 adults and 21 children, U=86.0, W =317.0, Z= -3.7768 
^uninfected vs. infected: p<0.0007, n=45, 22 infected and 23 uninfected, U= 104.0, W =357.0,
Z= -3.3833
 ^adults vs. children: p<0.005, n=59, 32 children and 27 adults, U=250.0, W =992.0, Z=-2.7807 
and uninfected vs. infected p<0.0063, n=59, 29 uninfected, 30 infected, U=255.5, W= 1049.5, Z -  
2.7331
^^adults vs children: p < 0 .0 1 , n = 3 9 , 19 adults, and 20 children, U =  102.0, W = 4 6 8 .0 , Z = -  
2.48
*^infected vs uninfected: p < 0 .0 2 , n = 3 9 , 17 infected and 22 uninfected, U =  107.0, W = 2 6 0 .0 , 
Z =  -2.2726
12 p<0.04, n=45, 21 children and 24 adults, U= 166.0, W=569.0, Z= -2.0641 
12 p<0.04, n=45, 21 children and 24 adults, U= 166.0, W=569.0, Z= -2.0353 
I4p<0.01, n=45, 24 adults, 21 children, U=141.0, W=594.0, Z=-2.7418 
I5p<0.003, n=45, 24 adults and 21 children, U=131.5, W =603.5, Z= -2.9776
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WWHi^ (figure 3.5) and SEA^^ (figure 3.6) over background levels (net data) than 
the PBMC from uninfected individuals. These differences remained significant 
when gross data were analysed (SEA** and WWHi^).
When gross data were analysed, PBMC from children produced more IL-4 than 
PBMC from adults, measured using Pharmingen antibody pairs as described in 
section 2.3, on stimulation with, SEA,20 although this significant difference was the 
result of low levels of IL-4 produced by four children (Appendix 2a and 2b), 
Conversely, when net IL-4, as measured using the Pharmingen antibody pairs, was 
analysed there was no significant difference between IL-4 produced by PBMC 
from children compared to adults, however, there was a significant difference 
between infected and uninfected individual s2i, however, uninfected individuals 
(who were predominantly adult) produced more IL-4 than infected individuals 
(who were predominantly children). This difference between infected and 
uninfected individuals, was also due to very low levels of IL-4 production by a few 
individuals (appendix 2c and 2d).
There was no significant difference between EL-2, IL-5, TNFa or GM-CSF 
production by PBMC from adults compared to children or infected individuals 
compared to uninfected individuals when cultured with SEA or WWH for 48 
hours.
p<0.02, n=45, 23 uninfected and 22 infected, U= 154.5, W=604.5, Z= -2.3265 
2^ p<0.02, n=45, 23 uninfected and 22 infected, U= 153.0, W=606.0, Z= -2.3953 
i*p<0.003, n=45, 23 uninfected and 22 infected, U= 130.0, W =629.0, Z= -3.0322  
1 V o .O O l, n=45, 23 uninfected and 22 infected, U=122.0, W=637.0, Z= -3.2306 
20p<0.05, n=59, 27 adults and 32 children, U=353.0, W=731.0, Z= -2.0197  
p<0.05, n=59, 29 uninfected and 30 infected, U=361.5, W=826.5, Z =-1.984
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Proliferation of PBMC on stimulation with SEA or WWH.
PBMC from adults proliferated more than PBMC from children, without 
stimulation^^ and stimulation with PHA^^, SEA^ "* and WWH^^. On stimulation with 
PHA26 and WWH,2? PBMC from uninfected individuals proliferated more than 
PBMC from infected individuals, but there were no significant differences when 
PBMC were stimulated with SEA or were cultured without stimulation. 
Proliferation on stimulation with mitogen or antigen was not significantly different 
between adults and children or between infected and uninfected individuals when 
net values were analysed.
3.3.2 Hypothesis 2: Thl and Th2 responses are dichotomous options in 
individuals.
No clustering was observed in cytokine produced on stimulation with SEA, WWH 
or PHA or when the cohort was split into infected and uninfected or child and 
adult (figure 3.7a and b) suggesting that Thl and Th2 responses during 
schistosomiasis infection (as indicated by capacity to produce IFNy and IL-4 
respectively) are not dichotomous options. IL-4 was measured using the Genzyme 
Kit ELISA and a sandwich ELISA using Pharmingen antibody pairs as described in 
section 2.3.
22p< 0.0043, n = 5 9 , 27 adults and 32 children, U = 2 4 4 , W = 997 .5 , Z =  -2.8529  
23 p < 0.0002, n = 5 9 , 27 adults and 32 children, U =  186.0, W =  1056.0, Z =  -3.7429  
2 4 p < 0.003, n = 5 9 , 27 adults and 32 children, U = 2 3 9 .5 , W =  1002.5, Z =  -2.9288  
25p< 0 .0 0 1 , n = 5 9 , 27 adults and 32 children, U = 2 1 9 .0 , W =  1023.0, Z =  -3.2408  
26p< 0 .0 0 0 9 , n = 5 9 , 30 infected and 29 uninfected, U = 2 1 5 .0 , W =  1090.0, Z =  -3.3358  
22p <0 .04 , n = 5 9 , 30 infected and 29 uninfected, U = 2 9 8 .0 , W =  1007.0, Z =  -2.0773
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3.3.3 Hypothesis 3: Cytokine responses to WWH were related to cytokine 
responses to SEA and vice versa as a result of cross reactive antigen.
Ceil proliferative responses^*, GM-CSF^^, IFNy^°, IL-4, measured using the 
Genzyme kit ELISA,^^ and TNFa^^ produced by SEA correlated with the response 
induced on stimulation with WWH, controlling for the response to PHA (figure 
3.8). This suggests that cross reactive epitopes in the antigen from the two life 
cycle stages have some effect on cytokine production. No such correlation was 
found in the case of IL-5, probably because of low overall IL-5 production. IL-4 
measured using the Pharmingen antibody pairs was significant, but the majority of 
samples contained undetectable levels of cytokine, so the result cannot be 
considered to be evidence supporting the hypothesis.
2 8 N = 5 9 ,  p < 0 . 0 0 1  
29n=59,p<0.001 
3 0 ^ = 4 5 , p < 0 .0 0 1  
31 N = 4 5 , p < 0 .0 0 1  
3 2 n = 5 9 ,  p < 0 . 0 0 1
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3.4 Discussion.
Hypothesis 1: protection against infection is associated with a Th2-type 
immune response.
Both net and gross data have been analysed in this chapter. Net cytokine 
production takes background cytokine levels into account, so it is less affected by 
variation due to factors other than the immune response to the stimulant in 
question than gross cytokine production. Sources of such variation could include 
concurrent infection, maturity of the immune system or MHC. Net data has been 
used by others, (Grogan et al, 1996) although Roberts et al (1993) preferred gross 
data.
PBMC from children or infected individuals produced more IFNy (a Thl-type 
cytokine) than PBMC from adults or uninfected individuals when cultured with 
either SEA or WWH. This observation was statistically significant whether gross 
or net data were analysed. PBMC from children produced more IL-4 (measured 
using Pharmingen antibody pairs) on stimulation with SEA than PBMC from adults 
when gross, but not net data, was analysed. Conversely, PBMC from uninfected 
people produced more IL-4 (measured using Pharmingen antibody pairs) than 
infected people.
These observations could be interpreted to mean that children produced cytokine 
(whether Thl or Th2-type) in response to schistosome antigen, whereas adults did 
not. However, the statistically significant difference between IL-4 produced when 
cultured with SEA, did not remain statistically significant when background levels 
were removed (net data) and the comparison of infected and uninfected people
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contrasted strongly with the comparison of children and adults. This was probably 
due to the very small number of people whose PBMC produced detectable levels 
of IL-4 (appendix 1). I would like to propose therefore that the overriding immune 
response exhibited by children and infected individuals to schistosome antigens 
could be considered comparable to a murine Thl-type response.
The data obtained using PHA as stimulant contrasted strongly with those using 
S.haematobium antigens. PBMC from adults or uninfected individuals produced 
more IL-4 on culture with PHA than children or infected individuals when net or 
gross data were considered. When gross data were analysed, PBMC from adults or 
uninfected individuals produced more IL-2 on stimulation with PHA than children 
or infected individuals. IFNy production on stimulation with PHA considering 
either net or gross data, was also higher in adults compared to children although 
the significance of the difference between uninfected and infected individuals was 
not significant.
Gross levels of cell proliferation were generally higher in adults or uninfected 
individuals compared to children or infected individuals. When stimulated with 
PHA and WWH both the differences in proliferative responses between adults and 
children, and infected and uninfected individuals were statistically significant. When 
cultured with SEA or cultured without stimulant, only the difference between 
adults and children was significant. These differences in proliferative response 
could be attributed to differences in spontaneous cell proliferation observed 
between adults and children, since whilst differences in gross proliferation were
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very significant (p<0.004) no significant differences were observed when net 
proliferative responses were considered.
As discussed above, PBMC from adults or uninfected individuals tended to 
produce more cytokine and proliferate more when cultured in the presence of PHA 
than PBMC from children or infected individuals. Since these observations were 
due to mitogen, rather than antigen stimulation, they could represent some 
difference other than schistosome infection, the most likely being age since in this 
study uninfected individuals roughly corresponds with adults and infected 
individuals with children.
It is reasonable to assume that the adults in this study have had past and continuing 
exposure to schistosomiasis because the people have a similar lifestyle to residents 
of the village of Madina, in the same area, where detailed water contact 
observations have been carried out (Wilkins et a l 1987, Hagan et ai, 1991). Given 
this assumption, the adults in this study are likely to have been exposed to infection 
for many more years than the children and have gained some degree of protection 
against infection since they have no detectable worm burden. The differences in 
immune response between children and adults could therefore be due to age related 
factors or reflect number of years of experience of S.haematobium.
Evidence from new foci would support the hypothesis that resistance was related 
to age rather than experience (Gryseels et al, 1987; Gryseels et al, 1994b) and 
observations of peak shift as predicted by mathematical models (Woolhouse et al, 
1991) and differences in the immune responses of children resident in a high
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transmission area compared to a low transmission area (chapter 4), suggest that 
experience is a factor.
Irrespective of whether experience of infection or age causes resistance, evidence 
primarily based on serological studies has suggested that Th2 responses play a 
predominantly protective role in schistosomiasis in humans. IgE and eosinophilia, 
hallmarks of Th2-type responses, have been associated with resistance to 
reinfection, although IgG4, the secretion of which is also elicited by the Th2-type 
cytokines IL-4 and IL-13 (Lehman et al, 1988; Rothman et al, 1988; Zurawski et 
al, 1994), was associated with susceptibility to reinfection (Hagan et al, 1991; 
Rihet et al, 1991; Dunne et al, 1992). However, the evidence from this present 
study for a protective Th2-type response rests on the greater net production by 
PBMC of adults and uninfected individuals of IL-4 when cultured with the mitogen 
PHA. Taken in the context of the other significant differences observed between 
either children and adults or infected and uninfected individuals, these results could 
be interpreted in another way. In particular, the observation that IFNy (a Thl-type 
cytokine), produced on stimulation with PHA, was also higher in adults compared 
to children is pertinent. The overall greater response by PBMC from adults to PHA 
could be due to longer experience of infection generally, or some other aspect of 
their greater maturity; for example, a different hormonal environment. 
Alternatively, since the adults group is also predominantly uninfected, these greater 
non-specific responses could represent a protective strategy. In this case the 
response would be more comparable to a murine ThO, rather than a Th2-type 
response. However, if the adults are assumed to have greater protection from 
infection than children, and they are still exposed, the results would suggest that
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this protection has more to do with producing less IFNy in response to antigenic 
stimulation than a positive Th2-type response.
Exploiting the background of the age-prevalence and age-intensity profiles from 
communities in endemic areas, most immuno-epidemiological studies have 
attempted to identify immune responses associated with resistance and/or 
susceptibility to infection. Williams and colleagues (1994) employed an alternative 
strategy. They examined cytokine production by PBMC from S.mansoni-infectGd 
individuals in relation to their degree of pathology arising from their infection. 
Williams and colleagues (1994) conclude that S.mansoni-VQlatQd pathology 
stemmed from the failure of patients to down-regulate Th2-type responses which 
predominated when PBMC from these individuals were stimulated in vitro with 
mitogens or egg antigen. Therefore, using a different approach, these authors have 
further confirmed the importance of an understanding of Th2 responses in 
determining protection from or the generation of pathology by schistosomiasis in 
humans.
In the murine model, Sher and colleagues (1991) found that Th2-type responses 
were primarily associated with the production of eggs by adults worms and 
therefore with the induction of pathology. In support of these findings, vaccination 
with IL-12, which favours the priming of Thl cells was shown to inhibit pathology 
in mice sensitised with eggs of .S', mansoni (Wynn et al, 1995). Host protective 
responses have been linked to a Thl-type cytokine profile, primarily IFNy 
production and macrophage activation, in mice vaccinated once with attenuated 
cercariae (Smythies et al, 1993).
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It should be noted that Smythies and colleagues (1993) studied not only a different 
species of host, but also a different species of schistosome from that considered in 
this chapter. Among other differences, S.mansoni occupies the intestinal and 
mesenteric veins, whereas S.haematobium is found in the blood vessels 
surrounding the bladder.
Th2 type responses have been associated with protection in mice, when vaccinated 
three times (Caulada-Benedetti et al, 1991). This vaccination protocol successfully 
induced a humoral as well as a cellular protective immune response and provided 
enhanced protection against subsequent challenge. Triple vaccination may mimic 
the natural situation better than the single vaccination model because people are 
naturally exposed on numerous occasions. However, the use of IL-12 as an 
adjuvant resulted in triple vaccinated mice displaying a Thl-type response with 
both cellular and humoral components. This protocol provided the most effective 
protective response of the three investigated (Wynn et al, 1996). It might 
therefore be possible to provide protection by inducing either a strong Thl or a 
strong Th2-type response. Eliciting a Thl-type response may have the advantage 
of avoiding any exacerbation of Th2-induced pathology. It would be interesting to 
see the effects of using Th2-inducing cytokine such as IL-4 or IL-13 as an adjuvant 
for triple vaccination o f mice.
In other helminth infections in mice, such as Nippostrongylus braziliensis, 
Trichuris muris and Strongyloides venezuelensis (Finkelman et al, 1992), there is 
evidence that Th2-type responses can play a key role in resistance (reviewed in
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Finkelman et al, 1992). Supporting evidence for a role for Th2-type responses in 
protection against schistosome infections in humans has come from studies of S. 
mansoni in which IL-5 production (a Th2-type cytokine) correlated positively with 
age and was associated with low intensity of infection (Roberts et al, 1993). The 
current study found no direct relationship between infection levels and IL-5 
production, indeed very little EL-5 was produced (appendix 1). Although Roberts 
and colleagues (1993) demonstrated evidence for IL-5 mediated protection, they 
found no significant relationship between EL-4 and protection. These differences 
between their study and the current investigation may reflect the different time 
points at which cell culture supernatants were harvested in the two studies and/or 
differences between the two parasite species. The parasites would primarily 
stimulate the lymph nodes draining different sites.
Hypothesis 2 : Thl-type and Th2-type responses are dichotomous options in 
individuals.
The results suggest that Thl and Th2 responses as indicated by levels of IFNy and 
IL-4 respectively are not dichotomous options. Although as a group, individuals 
infected with S.haematobium and children produce more IFNy and less EL-4 than 
uninfected individuals and adults, this does not mean than at an individual level 
high IFNy production necessitates low IL-4 production or vice versa. Del Prete 
and colleagues (1994) have reviewed the evidence that EFNy or IL-4 administered 
at a susceptible moment of a T-cell's development may direct it towards a Thl or 
Th2 route respectively. However, once a T-cell is mature, IL-4 is unable to induce 
a Thl-type cell to switch to a type 2 phenotype. I would speculate therefore that 
the T-cells in this study were mature cells of defined phenotype. It may also
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indicate that resistance to infection is not modulated by a switch from the 
dominance of one T-cell subset to another. It would lend further support to the 
hypothesis that levels of IL-4 production remain relatively stable, whereas IFNy 
levels change.
Hypothesis 3: Cytokine response to WWH is related to the cytokine response 
to SEA and vice versa as a result of cross reactive antigen.
Cross-reactive antigens have been suggested as a mechanism for concomitant 
immunity. Concomitant immunity, a concept first introduced by Smithers and Terry 
(1965) is regarded as a state of resistance to infection due to a current burden of 
adult worms. In principle, concomitant immunity suggests that the adult worms 
elicit an immune response that they are themselves unaffected by, but is effective in 
protecting the host against incoming larvae. Hagan and colleagues (1993b) suggest 
that cross reactive antigens released from adult worms and present on the larval 
stages may explain how a response that originates with the adult worms might be 
targeted at larvae and that the agent of this type of immunity maybe TNFa. TNFa 
was singled out as a prime suspect because of its capacity to induce granuloma 
formation and increase female worm fecundity whilst at the same time being 
directly toxic to schistosomula.
The results of the current study suggest that cross-reactive antigens affect cell 
proliferation and the production of IL-4, GM-CSF, IFNy and TNFa. No partial 
correlation between IL-5 produced in response to SEA and WWH, controlling for 
PHA, was observed, possibly because of low levels of IL-5 production overall.
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These results confirm that cytokine producing cells can be antigen-specific and 
have the ability to recognise similar epitopes on different stages of the parasite.
Potential improvements which could be made to the study design.
Diagnosis of schistosomiasis was ascertained on the basis of a single urine sample.
It was logistically impossible to acquire repeat urine samples on subsequent days.
For this reason the intensity of infection data is not as robust as I would wish and 
may have resulted in some false negative diagnoses. For the purposes of this study 
however, this is not a serious flaw because the test served to show that the greatest 
burden of worms was carried by children. The population could be split into 
juvenile and adult groups, which roughly approximated to infected and uninfected 
individuals respectively. Since the conclusions of this study are not altered by the 
consideration of either child versus adult, or infected versus uninfected this 
confirms the validity of the approach.
iÎ
Culture supernatants were harvested only after 48 hours. Different cytokines are
.produced at varying time points during ex vivo culture and stimulation, so it is 
.possible that peak production of some of the cytokines occurred earlier or later.
This does not invalidate statistically significant differences in levels of cytokine 
between groups. However, no conclusions should be drawn from the lack of a 
statistically significant result, or even the low overall production of a cytokine, for 
this reason.
PBMC were harvested in heterologous, rather than autologous human plasma 
despite laboratory observations that plasma could markedly effect the cytokine
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production of PBMC in culture (see chapter 2). Although autologous plasma 
would have been a preferred option, it was logistically impracticable. In each 
analysis however, conclusions have been drawn from comparative and not absolute 
levels of cytokine. Since the same batch of plasma was used throughout, the 
overall conclusions should remain unaffected.
Cytokines were detected using a single measurement, based on one well of an 
ELISA plate. Although duplicate or triplicate measurements would have been 
preferable, there was insufficient supernatant to do this. However, the well-to-well 
variability of each ELISA has been reduced to a minimal level where this approach 
was considered acceptable (chapter 2).
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Figure 3.1. Hypothetical clustering of H.-4 and IFNy.
A hypothetical example of clusters of cytokine produced by infected and uninfected 
individuals, as might be expected if the ratio of IL-4 to IFNy correlated with 
infection status.
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Table 3.1
Summary of net data comparing the cellular responses of PBMC from 
children with PBMC from adults and comparing the cellular responses of 
PBMC from uninfected and infected individuals on stimulation with SEA, 
WWH, PHA or without stimulation.
A summary of statistical comparisons between people who were infected or 
uninfected based on examination of filtered urine samples, or children (16 years or 
less) and adults (over 25 years) for proliferative responses of PBMC and the 
production of six cytokines by their PBMC. Cell proliferation was measured using a 
colorimetric assay (Promega), according to the manufacturer’s instructions. IL-4, 
IL-5, TNFa and GM-CSF, were measured using sandwich ELIS As as described in 
section 2.3, which have a sensitivity of luml-1 and an accuracy of O.Oluml-1, IL-4 
and IFNy were measured using Genzyme sandwich ELISA kits according to the 
manufacturers instructions. IL-2 was measured using a bioassay based on the 
proliferation of a CTLL cell line.
PBMC were separated from blood taken before treatment from Gambian people and 
cultured at a concentration of 1 x 106 in 0.1 ml aliquots for 5 days for the 
proliferation assays and in 1ml aliquots for 48 hours for the production of cytokine. 
Stimulants (all at lOfigml-1 ) were either PHA, SEA or WWH. All comparisons 
were made using Mann -Whitney U Rank test of net data. Net data are either 
proliferative responses, or cytokine concentration produced by PBMC cultured with 
either mitogen or antigen minus the level of proliferation or cytokine produced in 
PBMC cultured without stimulant. Full statistical details are given in the text where 
appropriate and in appendix 1.
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Table 3.1
Summary of net data comparing the cellular responses of PBMC from 
children with PBMC from adults and comparing the cellular responses of 
PBMC from uninfected and infected individuals on stimulation with SEA, 
WWH, PHA or without stimulation.
Comparison of cellular 
responses of PBMC from 
children with PBMC from 
adults on stimulation with:
Comparisc 
responses 
infected pi 
from unin
m of cellula 
of PBMC fi 
îople with I 
fected peop
r
om
'BMC
le.
Cellular
response.
SEA WWH PHA SEA WWH PHA
PBMC
Proliferation
• • • • • •
IL-2
IL-4
(Genzyme)
• • +++
(a>c) • •
4-H-
(M > i)
IL-4 (as in 
section 2.3)
+
( u>i )
IL-5
TNFa • ,
GM-CSF ,
IFNy +
(c>a)
+
(c>a)
+
(a>c) ( i >u)
+
(i>u) •
. = p > 0.05 + = p < 0.05 ++ = p<0.01 +++ = p < 0.001
c > a = PBMC from children produced more cytokine/proliferated more than 
PBMC from adults.
a > c = PBMC from adults produced more cytokine/proliferated more than PBMC 
from children.
i > u = PBMC from infected individuals produced more cytokine/proliferated more 
than PBMC from uninfected individuals.
u > i = PBMC from uninfected individuals produced more cytokine/proliferated 
more than PBMC from infected individuals.
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Table 3.2a.
Summary of gross data comparing the cellular responses of PBMC from 
children with PBMC from adults on stimulation with SEA, WWH, PHA or 
without stimulation.
A summary of statistical comparisons between children (16 years or less) and adults 
(over 25 years) for proliferative responses of PBMC and the production of six 
cytokines by their PBMC. Cell proliferation was measured using a colorimetric 
assay (Promega), according to the manufacturer’s instructions. IL-4, IL-5, TNFa 
and GM-CSF, were measured using sandwich ELIS As as described in section 2.3, 
which have a sensitivity of luml-1 and an accuracy of 0.0luml-1. EL-4 and IFNy 
were measured using Genzyme sandwich ELISA kits according to the 
manufacturers instructions. IL-2 was measured using a bioassay based on the 
proliferation of a CTLL cell line.
PBMC were separated from blood taken before treatment from Gambian people and 
cultured at a concentration of 1 x 106 in 0.1 ml aliquots for 5 days for the 
proliferation assays and in 1ml aliquots for 48 hours for the production of cytokine. 
Stimulants (all at lOp-gml-1 ) were either PHA, SEA or WWH. All comparisons 
were made using Mann -Whitney U Rank test of gross data. Full statistical details 
are given in the text where appropriate and in appendix 1.
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Table 3.2a.
Summary of gross data comparing the cellular responses of PBMC from 
children with PBMC from adults on stimulation with SEA, WWH, PHA or 
without stimulation.
Comparison of cellular responses of 
PBMC from children with PBMC 
from adults on stimulation with:
Cellular
response
media
alone
SEA WWH PHA
PBMC
Proliferation
+
(a>c)
+
(a>c)
+++
(a>c)
+++
(a>c)
H ^2 • • 4—h(a>c)
m -4
(Genzyme)
• • 4-H-(a>c)
Hj-4 (as in 
section 2.3)
+
(c>a)
++
(a>c)
IL-5
TN Fa
GM-CSF
IFNy • +
(O a)
++
(O a)
+
(a>c)
. =  p >  0 .0 5  +  =  p <  0 .0 5  + +  =  p < 0 . 0 1  + + +  =  p <  0 .0 0 1
c > a = PBMC from children produced more cytokine/proliferated more than 
PBMC from adults.
a > c = PBMC from adults produced more cytokine/proliferated more than PBMC 
from children.
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Table 3.2b.
Summary of gross data comparing the cellular responses of PBMC from 
infected individuals with PBMC from uninfected individuals on stimulation 
with SEA, WWH, PHA or without stimulation.
A summary of statistical comparisons between people who were infected or 
uninfected on the bases of examination of urine for S.haematobium eggs for 
proliferative responses of PBMC and the production of six cytokines by their 
PBMC. Cell proliferation was measured using a colorimetric assay (Promega), 
according to the manufacturer’s instructions. IL-4, IL-5, TNFa and GM-CSF, were 
measured using sandwich ELIS As as described in section 2.3, which have a 
sensitivity of luml-1 and an accuracy of O.Oluml-1. IL-4 and IFNy were measured 
using Genzyme sandwich ELISA kits according to the manufacturers instructions. 
IL-2 was measured using a bioassay based on the proliferation of a CTLL cell line.
PBMC were separated from blood taken before treatment from Gambian people and 
cultured at a concentration of 1 x 106 in 0.1 ml aliquots for 5 days for the 
proliferation assays and in 1ml aliquots for 48 hours for the production of cytokine. 
Stimulants (all at lOp.gml-1 ) were either PHA, SEA or WWH. All comparisons 
were made using Mann -Whitney U Rank test of gross data. Full statistical details 
are given in the text where appropriate and in appendix 1.
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Table 3.2b.
Summary of gross data comparing the cellular responses of PBMC from 
infected individuals with PBMC from uninfected individuals on stimulation 
with SEA, WWH, PHA or without stimulation.
Comparison of cellular responses of 
PBMC from infected people with 
PBMC from uninfected people on 
stimulation with:
Cellular
response
media
alone
SEA WWH PHA
PBMC
Proliferation • •
+
(u>i )
+++
(u>i )
m -2 • • • +(u>i )
DL-4
(Genzyme) • • •
+++
(u>i )
Hj-4 (as in 
section 2.3)
++
(U>i)
Hv-5
TNFa ,
GM-CSF
IFNy • -H-( i>u)
++ •
. = p > 0.05 + = p < 0.05 ++ = p<O.Ol +++ — p <  0.001
i > u = PBMC from infected individuals produced more cytokine/proliferated more 
than PBMC from uninfected individuals.
u > i = PBMC from uninfected individuals produced more cytokine/proliferated 
more than PBMC from infected individuals.
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Figure 3.2. S.haematobium intensity of infection in the study group.
Intensity of infection was determined before treatment in Gambian individuals in 
the cohort by counting S.haematobium eggs in 10ml of urine after filtration through 
20jim filters. Intensity of infection was higher in children (under 16 years) than in 
adults (over 25 years). p<0.0001, n=59, 32 children, 27 adults, U=50.0, W=428.0, 
Z=-6.1912. The statistical significance of this difference was determined using a 
Mann-Whitney U comparison.
Figure 3.3. A comparison of peripheral blood eosinophil counts in 
S.haematobium infected and uninfected individuals in The Gambia.
A comparison of absolute eosinophils counts determined in a Fuchs-Rosenthal 
cytometer, after dilution of blood in a Phloxin B-based stain. Eosinophil levels were 
higher in individuals infected with S.haematobium compared to uninfected 
individuals. Infection status was as determined by the presence of S.haematobium 
eggs in urine. The statistical significance of this difference was determined using a 
Mann-Whitney U comparison, p<0.003, n=59 29 uninfected individuals, 30 
infected individuals, U=238.5, W=673.5, Z=-2.9794.
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Figure 3.2. S. haematobium intensity of infection in the study group
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Figure 3.3. A comparison of peripheral blood eosinophil counts in 
S.haematobium infected and uninfected individuals in The Gambia.
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Figure 3.4. A comparison of IL-4 produced by PBMC incubated with PHA 
from S.haematobium infected and uninfected individuals from The Gambia.
A comparison of net IL-4 concentration produced by PBMC collected before 
treatment from Gambian individuals and cultured at a concentration of 1 x 106 
cellsml-1 in 1ml aliquots, for 48 hours in the presence of lOjLigml-1 PHA. IL-4 
concentration was determined using a Genzyme sandwich ELISA kit. Net data are 
the amount of cytokine produced by PBMC when cultured with PHA minus levels 
produced by PBMC cultured without stimulant. Background levels were less than 
the sensitivity of the assay. Net IL-4 production was higher in individuals 
uninfected with S.haejnatobium compared to infected individuals. Infection status 
was determined by the presence of S.haematobium eggs in urine. The statistical 
significance of this difference was determined using a Mann-Whitney U 
comparison. p<0.0007, n=45, 23 uninfected individuals, 22 infected individuals, 
U= 103.0, W=356.0, Z=-3.4059.
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Figure 3.4. A comparison of IL-4 produced by PBMC incubated with PHA 
from S.haematobium infected and uninfected individuals from The Gambia.
i;
7
6
5
4
3
2
1
0
Infected Individuals.Uninfected Individuals.
102
Chapter 3: Cytokine Production in Gambian Individuals
Figure 3.5. A comparison of IFN7 produced by PBMC incubated with WWH 
from S.haematohium infected and uninfected individuals from The Gambia.
A comparison of net IFN7 concentration produced by PBMC collected before 
treatment from Gambian individuals and cultured at a concentration of 1 x 106 
cellsml-1 in 1ml aliquots, for 48 hours in the presence of 10)Xgml-l WWH. IFN7 
concentration was determined using a Genzyme sandwich ELISA kit. Net data are 
the amount of cytokine produced by PBMC when cultured with WWH minus levels 
produced by PBMC cultured without stimulant. Background levels were less than 
the sensitivity of the assay. Net IFN7 production was higher in individuals infected 
with S.haematobium compared to uninfected individuals. Infection status was 
determined by the presence of S.haematobium eggs in urine. The statistical 
significance of this difference was determined using a Mann-Whitney U 
comparison. p<0.02, n=45, 23 uninfected individuals, 22 infected individuals, 
U=154.5, W=604.5, Z=-2.3265.
Figure 3.6. A comparison of IFN7  produced by PBMC incubated with SEA 
from S.haematobium infected and uninfected individuals from The Gambia.
A comparison of net IFN7 concentration produced by PBMC collected before 
treatment from Gambian individuals and cultured at a concentration of 1 x 106 
cellsml-1 in I ml aliquots, for 48 hours in the presence of lOpgml-l SEA. IFN7 
concentration was determined using a Genzyme sandwich ELISA kit. Net data are 
the amount of cytokine produced by PBMC when cultured with SEA minus levels 
produced by PBMC cultured without stimulant. Background levels were less than 
the sensitivity of the assay. Net IFN7 production was higher in individuals infected 
with S.haematobium compared to uninfected individuals. Infection status was 
determined by the presence of S.haematobium eggs in urine. The statistical 
significance of this difference was determined using a Mann-Whitney U 
comparison. p<0.02, n=45, 23 uninfected individuals, 22 infected individuals, 
U=153.0, W=606.0, Z=-2.3953.
Facing page 103
Chapter 3: Cytokine Production in Gambian Individuals
Figure 3.5. A comparison of IFNy produced by PBMC incubated with WWH 
from S.haematobium infected and uninfected individuals from The Gambia.
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Figure 3.6. A comparison of IFNy produced by PBMC incubated with SEA 
from S.haematobium infected and uninfected individuals from The Gambia.
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Figure 3.7a A comparison of levels of IL-4 (measured using a Genzyme Kit 
ELISA) and IFNy in S.haematobium infected and uninfected individuals from 
The Gambia on stimulation of PBMC with PHA, SEA or WWH.
If Thl and Th2 responses are dichotomous options, one would expect to find 
relatively low amounts of IFNy in individuals with relatively high amounts of IL-4, 
and vice versa. It follows that the relative amounts of IL-4 and IFNy may be 
responsible for driving an immune response in a particular direction, rather than the 
absolute amount of either cytokine. If this is the case, it might be expected that 
ratios between IL-4 and IFNy might fall into two distinct clusters, hypothetically 
depicted in figure 3.1, or be negatively correlated. No clustering or negative 
correlation was observed in cytokine produced with SEA, WWH or PHA.
Net IFNy produced on culture with either WWH, SEA or PHA was plotted against 
net IL-4 produced on culture with either WWH, SEA or PHA respectively. Both 
cytokines were produced by PBMC collected before treatment from Gambian 
individuals and cultured at a concentration of 1 x 106 cellsml-1 in 1ml aliquots, for 
48 hours in the presence of lOjigml-l of either WWH, SEA and PHA. IFNy and IL- 
4 concentrations were determined using a Genzyme sandwich ELISA kit. Net data 
are the amount of cytokine produced by PBMC when cultured with SEA minus 
levels produced by PBMC cultured without stimulant. Infection status was 
determined by examination of 10ml urine for S.haematobium eggs.
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Figure 3.7a. A comparison of levels of IL-4 (measured using a Genzyme 
ELISA Kit) and IFNy in S.haematobium infected and uninfected individuals 
from The Gambia on stimulation of PBMC with PHA, SEA or WWH.
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Figure 3.7b A comparison of levels of IL-4 (measured using a Sandwich 
ELISA using Pharmingen antibody pairs as described in section 2.3) and IFNy 
in S.haematobium infected and uninfected individuals from The Gambia on 
stimulation of PBMC with PHA, SEA or WWH.
If Thl and Th2 responses are dichotomous options, one would expect to find 
relatively low amounts of IFNy in individuals with relatively high amounts of IL-4, 
and vice versa. It follows that the relative amounts of IL-4 and IFNy may be 
responsible for driving an immune response in a particular direction, rather than the 
absolute amount of either cytokine. If this is the case, it might be expected that 
ratios between IL-4 and IFNy might fall into two distinct clusters, hypothetically 
depicted in figure 3.1, or be negatively correlated. No clustering or negative 
correlation was observed in cytokine produced with SEA, WWH or PHA.
Net IFNy produced on culture with either WWH, SEA or PHA was plotted against 
net EL-4 produced on culture with either WWH, SEA or PHA respectively. Both 
cytokines were produced by PBMC collected before treatment from Gambian 
individuals and cultured at a concentration of 1 x 106 cellsml-1 in 1ml aliquots, for 
48 hours in the presence of lOpgml-1 of either WWH, SEA and PHA. IFNy and EL- 
4 concentrations were determined using a sandwich ELISA using Pharmingen 
antibodies as described in section 2.3. Net data are the amount of cytokine produced 
by PBMC when cultured with SEA minus levels produced by PBMC cultured 
without stimulant. Infection status was determined by examination of 10ml urine 
for S.haematobium eggs.
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Figure 3.7b. A comparison of levels of IL-4 (measured using a Sandwich 
ELISA using Pharmingen antibody pairs as described in section 2.3) and 
IFNy in S.haematobium infected and uninfected individuals from The 
Gambia on stimulation of PBMC with PHA, SEA or WWH,
° Uninfected individuals.
• Infected individuals.
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Figure 3.8. An investigation into the potential effect of cross reactive antigen 
on cellular immune responses in Gambian individuals.
Levels of net cell proliferation and net production of IL-4, GM-CSF, IFNy, TNFa 
and IL-5 on incubation with lOp.gml-1 SEA are plotted against the equivalent levels 
produced on incubation with lOpgml-1 WWH. These associations were positively 
correlated using a partial Kendall non-parametric correlation coefficient, controlling 
for cell proliferation and production of IL-4, GM-CSF, IFNy and TNFa on 
incubation with 10|igml-l PHA. Details of statistical results were; Cell 
proliferation: N=59, p<0.001, GM-CSF: N=59, p<0.001, IFNy: N=45, p<0.001, IL- 
4 (Genzyme ELISA): N=45, p<0.001, TNFa: N=59, p<0.005, IL-2, IL-4 
(Pharmingen ELISA) and IL-5 = the majority of samples contained undetectable 
levels of cytokine.
Cell proliferation was measured using a colorimetric assay (Promega), according to 
the manufacturer’s instructions. IL-4, IL-5, TNFa and GM-CSF, were measured 
using sandwich ELIS As as described in section 2.3, which have a sensitivity of 
luml-1 and an accuracy of O.Oluml-1, IL-4 and IFNy were measured using 
Genzyme sandwich ELISA kits according to the manufacturers instructions. IL-2 
was measured using a bioassay based on the proliferation of a CTLL cell line. 
PBMC were separated from blood taken before treatment and cultured at a 
concentration of 1 x 106 in 0.1 ml aliquots for 5 days the proliferation assays and 
1ml aliquots for 48 hours for the production of cytokine with lOp.gml-1 of either 
PHA, SEA or WWH. Net data are cell proliferation or the amount of cytokine 
produced by PBMC when cultured with either PHA, SEA or WWH minus cell 
proliferation or cytokine produced when cultured without stimulant.
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Figure 3.8. An investigation into the potential efTect of cross reactive antigen 
on cellular immune responses in Gambian individuals.
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Chapter 4.
Cytokine Production in response to Schistosoma 
haematobium infection in Zimbabwean children one year 
post treatment.
Chapter 4: Cytokine Production in Zimbabwean children
4.1 Introduction.
This chapter describes the production of cytokines in whole blood, stimulated in 
vitro with mitogen or schistosome antigens taken from 137 Zimbabwean children 
who have been resident in one of two areas endemic for S. haematobium for one 
year following chemotherapy. Residents of one area had a high prevalence of 
infection and residents of the other a low prevalence of infection prior to treatment.
In a previous study in The Gambia (Chapter 3) a confounding difficulty was that, to 
a large extent, infected people were children and uninfected people were adults, 
such that the Thl/Th2 dichotomy observed could be explained either by age or 
infection status. The Gambian study could not therefore address the question of 
whether age or experience of infection was responsible for the observed changes in 
immune response.
An age-structured immigration-death model predicted that if protective immunity 
developed faster in areas of high transmission compared to low transmission 
(Woolhouse et al, 1991) the age at which the peak of intensity of infection 
occurred would be younger in areas of high transmission than in areas of lower 
transmission, a phenomena known as peak shift. Peak shift was observed in a study 
of seventeen primary schools in the Zimbabwean highveld. This Zimbabwean study 
was designed to extrapolate from these ideas. It addresses the hypothesis that, given 
that protection against infection is associated with a Th2-type immune response, a 
protective type of immune response will develop faster in an area with a high 
transmission rate compared to an area with a low rate of transmission, if past 
experience of infection is associated with the acquisition of resistance to infection.
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The Gambian study found that IL-4, GM-CSF, IFNy and TNFa production was 
affected by cross-reactive antigen. This hypothesis has also been addressed in the 
Zimbabwean study.
Grogan and colleagues (1996) observed that IL-4 but not IL-5 was up-regulated as 
a result of treatment for S.haematobium infection with Praziquantel. They 
speculated that this was because IL-4 and EL-5, although both Th2-type cytokines, 
are separately regulated in schistosomiasis. This hypothesis is consistent with the 
results of intra-cellular cytokine staining experiments which have shown that IL-4 
and EL-5 maybe produced by separate T cell populations in humans (Jung et al, 
1995; Sewell et al, 1996). If IL-4 and IL-5 are produced by separate cell 
populations and only one of these populations is stimulated by schistosome antigen, 
then in blood from an individual, only one of the cytokines would be detected in a 
single supernatant. This hypothesis was also addressed.
4.2 Methods
One hundred and thirty seven children were recruited from two areas, 
approximately 10km apart in the Burma Valley in the Eastern Highlands of 
Zimbabwe in August 1994. All the children were permanent residents of the area. 
Their ages ranged from 6 to 15 years with age not reported in three cases. The main 
industry in the Burma Valley is fruit plantations. Families tend to live in 
communities of farm workers, associated with one of the several large commercial 
farms. S.haematobium is endemic throughout the valley, but communities differ in 
terms of the quality of sanitation provided and the accessibility o f piped water. 70 
children, 30 girls and 40 boys, attending Valhalla School, were resident in an area
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with a high prevalence of S.haematobium infection. The residents of the high 
prevalence area used a river, which was not seasonal, for domestic purposes and 
had only limited access to piped water and Blair toilets. Blair toilets are pit latrines, 
commonly used in Zimbabwe, designed by The Blair Research Institute as low cost 
sanitary provision. In the high prevalence area, the water contact sites were heavily 
used by residents, compared with usage of water contact sites in the other area, as 
evidenced by analysis of returns of a questionnaire concerning water contact usage 
(Woolhouse, Hagan and colleagues, unpublished data).
Sixty-seven children attending Kaswa School, 32 girls and 35 boys were resident in 
an area with a low prevalence of S.haematobium infection. These children were 
resident in a village with better sanitary infrastructure when compared to the high 
prevalence area. Use of the river was limited and the river itself was seasonal. They 
had better access to piped water and Blair toilets compared to children resident in 
the high prevalence area.
In both areas Ascaris spp. eggs were observed in kato preparations from some stool 
samples, although prevalence of hookworm was low, probably due to the recent 
hookworm control program in the area. The area was selected because it had a low 
prevalence of S.mansoni infection. None of the children in the cohort were positive 
ÏOÏ S.mansoni. Prevalence of HIV infection in Zimbabwe is generally high, however 
HIV positive people tend to be either below school age or adult, so the children in 
the cohort were unlikely to be HIV positive.
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Intensity of infection was determined for each child by counting S.haematobium 
eggs in 10ml of urine after filtration through 25mm diameter polycarbonate filters. 
Eggs were stained with Lugol’s iodine (as described in section 3.2) to aid visibility. 
Prevalence of infection was measured in the cohort in November 1994, February, 
March, May and August 1995. Each child was successfully drug treated in 
November 1994 with 40mgkg"l Praziquantel and gave at least two urine samples in 
August 1995.
In November 1995 30ml blood samples were taken from each child. Ten millilitres 
was used for studies of cytokine production and 20ml for other studies. Blood was 
transported overnight at ambient temperature from the study site to Harare where it 
was diluted in 50% RPMI and incubated in a humidified environment at 37°C and 
5% CO2 in the presence of lOpgmpl of either the mitogen phytohaemagglutinin 
(PHA), antigen: schistosome egg antigen (SEA), whole adult worm homogenate 
(WWH), cercarial homogenate (CERC) or incubated without stimulant. 24, 48 or 
72 hours post incubation, culture supernatants were harvested and stored at -20°C 
for future use.
Antigens were purchased in freeze dried form from the Schistosome Biological 
Supply Programme, Theodore Bilharz Research Institute, Giza, Egypt (section 
2.5.2) IL-4, IL-5, IL-10, GM-CSF, IFNy and TNFa were detected in culture 
supernatants using sandwich ELIS As (chapter 2). Because limited volumes of blood 
and antigen were available, not all samples provided supernatants at all three time 
points.
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4.3 Statistical treatment of results.
Data were analysed using SPSS for Windows version 6. Net levels of cytokine have 
been used throughout. Net cytokine is cytokine produced as a result of culture in 
the presence of a stimulant such as antigen or mitogen minus cytokine produced 
with no stimulation. Six statistical tests have been used: Wilcoxon signed ranks test, 
logistic regression analyses, multiple linear regression, Mann Whitney U, y} and 
Kendall partial correlation.
Differences between cytokine produced at 24, 48 or 72 hours post incubation were 
tested using a Wilcoxon signed ranks test, because the data sets were not normally 
distributed (figure 4.1a) and could not be successfully transformed (figure 4.1b) 
(Siegel et al, 1988b). There are more than two groups, so a Friedman two-way 
analysis of variance by ranks could be argued to be the more appropriate test 
(Siegel et al, 1988a). However, the Friedman test could only be carried out on data 
that were available for all three time points from each individual. This reduced the 
sample size considerably. Instead the difference between 24 hours and 48 hours, 24 
hours and 72 hours and 48 and 72 hours were tested separately. In each case the 
result was accepted if the total sample size was greater than 10. In order to correct 
for the multiple tests, the level of significance was set using a sequential Bonferroni 
technique (Rice, 1989).
A continuous dependent variable can be regressed linearly against a number of 
either continuous, categorical or ordinal variables provided that the residuals of the 
model are normally distributed. The dependent variable of a logistic regression must 
be binary, for example male and female, or cytokine producer compared to non-
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cytokine producer, but independent variables can be continuous or categorical. For 
both tests, the sample size must be at least five times the number of independent 
variables.
Logistic regression analysis was used as the primary means of analysing cytokine 
data because models of most cytokine-dependent variables did not conform to the 
assumptions of linear regression. An individual was classified either as net cytokine 
producer (blood produces >0 uml"^ of cytokine over background levels) or net 
cytokine non-producer (blood produces <0 uml"l of cytokine over background 
levels) (figure 4.2a). Multiple logistic and linear regression had the advantage over 
Mann-Whitney-U in that a number of factors could be considered at the same time. 
This allowed specific hypotheses to be addressed whilst controlling for potentially 
confounding factors. For example it was possible to address the hypothesis that 
area of residence explained a significant proportion of variation in cytokine 
production controlling for age, sex, pretreatment infection status and post­
treatment infection status.
The logistic regression analysis has the disadvantage that any difference in the 
amount of cytokine produced was not taken into account, and thus the full 
information content of the data set is not exploited. There was also a particular 
problem in the case of PHA stimulated production of all cytokines, with the 
exception of IL-4, because blood from almost every child produced cytokines over 
the level in non-stimulated blood (figure 4.2b). However, it was possible in these 
instances to utilise a multiple linear regression because the residuals of the model 
were normally distributed.
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For both linear or logistic regression the forward stepwise approach to model fitting 
was used to ascertain which independent variable or variables best explained the 
variation in cytokine data. Five categorical independent variables; area, sex, age, 
pretreatment infection status and infection status eight months after treatment were 
used to attempt to explain the variation in cytokine data. Age was split into ten one 
year intervals, although there was no difference to the conclusions of the analysis if 
two five year intervals were used instead (results not shown). A minimum sample 
size of 25 was considered appropriate because five independent variables were 
being considered. Cytokine data were first regressed against the independent 
variable which explained variation in cytokine data with the highest level of 
significance. If none of the independent variables explained cytokine variation to a 
significance level of p<0.05, none were entered into the model. Subsequent 
variables had to explain the remaining variation in the cytokine data to a 
significance level of p<0.05 to be included in the model.
The explanatory independent variable was then entered into the model after all 
other independent variables. If it could still significantly explain variation in 
cytokine data, it was accepted. For example, this method made it possible to test 
the hypothesis that children from one area produced more cytokine than children 
from the other area, controlling for the potentially confounding factors o f sex, age, 
pretreatment infection status and infection status eight months after treatment.
To test the hypothesis that cytokine production is influenced by cross-reactive 
antigen, cytokine levels were compared in blood incubated for a defined duration 
with either of three antigens or with PHA. Cytokine levels produced on stimulation
114
Chapter 4: Cytokine Production in Zimbabwean childreft
with SEA were partially correlated against levels produced on stimulation with 
WWH, controlling for cytokine produced on stimulation with PHA. A Kendall 
partial correlation coefficient was used to analyse these data because the majority of 
cytokine data were not normally distributed (figure 4.1a). and could not be 
successfully be transformed (figure 4.2b). A minimum sample size of 10 was 
accepted for a valid comparison. Where a large proportion of the children produced 
no net cytokine in response to one or both antigens, a significant positive partial 
correlation between the two antigens could be the result of one or two outlying 
data points. For this reason, a correlation was only accepted as supporting the 
hypothesis if a simple majority samples produced detectable levels of cytokine over 
background for both antigens. It was not possible to control for age, sex, 
pretreatment or post treatment infection status using this type of analysis. However, 
for reasons explained in section 4.4, the major confounding factor was likely to be 
the area in which the child was resident. This method of analysis was used 
separately for data from each area.
For each of the above methods, non-statistically significant results have not been 
discussed because they do not prove that there is not a relationship between the 
variables considered, only that a relationship could not be proved with this data set 
and analysis, i.e. to avoid type II errors. For each combination of cytokine and 
antigen, there were data resulting from the three time points. This effectively 
allowed three opportunities to obtain a significant result, so the significance values 
were corrected to account for multiple tests using a sequential Bonferroni technique 
(Rice, 1989). Significance values have been quoted after correction for multiple 
tests.
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A test was used to consider the hypothesis that children produced either IL-4 or 
IL-5 but not both, on stimulation with the same antigen or mitogen and incubated 
for the same length of time. A minimum sample size of 10 was considered adequate. 
Children were categorised as producing either IL-4 or IL-5 or both. Children who 
produced undetectable amounts of both cytokines were not included. This 
quantitative method treated the data as categorical, rather than as continuous 
variables and so had some imperfections: for example, a child whose blood 
produced a lot of IL-4 and very little IL-5 was categorised with a child whose 
blood produced a lot of IL-5 and very little IL-4, whereas it was evident from 
scatter graphs that they do not necessarily belong in the same category. This 
method could thus result in false negative conclusions on the basis of the test 
alone. A scatter graph has therefore been presented for each data set with a sample 
size of greater than ten whether the difference between the number of children 
whose blood produced both IL-4 and IL-5, compared to the number of children 
whose blood produced either one or the other cytokine was significant or non­
significant according to the y} test, because a qualitative approach was considered a 
useful adjunct to the quantitative approach.
4.4 Results.
4.4.1 Prevalence of S, haematobium Infection.
Prevalence of infection was higher in children attending Valhalla School than 
Kaswa School, before treatment^ and 8 month's post-treatment^ after controlling for 
the effects of age and sex in a logistic regression analysis (figure 4.3 a and b).
l(p<0.0001, B= -0.855, S.E.=0.2032, Wald=17.7005, R=-02936, Exp (B)=0.4253)
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Prevalence of infection was not found to be significantly greater in young children 
(6-10 years) than in older children (11-15 years) before treatment or for three or 
four months following treatment. By the third follow up survey in May 1995, six 
months after treatment, prevalence of infection amongst younger children was 
significantly higher than in older children^. Nine months after treatment in August 
1995, the younger children still had a higher prevalence and intensity of infection 
than older children'^ (figure 4.3a and b). These significant differences were 
measured by logistic regression analyses after controlling for the effects of area and 
sex. Intensity of infection followed a similar pattern to prevalence of infection (data 
not shown).
25.9% of children who were infected before treatment had been re-infected by eight 
months post treatment compared to 16.0% of the children who were uninfected 
before treatment. This difference was statistically significant^ when tested with a y}, 
but when area, sex and age had been taken into account by means of a logistic 
regression analysis, pretreatment infection was no longer a significant explanatory 
variable of post-treatment infection status.
4.4.2 Cytokine production over time.
Statistical analysis of cytokine production over time is summarised in tables 4.1 and 
4.2. On stimulation with either SEA, WWH or CERC, there was no significant 
difference between IL-4 (figure 4.4a) or IL-IO (figure 4.4c) produced at any of the
2 (p<0.032B = -0.5038, S.E.=0.2351, Wald=4.5896, R= -0.1192, Exp (B)=0.6043)
3 (p<0.05, B = 1.0689, S.E. = 0.5331, Wald = 4.0207, R = 0.1103, Exp (B) = 2.9121)
4 (p<0.023, B = 0.6162 S.E. = 0.271, Wald = 5.1 
697, R =  0.1336, Exp (B) = 1.8519)
5 (p<0.03, x2 = 4.8, d.f. = 1, N=137)
_
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time points. Production of IL-5 on stimulation with antigen (figure 4.4b) appeared 
to increase gradually with time, although the differences were only significant when 
IL-5 produced 24 hours post incubation was compared with EL-5 produced after 
incubation for 72 hours. IFNy production (figure 4.4d) did increase with time: more 
was produced after 72 hours compared to 48 hours, and more was produced at 48 
hours compared to 24 hours. GM-CSF production peaked after 48 hours of 
incubation and TNFa production had peaked by 24 hours of incubation.
On incubation with PHA, there was no significant difference in production of EL-5 
(figure 4.5b) or IL-IO (figure 4.5c ) between different time points, TNFa 
production (figure 4.5f) peaked after 24 hours of incubation, more GM-CSF was 
produced at 48 hours post incubation compared to the 24 hour time point (figure 
4.5e), and IL-4 (figure 4.5a) and IFNy (figure 4.5d) production peaked at 72 hours 
post-incubation.
4.4.3 Cytokine produced in response to stimulation with mitogen or antigen.
I have attempted to identify factors that could explain the difference observed 
between children in their levels of cytokine production when blood was stimulated 
with the mitogen, PHA, or any of the antigens: SEA, WWH or CERC. To do this, I 
analysed data for all six cytokines, at all the time points and for each stimulant using 
either multiple logistic or linear regression methods as appropriate. The criteria for 
the use of each method is discussed in section 4.3. In each analysis, the variables 
investigated were age, area (either low or high prevalence area), sex, pretreatment 
infection status and infection status eight months after treatment.
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It was possible to use the more powerâil method of analysis, multiple linear 
regression for only two data sets. These sets were for IFNy and GM-CSF 
production, 24 hours after stimulation with PHA. As explained previously, to avoid 
type II errors, I will consider and discuss only those sets of data where a statistically 
significant explanatory variable (after correction for multiple tests) was identified. 
All significant results are summarised in Table 4.3.
4.4.3.1 Cytokines produced on incubation with PHA.
Area was a significant explanatory variable of IL-4 production on stimulation with 
PHA 24 hours post incubation after controlling for age, sex, pretreatment infection 
and infection eight months after treatment. Blood from 72% of children from the 
low prevalence area produced IL-4 after incubation for 24 hours with PHA, 
compared to blood from 13% of children from the high prevalence area (figure 4.6).
Blood from children resident in the low prevalence area produced more IFNy on 
stimulation with PHA 24 hours post incubation than blood from children in the high 
prevalence area. Area explained 20% of the variation in IFNy produced after 
incubation with PHA for 24 hours after controlling for age, sex pretreatment 
infection and infection eight months after treatment (figure 4.7). The five 
independent variables were regressed against IFNy on data transformed using the 
equation [ln(data +25)] to normalise the residuals of the model.
Blood from children resident in the low prevalence area produced more GM-CSF 
produced on stimulation with PHA 24 hours post incubation than children in the 
high prevalence area. Area explained 26% of the variation in GM-CSF produced
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after incubation with PHA for 24 hours after controlling for confounding variables 
(figure 4.8).
After controlling for age, sex pretreatment infection and infection eight months 
after treatment pre-treatment infection was a significant explanatory variable of BL- 
5 production on stimulation with PHA 24 hours post incubation (figure 4.9). Blood 
from 75% of children who were infected before treatment produced IL-5 on 
incubation with PHA for 24 hours compared to 40% of blood from children who 
were not infected.
4.4.3.2 Cytokine produced in response to antigen.
Pre-treatment infection was a significant explanatory variable of IL-4 production on 
stimulation with SEA, produced 24 hours post incubation after controlling for age, 
sex, pretreatment infection and infection eight months after treatment (figure 4.10). 
Blood from 42% of children who were uninfected before treatment produced IL-4 
on incubation with SEA compared to 8.1% of blood from children who were 
infected before treatment.
After controlling for age, sex, pretreatment infection status and infection eight 
months after treatment, area was a significant explanatory variable of IL-IO 
production on stimulation with SEA produced after 48 hours of culture (figure 
4.11). Blood from 36.3% of children resident in the low prevalence area produced 
IL-IO on stimulation with SEA compared to blood from 83.9% of children resident 
in the high prevalence area.
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Area was a significant explanatory variable of GM-CSF production produced after 
incubation for 48 hours with SEA after controlling for age, sex, pretreatment 
infection status and infection eight months after treatment (figure 4.12). Blood ft"om 
25% of children in the low prevalence area produced GM-CSF when cultured with 
SEA, compared with blood from 69% of children from the high prevalence area.
Post treatment infection was an explanatory factor for IFNy produced 48 hours 
post-incubation with WWH after controlling for age, sex pretreatment infection and 
infection eight months after treatment (figure 4.13). Blood from 57% of uninfected 
children produced IFNy compared to blood from 23% of infected children.
4.4.5 Is cytokine production influenced by cross reactive antigen?
Evidence of cross reactive antigen between SEA and WWH was observed for IL-5 
(figure 4.14) in the low prevalence area, and for IFNy (figure 4.15), EL-5 (figure 
4.16) and TNFa (figure 4.17) in the high prevalence area. Cytokine produced on 
stimulation with WWH by blood taken from children resident in the same 
prevalence area correlated positively with cytokine produced on stimulation with 
SEA, controlling for that produced on stimulation with PHA, for the following 
results: EL-5 produced at 72 hours post-incubation by blood from children resident 
in the low prevalence area, IFNy produced at 48 hours post-incubation, EL-5 
measured in supernatants after 48 hours of incubation, and TNFa produced at 24 
and 48 hours of incubation by blood from children resident in the high prevalence 
area. These results are in agreement with results obtained in the Gambian study 
(section 3.4.5) and supports the hypothesis that cross reactive epitopes in the
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antigen from the two life cycle stages have some effect on cytokine production. The 
statistical significance levels are summarised in table 4.4.
4.4.6 Children either produce IL-4 or EL-5 but not both.
Blood from more children produced either EL-4 or IL-5 than produced both 
cytokines on stimulation with SEA, WWH and PHA 24 hours post incubation 
(table 4.5, figure 4.18). Blood from more children produced either IL-4 or EL-5 but 
not both cytokines on stimulation with CERC, SEA and WWH 48 hours post 
incubation. There was no significant difference in the number of children whose 
blood produced either IL-4 or IL-5 compared to children whose blood produced 
both cytokines on stimulation with PHA 48 hours post incubation (table 4.6), 
although the scatter graph indicates that the majority of children produced 
predominantly one or the other cytokine (figure 4.19). There was no significant 
difference in the number of children whose blood produced either IL-4 or EL-5 
compared to children whose blood produced both cytokines on stimulation with 
WWH and PHA 72 hours post incubation (figure 4.20, table 4.7).
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4.5 Discussion.
Prevalence of Infection.
The higher prevalence of infection amongst children attending Valhalla School 
compared to children attending Kaswa School was assumed to be due to difference 
in transmission dynamics in the two areas. However, with the absence of data 
regarding contact with infected water, it is also formally possible that it reflected in 
addition, differences in the level of immunity to S.haematobium between the two 
groups of children.
The observed differences in prevalence of re-infection between the younger (6-10 
years) and older (11-15 years) children may be because the older children were 
either less exposed to infection, or have developed a partial immunity to infection. 
There are three possible hypotheses that could explain the effect that partial 
immunity might have had.
First, older children may have developed a level of immunity before treatment that 
allowed them to maintain a lower prevalence of infection than younger children. 
The worm burdens of older children before treatment would then reflect infections 
sustained earlier in life. A second possibility, is that partial immunity may have 
allowed older children to slow the build up of infection after treatment although 
eventually prevalence of infection would reach the same levels as their younger 
colleagues. This would explain why there was no difference between prevalence of 
infection in the two age groups before treatment because both groups had had 
enough time to gain maximal worm burdens. Thus the prevalence of infection 
before treatment would reflect maximum levels sustainable at each of the two sites
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given their differing transmission dynamics. Alternatively, praziquantel used in 
treating the children or their subsequent exposure to antigen resulting from the 
death of the adult worms, may have stimulated the immune system of older children 
allowing them to successfully defend themselves against further infection in a way 
unavailable to the possibly less mature and/or less experienced immune systems of 
the younger children.
In this case, it might be expected that a combination of age and infection before 
treatment could explain a significant amount of post treatment infection. However, 
there is no evidence from this study to suggest that this is the case since 
pretreatment infection status does not explain any more of the post treatment 
infection than age, sex and area without a consideration of pretreatment infection.
Cytokine production in response to antigen and mitogen.
Blood from children resident in the low prevalence area produced more IL-4, IFNy 
and GM-CSF than blood from children resident in the high prevalence area. These 
results, which are more significant than other comparisons, could imply that 
residence in the low prevalence area resulted in a stronger ThO-type response than 
residence in the high prevalence area, or that the more frequent challenge faced by 
children resident in the high prevalence area resulted in a reduction of their capacity 
to produce cytokines generally. Alternatively, since these differences in cytokine 
production were found in PHA stimulated samples, cytokine production may reflect 
something other than S.haematobium infection. For example, the immune systems 
of children resident in the low prevalence area may have a greater overall "fitness" 
than children resident in the high prevalence area, allowing their cytokine-producing
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cells to have a larger capacity to produce any cytokine than their colleagues in the 
high intensity area.
IL-5 produced on stimulation with PHA was associated with being infected before 
treatment whereas, IL-4 produced on stimulation with SEA was associated with a 
lack of infection before treatment. This could imply that a capacity to produce EL-5 
(a Th2 type cytokine) was associated with a susceptibility to infection and EL-4 
(also a Th2 type cytokine) production, on stimulation with SEA was associated 
with an immunity to infection. Alternatively, treatment of an infection with 
praziquantel may effectively result in vaccination by means of the sudden release of 
antigen; children who were infected before treatment could have been Vaccinated' 
whereas children who were uninfected would not have had their immune reactivity 
boosted in this way. The production of EL-5 by children who were infected before 
treatment, and the production of EL-4 by those uninfected before treatment might 
have been as a result of this 'vaccination'. The relevance of this IL-4 and IL-5 data 
will be discussed in more detail in the next section.
EL-10 and GM-CSF produced on stimulation with SEA was associated with 
residence in the high prevalence area. IL-IO and GM-CSF are both produced by 
macrophages (de Waal Malefyt et ai, 1991). IL-IO is classically considered to be a 
Th2-type cytokine although the cellular source of IL-IO is not as clear from 
experiments on human cells as it is for murine cell lines (Mosmann, 1994). GM- 
CSF is expressed by a number of cell types including Thl and Th2 cells (Rasko et 
al, 1994). Therefore macrophages or Th2 cells are likely to be responsible for more
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of the cytokine production in the high prevalence area than they are in the low 
prevalence area.
IFNy produced on stimulation with WWH was associated with a lack of infection 
after treatment. This might suggest that a Thl type response was associated with 
immunity to infection after treatment. Araujo and colleagues (1994) suggested that 
IFNy production was depressed in people exposed to S.mansoni. This result might 
be considered supporting evidence of this hypothesis, however this is the least 
statistically robust of the cytokine production results. The population of uninfected 
children, post treatment, could represent a much more heterogeneous group than 
uninfected children pre-treatment, in terms of the state of the development of their 
immune responses because very low rainfall as well as any degree of immunity, may 
have been a significant contributing factor to the low prevalence of infection eight 
months post treatment (see figure 4.12).
The cytokine profiles in both the high and low prevalence areas appear to be 
sending mixed signals, possibly as part of their regulatory processes. IL-IO is an 
inhibitor of macrophage cytokine synthesis, nitric oxide production and reduces 
their ability to present antigen to Thl cells (Mosmann, 1994). This would appear to 
be antagonistic to the effects of macrophage colony stimulating factor. A 
mechanism could be envisaged whereby in the low prevalence area IL-4 enhances 
CD23, a low affinity receptor of IgE-FcsRji, on B cells (Defrance et al, 1987b; 
Hivroz et al, 1989), whereas IFNy blocks this IL-4 dependent increase of CD23 
(Banchereau et al, 1991). IgE has been shown to be a strong feature of an effective
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immune response to schistosomiasis in humans (Hagan et al, 1991; Rihet et al, 
1991; Dunne et al, 1992).
Considering all of the cytokine results together, it would appear that area is the 
dominant factor in determining cytokine profile. I would postulate that the cytokine 
production is of a ThO type in the low prevalence area, compared to the high 
prevalence area, whereas in the high prevalence area, a pattern that could be 
described as either macrophage or Th2 type predominates. This would explain the 
distribution of GM-CSF and IL-IO produced on stimulation with SEA and IL-4, 
GM-CSF and IFNy produced on stimulation with PHA.
Studies in a community recently exposed to S.mansoni by Gryseels & colleagues 
(Gryseels, 1994a; Gryseels e ta l, 1994b; van Dam et al, 1996) have suggested that 
IgE-mediated immunity is an age-dependent, rather than an experience of infection- 
dependent phenomena. The current study would suggest that experience of 
infection does have an affect on the immune responses. In the absence of an adult 
immune cohort it was difficult to determine a cytokine profile that was definitively 
associated with resistance to infection. However previous studies would suggest 
that resistance to infection is mediated by Th2-type cytokines (Hagan et al, 1985; 
Hagan et al, 1991; Rihet et al, 1991; Dunne et al, 1992; Roberts et al, 1993). If 
this is an accurate picture, I would like to speculate that the greater production of 
Th2-type cytokines by children resident in the high prevalence area suggests that 
their immune responses to schistosomiasis are developing towards a protective type 
at a faster rate than children from the low prevalence area, although IL-4 
production is not significantly different. This does not preclude the possibility that
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physiological changes that occur with age might also be of importance in the 
development of an effective immune response.
A dichotomous relationship between EL-4 and EL-5
Analysis of IL-4 and IL-5 production suggests a possible subdivision of the Th2 
subset based on IL-4 and IL-5 production in both humans (Jung et al, 1995) and 
mice (Bucy et al, 1995). If Th2 cells are of two subtypes, one that produces IL-5 
but not IL-4 and the other, a IL-4 producer, but not an IL-5 producer then this 
might imply that treatment of infected children with praziquantel resulted in the 
dominance of a IL-5+/IL-4- Th2 cell subtype whereas in children who were 
uninfected before treatment the IL-5-/IL-4+ Th2 cell subset was dominant.
Grogan and colleagues (1996) reported that IL-5 secretion by peripheral blood 
mononuclear cells taken from infected individuals, increased five weeks post 
treatment compared to pretreatment levels. They attributed this change to either the 
lifting of an adult worm-induced Th2 suppression or the stimulation of EL-4+ Th2 
cells with antigen released by virtue of praziquantel treatment. Evidence from the 
current study would support the latter hypothesis. They did not report any changes 
in IL-4 levels after treatment, which they suggest indicates a lack of linkage 
between IL-4 and IL-5, implying that the two cytokines are produced by distinct 
cell sub-types. However, this conclusion could be considered a type II error, since it 
is based upon a result with a non-significant difference between two groups.
The dichotomy between IL-4 and IL-5 production, 24 and 48 hours post 
incubation, lends further support to the distinctive nature of IL-4 and IL-5
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production. However at 72 hours post incubation blood began to produce both 
cytokines. Possibly there are two population of cells as suggested by the 24 hour 
and 48 hour data. First one or the other is stimulated, but by 72 hours the other 
population comes into play. Alternatively, maybe in an individual a single cell 
population starts by producing only IL-4 or only IL-5 and then later starts to 
produce the other cytokine. Jung and colleagues (1995) found that T-cell clones 
and freshly isolated human T-cells subjected to multiple stimulation and culture for 
fourteen days were capable of producing both IL-4 and IL-5, supporting the latter 
hypothesis.
Cytokine production was influenced by cross reactive antigen.
There was a correlation between cytokine produced on stimulation with SEA and 
WWH, controlling for PHA, for IL-5 in the low prevalence area, and in the high 
prevalence area, for IFNy, IL-5, and TNFa. This suggests that cross reactive 
epitopes influence cytokine production in these cases as previously discussed in 
section 3.6.
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Figure 4.1a. An example of a non-normally distributed frequency distribution of 
cytokine production.
A frequency distribution of net IL-4 produced by whole blood taken from 
Zimbabwean children 12 months after treatment and cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots, for 72 hours in the presence of lOiigmf^ PHA. IL-4 
concentration was determined using a sandwich ELISA as described in section 2.3. 
Net data are the amount of cytokine produced by blood when cultured with PHA 
minus levels produced by blood cultured without stimulant.
Figure 4.1b. An example of a frequency distribution of log + 1  transformed data 
of cytokine production, which is also non-normally distributed.
A frequency distribution of net IL-4 produced by whole blood taken from 
Zimbabwean children 12 months after treatment and cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots, for 72 hours in the presence of lOf^gmf^ PHA. IL-4 
concentration was determined using a sandwich ELISA as described in section 2.3. 
Net data are the amount of cytokine produced by blood when cultured with PHA 
minus levels produced by blood cultured without stimulant. The data were 
transformed using the function log + 1.
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Figure 4.1a. An example of a non-normally distributed frequency distribution 
of cytokine production.
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Figure 4.1b. An example of a frequency distribution of log+1 transformed 
data of cytokine production, which is also non-normally distributed.
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Figure 4.2a. An example of a cytokine data set that was analysed using logistic 
regression analyses.
A frequency distribution o f net IL-4 produced by whole blood taken from 
Zimbabwean children 12 months after treatment and cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots, for 24 hours in the presence of lOpgml"^ PHA. IL-4 
concentration was determined using a sandwich ELISA as described in section 2.3. 
Net data are the amount of cytokine produced by blood when cultured with PHA 
minus levels produced by blood cultured without stimulant. The salient information 
for analysis by logistical regression was categorised as to whether blood from an 
individual produced cytokine or not.
Figure 4.2a. An example of a cytokine data set that was analysed using multiple 
linear regression analyses.
A frequency distribution of net IFNy produced by whole blood taken from 
Zimbabwean children 12 months after treatment and cultured at a dilution of 1 in 2 
with RPME in 1ml aliquots, for 24 hours in the presence of lOpgml'^ PHA. IFNy 
concentration was determined using a sandwich ELISA as described in section 2.3. 
Net data are the amount of cytokine produced by blood when cultured with PHA 
minus levels produced by blood cultured without stimulant. Multiple linear 
regression analysis enabled the level of cytokine production to be considered as a 
continuous dependent variable.
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Figure 4.2a. An example of a cytokine data set that was analysed using 
logistic regression analyses.
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Figure 4.2b. An example of a cytokine data set that was analysed using 
multiple linear regression analyses.
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Figure 4.3a. Prevalence of infection: Valhalla School.
Prevalence of infection, as determined by S.haematobium eggs observed in urine 
samples from children attending Valhalla School aged 6 to 10 years compared with 
children aged 11 to 15 years before treatment and at 3,4,6 and 8 months post 
treatment.
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Figure 4.3b. Prevalence of infection: Kaswa School.
Prevalence of infection, as determined by S.haematobium eggs observed in urine 
samples from children attending Kaswa School aged 6 to 10 years compared with 
children ages 11 to 15 years before treatment and at 3,4,6 and 8 months post 
treatment
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Table 4.1. Summary of the analysis of differences in cytokine production with 
time on stimulation with either SEA, WWH or CERC.
Cytokines were produced by whole blood from Zimbabwean children taken 12 
months after treatment for S.haematobium infection, cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots in the presence of lOpgml'^ of either SEA, WWH or 
CERC and measured using sandwich ELIS As as described in section 2.3, which have 
a sensitivity of 0.0625uml'^ and an accuracy of 0.01uml'\ Differences in net cytokine 
produced at different time points were compared using Wilcoxon signed ranks test 
followed by a sequential Bonferroni correction for multiple tests. Net cytokine is 
cytokine produced on stimulation with SEA, WWH or CERC minus cytokine 
produced when cultured without stimulant.
Table 4.2. Summary of the analysis of differences in cytokine production with 
time on stimulation with PHA.
Cytokines were produced by whole blood from Zimbabwean children taken 12 
months after treatment for S.haematobium infection, cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots in the presence of lOpgmf* of PHA and measured using 
sandwich ELISAs as described in section 2.3, which have a sensitivity o f 0.0625 
uml'^ and an accuracy o f 0.01uml'\ Differences in cytokine produced at different 
time points were compared using Wilcoxon signed ranks test followed by a 
sequential Bonferroni correction for multiple tests. Net cytokine is cytokine produced 
on stimulation with PHA minus cytokine produced when cultured without stimulant.
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Table 4.1. Summary of the analysis of differences in cytokine production with 
time on stimulation with either SEA, WWH or CERC.
Cytokine 24 verses 48 hours 48 verses 72 hours 24 verses 72 hours
N Z P< N Z P< N Z P< _
Hv-4 117 ns 43 ns 46 ns
H^5 111 ns 40 ns 46 -1.225 0.01
HU-10 77 ns 39 ns 40 ns
IFNg 117 -3.599 0.01 42 -2.444 0.05 42 -3.186 0.01
GM-CSF 74 -2.857 0.02 ~ ~
TNFa 44 -3.911 0.001 ~ ~ - -
~ = no comparison could be made because of low sample size.
All p values have been corrected to take into account multiple tests, 
ns = not significant.
Table 4.2.Summary of the analysis of differences in cytokine production with 
time on stimulation with PHA.
Cytokine 24 verses 48 hours 48 verses 72 hours 24 verses 72 hours
N Z P< N Z P< N z P<
HL-4 46 ns 18 ns 16 -2.953 0.01
m -5 39 ns 15 ns 14 ns
IL-IO 28 ns 13 ns 10 ns
IFNg 46 -4.441 0.01 18 -3.332 0.01 15 -3.237 0.01
GM-CSF 29 -2.857 0.004 ~ ~ ~
TNFa 17 -2.223 0.026 - ~ ~ ~ -
~ = no comparison could be made because of low sample size.
All p values have been corrected to take into account multiple tests, 
ns = not significant.
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Figure 4.4. A comparison of cytokine produced on stimulation with SEA, WWH 
or CERC at 24, 48 and 72 hours post incubation.
Cytokines were produced by whole blood from Zimbabwean children taken 12 
months after treatment for S. haematobium infection, cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots in the presence of lOpgml'^ of either SEA, WWH or 
CERC and measured using sandwich ELIS As as described in section 2.3, which have 
a sensitivity of 0.0625umf^ and an accuracy of 0.01uml"\ Differences in net cytokine 
produced at different time points were compared using Wilcoxon signed ranks test 
followed by a sequential Bonferroni correction for multiple tests. The statistically 
significant differences between time points are summarised in table 4.1. Net cytokine 
is cytokine produced on stimulation with SEA, WWH or CERC minus cytokine 
produced when cultured without stimulant.
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Figure 4.4
A comparison of cytokine produced on stimulation with SEA, WWH or 
CERC at 24, 48 and 72 hours post incubation.
Figure 4.4a: IL-4 Figure 4.4d: IFNy
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Figure 4.5. A comparison of cytokine produced on stimulation with PHA at 24, 
48 and 72 hours post incubation.
Cytokines were produced by whole blood from Zimbabwean children taken 12 
months after treatment for S.haematobium infection, cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots in the presence of lOpgml'^ of PHA and measured using 
sandwich ELIS As as described in section 2.3, which have a sensitivity of 0,0625 
umf* and an accuracy of 0.01uml'\ Differences in net cytokine produced at different 
time points were compared using Wilcoxon signed ranks test followed by a 
sequential Bonferroni correction for multiple tests. The statistically significant 
differences between time points are summarised in table 4.2, Net cytokine is 
cytokine produced on stimulation with PHA minus cytokine produced when cultured 
without stimulant.
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Figure 4.5
A comparison of cytokine produced on stimulation with PHA at 24, 48 and 
72 hours post incubation.
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Table 4.3 Summary of significant explanatory variables of cytokine production.
Cytokines were produced by whole blood from Zimbabwean children taken 12 
months after treatment for S.haematobium infection, cultured at a dilution of 1 in 2 
with RPMI in 1ml aliquots in the presence of lOpgmf^ of either SEA, WWH or PHA 
and measured using sandwich ELIS As as described in section 2.3, which have a 
sensitivity of 0.0625 uml"  ^ and an accuracy of O.OlumfV Net data were used 
throughout. Net data are cytokine produced on culture with mitogen or antigen minus 
cytokine produced on culture without stimulus.
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Table 4.3. Summary of statistically significant explanatory variables of
Cytokine Stimulant Time point 
post 
incubation
Type of 
multiple 
regression.
Significant
explanatory
variable.
B P<
(N)
Explanation.
IL-4 PHA 24 Logistic Area 1.7033 0.001
(55)
Production o f IL-4 
measured at 24 hours post 
incubation, on stimulation 
with PHA was associated 
with residence in the low 
prevalence area.
IFNy PHA 24 Linear Area -0.347 0.0005
(52)
IFNy measured at 24 hours 
post incubation, on 
stimulation witli PHA was 
associated with residence 
in the low prevalence area.
GM-CSF PHA 24 Linear Area -6.12 0.0005
(42)
GM-CSF measured at 24 
hours post incubation, on 
stimulation with PHA was 
associated with residence 
in the low prevalence area.
IL-IO SEA 48 Logistic Area 2.367 0.05
(42)
Production o f IL-10 
measured at 48 hours post 
incubation, on stimulation 
with SEA was associated 
witli residence in tlie high 
prevalence area.
GM-CSF SEA 48 Logistic Area -1.2834 0.05
(42)
Production o f GM-CSF 
measured at 48 hours post 
incubation, on stimulation 
with SEA was associated 
with residence in the high 
prevalence area.
IL-5 PHA 24 Logistic Pre­
treatment
infection
status
-1.1466 0.05
(49)
Production o f IL-5 
measured at 24 hours post 
incubation, on stimulation 
with PHA was associated 
with infection before 
treatment.
IL-4 SEA 24 Logistic Pre­
treatment
infection
status
-1.4095 0.05
(54)
Production o f  IL-4 
measured at 24 horns post 
incubation, on stimulation 
with SEA was associated 
witli a lack o f infection 
before treatment.
IFNy WWH 48 Logistic Post­
treatment
infection
status
-1.3718 0.05
(67)
Production o f IFNy 
measured at 48 hours post 
incubation, on stimulation 
with WWH was associated 
with infection status eight 
months after treatment.
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Figure 4.6. A comparison of the effects of residence in an area of low or high 
prevalence for S.haematobium on production of IL-4 by blood samples from 
Zimbabwean children when stimulated with PHA for 24 hours.
Blood from children resident in the low prevalence area was more likely to produce 
net IL-4 than blood from children resident in the high prevalence area (multiple 
logistic regression analysis controlling for age, sex, pre- and post-treatment 
infection status: B=1.70, n=55, p<0.001). Blood was taken from Zimbabwean 
children 12 months post treatment for S.haematobium infection and cultured for 24 
hours with lOpgml'^ PHA. Blood was cultured at a dilution o f 1 in 2 with RPMI in 
1ml aliquots and measured using sandwich ELISAs as described in section 2.3, 
which have a sensitivity of 0.0625umf^ and an accuracy of O.Olumf*. Net IL-4 was 
comprised of IL-4 produced when blood was cultured with PHA minus IL-4 
produced when blood was cultured without stimulant.
Producer
IL-4 Category.
N o n ­
producer
High Prevalence 
Low Prevalence
Area.
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Figure 4.7. A comparison of the effects of residence in an area of low or high 
prevalence for haematobium on production of IFNy by blood samples from 
Zimbabwean children when stimulated with PHA for 24 hours.
Blood from children resident in the low prevalence area produced more net IFNy 
than blood from children resident in the high prevalence area (multiple linear 
regression analysis controlling for age, sex, pre- and post-treatment infection status 
B= -0.347, n=52, p<0.0005). Blood was taken from Zimbabwean children 12 
months post treatment for S.haematobium infection and cultured for 24 hours with 
lOpgmf^ PHA. Blood was cultured at a dilution of 1 in 2 with RPMI in 1ml 
aliquots and measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0,0625 uml'^ and an accuracy of 0.01uml'\ Net IFNy was 
comprised of IFNy produced when blood was cultured with PHA minus IFNy 
produced when blood was cultured without stimulant.
100
80
60
s3 40jg-
a
20
0
-20
1 1
Low Prevalence Area High Prevalence Area
138
Chapter 4: Cytokine Production in Zimbabwean children
Figure 4.8. A comparison of the effects of residence in an area of low or high 
prevalence for S.haematobium on production of GM-CSF by blood samples 
from Zimbabwean children when stimulated with PHA for 24 hours.
Blood from children resident in the low prevalence area produced more net GM- 
CSF than blood from children resident in the high prevalence area (multiple linear 
regression analysis controlling for age, sex, pre- and post-treatment infection status 
B--0.347, n=42, p<0.0005). Blood was taken from Zimbabwean children 12 
months post treatment for S.haematobium infection and cultured for 24 hours with 
lOpgml'^ PHA. Blood was cultured at a dilution of 1 in 2 with RPMI in 1ml 
aliquots and measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625 uml'^ and an accuracy of 0.01uml'\ Net GM-CSF was 
comprised of GM-CSF produced when blood was cultured with PHA minus GM- 
CSF produced when blood was cultured without stimulant.
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Figure 4.9. A comparison of the effects pre-treatment infection status for 
S.haematobium on production of IL-5 by blood samples from Zimbabwean 
children when stimulated with PHA for 24 hours.
Blood from children who were infected before treatment, as ascertained by 
S.haematobium eggs found in urine samples, were more likely to produce net IL-5 
than blood from children who were not infected before treatment (multiple logistic 
regression analysis controlling for age, sex, post-treatment infection status and 
area: B=-1.147, n~49, p<0.05). Blood was taken from Zimbabwean children 12 
months post treatment for S.haematobium infection and cultured for 24 hours with 
lOpgml'^ PHA. Blood was cultured at a dilution of 1 in 2 with RPMI in 1ml 
aliquots and measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625umr^ and an accuracy of O.Oluml'V Net IL-5 was 
comprised of IL-5 produced when blood was cultured with PHA minus IL-5 
produced when blood was cultured without stimulant.
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Figure 4.10. A comparison of the effects of pre-treatment infection status for 
S,haematobium on production of IL-4 by blood samples from Zimbabwean 
children when stimulated with SEA for 24 hours.
Blood from children who were not infected before treatment, as ascertained by 
S.haematobium eggs found in urine samples, were more likely to produce net IL-4 
than blood from children who were infected before treatment (multiple logistic 
regression analysis controlling for age, sex, post-treatment infection status and 
area: B==-1.410, n=54, p<0.05). Blood was taken from Zimbabwean children 12 
months post treatment for S.haematobium infection and cultured for 24 hours with 
lO^igml'^ PHA. Blood was cultured at a dilution of 1 in 2 with RPMI in 1ml 
aliquots and measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625uml'^ and an accuracy of 0.01uml"\ Net IL-4 was 
comprised of IL-4 produced when blood was cultured with PHA minus IL-4 
produced when blood was cultured without stimulant.
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Figure 4.11. A comparison of the effects of residence in an area of low or high 
prevalence for S.haematobium on production of IL-10 by blood samples from 
Zimbabwean children when stimulated with SEA for 48 hours
Blood from children resident in the high prevalence area was more likely to 
produce net EL-10 than blood from children resident in the low prevalence area 
(multiple logistic regression analysis controlling for age, sex, pre- and post­
treatment infection status: B=2.37, n=42, p<0.05). Blood was taken from 
Zimbabwean children 12 months post treatment for S.haematobium infection and 
cultured for 48 hours with lOpgmf^ SEA. Blood was cultured at a dilution of 1 in 
2 with RPMI in 1ml aliquots and measured using sandwich ELISAs as described in 
section 2.3, which have a sensitivity o f 0.0625umf^ and an accuracy of 0.01uml‘\  
Net IL-10 was comprised of EL-10 produced when blood was cultured with SEA 
minus EL-10 produced when blood was cultured without stimulant.
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Figure 4.12. A comparison of the effects of residence in an area of low or high 
prevalence for S. haematobium on production of GM-CSF by blood samples 
from Zimbabwean children when stimulated with SEA for 48 hours
Blood from children resident in the high prevalence area was more likely to 
produce net GM-CSF than blood from children resident in the low prevalence area 
(multiple logistic regression analysis controlling for age, sex, pre- and post­
treatment infection status: B=-1.283, n=42, p<0.05). Blood was taken from 
Zimbabwean children 12 months post treatment for S.haematobium infection and 
cultured for 48 hours with lOpgml'^ SEA. Blood was cultured at a dilution of 1 in 
2 with RPMI in 1ml aliquots and measured using sandwich ELISAs as described in 
section 2.3, which have a sensitivity of 0.0625uml'^ and an accuracy of 0.01uml'\ 
Net GM-CSF was comprised of GM-CSF produced when blood was cultured with 
SEA minus GM-CSF produced when blood was cultured without stimulant.
No. of children
OVf-CSF Non­
producer
GM-CSF Categoiy
GM-CSF
Producer
High Prevalence 
Low Prevalence A re a
143
Chapter 4: Cytokine Production in Zimbabwean children
Figure 4.13, A comparison of the effects of infection status for S. haematobium 
eight months after treatment on production of IFNy by blood samples from 
Zimbabwean children when stimulated with WWH for 48 hours
Blood from children who were uninfected eight months after treatment for 
S.haematobium infection as ascertained by S.haematobium eggs found in urine 
samples were more likely to produce net IFNy than blood from children who were 
uninfected eight months after treatment (Multiple logistic regression analysis 
controlling for age, sex, pre-treatment infection status and area: B=-1.3718, n==67, 
p<0.05). Blood was taken from Zimbabwean children 12 months post treatment for 
S.haematobium infection and cultured for 48 hours with lOfagml'  ^ WWH. Blood 
was cultured at a dilution of 1 in 2 with RPMI in 1ml and measured using sandwich 
ELISAs as described in section 2.3, which have a sensitivity of 0.0625uml'^ and an 
accuracy of O.OlumfVNet IFNy was comprised of IFNyproduced when blood was 
cultured with SEA minus IFNyproduced when blood was cultured without 
stimulant.
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Figure 4.14. A correlation analysis of levels of BL-5 produced from blood 
samples taken from Zimbabwean children when stimulated with either SEA 
or WWH.
Net IL-5 produced by blood taken from children resident in the low prevalence 
area on stimulation with 10 pgml'^ WWH correlated positively with net IL-5 on 
stimulation with 10 lagml'  ^ SEA 72 hours post incubation controlling for 
production of net IL-5 produced on culture with 10 pgml'^ PHA for 72 hours 
(p<0.025, n = ll, Txy.z = 0.471 using a Kendall partial correlation followed by a 
sequential Bonferroni correction for multiple tests). Blood was taken 12 months 
post treatment for S.haematobium and cultured at a dilution of 1 in 2 with RPMI in 
1ml. IL-5 was measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625uml'^ and an accuracy of O.Oluml'V Net IL-5 was 
comprised of IL-5 produced when blood was cultured with stimulant minus IL-5 
produced when blood was cultured without stimulant.
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Figure 4.15. A correlation analysis of levels of IFNy produced from blood 
samples taken from Zimbabwean children when stimulated with either SEA 
or WWH.
Net IFNy produced by blood taken from children resident in the high prevalence 
area on stimulation with 10 pgmf^ WWH correlated positively with net IFNy on 
stimulation with 10 pgml'^ SEA 48 hours post incubation controlling for 
production of net IL-5 produced on culture with 10 jigml'^ PHA for 48 hours 
(p<0.025, n=28, Txy.z ~ 0.471, using a Kendall partial correlation followed by a 
sequential Bonferroni correction for multiple tests). Blood was taken 12 months 
post treatment for S.haematobium and cultured at a dilution of 1 in 2 with RPMI in 
1ml. IFNy was measured using sandwich ELISAs as described in section 2.3, 
which have a sensitivity of 0.0625umf^ and an accuracy of 0.01umf\ Net IFNy 
was comprised of IFNy produced when blood was cultured with stimulant minus 
IFNy produced when blood was cultured without stimulant.
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Figure 4.16. A correlation analysis of levels of IL-5 produced from blood 
samples taken from Zimbabwean children when stimulated with either SEA 
or WWH.
Net IL-5 produced by blood taken from children resident in the high prevalence 
area on stimulation with 10 jj-gml’  ^ WWH correlated positively with net IL-5 on 
stimulation with 10 pgml'^ SEA 48 hours post incubation controlling for 
production of net IL-5 produced on culture with 10 pgml'* PHA for 48 hours 
(p<0.001, n=27, Txy.z = 0.427, using a Kendall partial correlation followed by a 
sequential Bonferroni correction for multiple tests). Blood was taken 12 months 
post treatment for S.haematobium and cultured at a dilution of 1 in 2 with RPMI in 
1ml. IL-5 was measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625uml'^ and an accuracy of 0.01uml'\ Net IL-5 was 
comprised of IL-5 produced when blood was cultured with stimulant minus IL-5 
produced when blood was cultured without stimulant.
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Figure 4.17 . A correlation analysis of levels of TNFa produced from blood 
samples taken from Zimbabwean children when stimulated with either SEA or 
WWH.
Net TNFa produced by blood taken from children resident in the high prevalence 
area on stimulation with 10 ngmf^ WWH correlated positively with net TNFa on 
stimulation with 10 figml'^ SEA 24 or 48 hours post incubation controlling for 
production of net TNFa produced on culture with 10 tigml'^ PHA for 24 or 48 hours 
respectively (24 hours: p<0.002, n=19, Txy.z = 0.608, 48 hours: p<0.025, n= 20, Txy.z 
= 0.345, in both cases, using a Kendall partial correlation followed by a sequential 
Bonferroni correction for multiple tests). Blood was taken 12 months post treatment 
for S.haematobium and cultured at a dilution of 1 in 2 with RPMI in 1ml. TNFa was 
measured using sandwich ELISAs as described in section 2.3, which have a 
sensitivity o f 0.0625uml‘  ^ and an accuracy o f 0.01uml'\ Net TNFa was comprised of 
TNFa produced when blood was cultured with stimulant minus TNFa produced 
when blood was cultured without stimulant.
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Figure 4.17. A correlation analysis of levels of TNFa produced from blood 
samples taken from Zimbabwean children when stimulated with either SEA 
or WWH.
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Table 4.4.
A summary of the statistical analysis addressing the hypothesis that cytokine 
production is influenced by cross reactive antigens.
A partial correlation analysis between levels of net cytokine production for each of 
cytokines on stimulation with 10 jagml'* of either SEA or WWH, controlling for 
levels produced on stimulation with 10 p-gml'  ^ of PHA. Kendall partial correlation 
analysis was conducted in each case and levels of significance determined after 
correction for multiple tests by a sequential Bonferroni technique. Statistical analysis 
using this methodology was inappropriate when n<10 or the majority o f samples 
produced no net cytokines for one or both antigens. Cytokines were produced by 
whole blood from Zimbabwean children taken 12 months after treatment for 
S.haematobium infection, cultured at a dilution of 1 in 2 with RPMI in 1ml and 
measured using sandwich ELISAs as described in section 2.3, which have a 
sensitivity of 0.0625uml'^ and an accuracy of O.OlumfV Net cytokine was comprised 
of cytokine produced when blood was cultured with a stimulant minus cytokine 
produced when blood was cultured without a stimulant.
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Table 4.4.
A summary of the statistical analysis addressing the hypothesis that cytokine 
production is influenced by cross reactive antigens.
Low Prevalence Area.
Hour post incubation.
Cytokine 24 48 72
GM-CSF
IFNy ns ns
IL-10 . .
IL-4 ns ns ns
IL-5 ns 0.025
TN Fa
High Prevalence Area.
Hour post incubation.
Cytokine 24 48 72
GM-CSF ns ns
IFNy 0.025
IL-10 ns ns
IL-4 ns
IL-5 0.001
TNFa 0.002 0.025
ns = Not significant 
- = sample size of less than 10.
~ = a majority of data points were Ouml"! for one or both antigens.
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Table 4.5, 4.6 and 4.7, A comparison of the number of children whose blood 
produced either IL-4 or IL-5 compared to those whose blood produced both IL- 
4 and IL-5.
Blood samples were taken from Zimbabwean children 12 months after treatment for 
S.haematobium infection, cultured at a dilution of 1 in 2 with RPMI in 1ml aliquots 
in the presence of lOngmf^ of one of four antigens SEA, WWH, CERC or PHA for 
either 24, 48 or 72 hours. Levels of net IL-4 and IL-5 were measured using sandwich 
ELISAs as described in section 2.3, which have a sensitivity of 0.0625uml'^ and an 
accuracy of 0.01uml'\ Statistical tests were made by test. Net cytokine was 
comprised of cytokine produced when blood was cultured with a stimulant minus 
cytokine produced when blood was cultured without a stimulant.
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Table 4.5. IL-4 and IL-5 produced 24 hours post incubation.
Stimulant. Number of 
children whose 
blood produced 
either IL-4 or IL-5
Number of children 
whose blood 
produced both IL-4 
and IL-5.
(P<) Degreesof
freedom
CERC
SEA 14 1 0.0008 11.27 1
WWH 28 5 0.0001 16.03 1
PHA 31 10 0.001 10.8 1
~ = sample size of less than 10.
Table 4.6. IL-4 and IL-5 produced 48 hours post incubation.
Stimulant. Number of 
children whose 
blood produced 
either IL-4 or IL-5
Number of children 
whose blood 
produced both IL-4 
and IL-5.
(p<) iC Degreesof
freedom
CERC 9 1 0.01 6.40 1
SEA 24 4 0.0002 14.29 1
WWH 27 13 0.03 4.9 1
PHA 23 19 ns 0.38 1
~ = sample size of less than 10. ns = 
Table 4.7 IL-4 and IL-5 producec
not significant.
72 hours post incubation.
Stimulant. Number of 
children whose 
blood produced 
either IL-4 or IL-5
Number of children 
whose blood 
produced both IL-4 
and IL-5.
(P<) Degreesof
freedom
CERC
SEA
WWH 10 8 ns 0.11 1
PHA 10 10 ns 0.00 1
= sample size of less than 10, ns = not significant.
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Figure 4.18, A comparison of the levels of production of IL-4 and IL-5 after 
culturing for 24 hours in the presence of one of three stimulants: SEA, WWH or 
PHA.
Cytokines were produced by whole blood samples from Zimbabwean children taken 
12 months after treatment for S.haematobium infection, cultured at a dilution of 1 in 
2 with RPMI in 1ml aliquots in the presence of lOpgml’  ^ o f either SEA, WWH or 
PHA. Cytokines were measured using sandwich ELISAs as described in section 2.3, 
which have a sensitivity of 0.0625uml'^ and an accuracy of 0.01uml'\ Net levels of 
cytokine were compared. Net cytokine was comprised of cytokine produced when 
blood was cultured with a stimulant minus cytokine produced when blood was 
cultured without a stimulant.
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Figure 4.18.
A comparison of the levels of production of IL-4 and TL-5 after culturing for 
24 hours in the presence of one of three stimulants: SEA, WWH or PHA.
Blood stimulation with SEA. Blood stimulated with W W H.
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Figure 4.19. A comparison of the levels of production of BL-4 and IL-5 after 
culturing for 48 hours with presence of one of four stimulants: CERC, SEA, 
WWH or PHA.
Cytokines were produced by whole blood samples from Zimbabwean children taken 
12 months after treatment for S.haematobium infection, cultured at a dilution of 1 in 
2 with RPMI in 1ml aliquots in the presence of lOpgmf^ of either SEA, WWH, 
CERC or PHA. Cytokines were measured using sandwich ELISAs as described in 
section 2.3, which have a sensitivity of 0.0625uml‘  ^ and an accuracy of 0.01uml'\ 
Net levels of cytokine were compared. Net cytokine was comprised of cytokine 
produced when blood was cultured with a stimulant minus cytokine produced when 
blood was cultured without a stimulant.
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Figure 4.19.
A comparison of the levels of production of IL-4 and IL-5 after culturing for 
48 hours in the presence of one of four stimulants: CERC, SEA, WWH or 
PHA.
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Figure 4.20. A comparison of the levels of production of IL-4 and IL-5 after 
culturing for 72 hours with presence of one of two stimulants: WWH or PHA.
Cytokines were produced by whole blood samples from Zimbabwean children taken 
12 months after treatment for S.haematobium infection, cultured at a dilution of 1 in 
2 with RPMI in 1ml aliquots in the presence of lOpgmf^ o f either WWH or PHA . 
Cytokines were measured using sandwich ELISAs as described in section 2.3, which 
have a sensitivity of 0.0625umf* and an accuracy of 0.01um f\ Net levels of 
cytokine were compared. Net cytokine was comprised of cytokine produced when 
blood was cultured with a stimulant minus cytokine produced when blood was 
cultured without a stimulant.
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Figure 4.20.
A comparison of the levels of production of IL-4 and IL-5 after culturing for 
72 hours in the presence of one of two stimulants; WWH or PHA.
Blood stimulated with W W H. Blood stimulated with PHA.
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Chapter 5.
General Discussion
Chapters: General Discussion
5.1 PBMC from children produce more IFNy on stimulation with antigen 
than PBMC from adults.
In the cross-sectional study in The Gambia, PBMC from children or infected 
individuals produced more net IFNy on stimulation with WWH and SEA compared 
to PBMC from adults or uninfected individuals. I would therefore like to propose 
that the overriding immune response exhibited by children and infected individuals 
to schistosome antigens could be considered comparable to a murine Thl-type 
response.
Resistance to S.mansoni infection in the mouse can be mediated either by a Thl- 
type response when mice are vaccinated a single time with attenuated cercariae, or 
a Th2-type response in mice vaccinated three times with the same vaccine 
(Caulada-Benedetti et al, 1991; Wynn et al, 1996). If it is assumed that adults 
have a response that is more closely related to a Th-2-type, due to their lack of a 
Thl-type response, the multiple-vaccination model could be considered to mimic 
the type of immune response observed in adult humans, who would have gained 
their exposure as a result of trickle infections over a period of years.
In contrast with responses to antigen stimulation, PBMC stimulated with the 
mitogen PHA, from adults or uninfected individuals tended to produce more 
cytokine and proliferate than PBMC from children or infected individuals. Since 
these observations were due to mitogen, rather than antigen stimulation, they could 
represent some difference other than schistosome infection, the most likely being 
age since in the Gambian study uninfected individuals roughly corresponded 
with adults and infected individuals with children. It is reasonable to assume that
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the adults in this study had past and continuing exposure to schistosomiasis 
because the people had a similar lifestyle to residents of the village of Madina, 
in the same area, where detailed water contact observations have been carried 
out (Wilkins et al. 1987, Hagan et al., 1991). Given this assumption, the adults 
in this study were likely to have been exposed to infection for many more years 
than the children and have gained some degree of protection against infection 
since they had no detectable worm burden. The differences in immune response 
between children and adults could therefore be due to age related factors or 
reflect number of years of experience of S.haematobium.
Some evidence, however, suggests that Th2-type responses are also associated 
with pathology in mice (Sher et al, 1991; Wynn et al, 1995) and humans 
(Williams et al, 1994). Extrapolating from the murine model, although natural 
immunity may be Th2-mediated in humans, it may be possible for a future vaccine 
to stimulate an artificial, but effective Thl-type of protection, which might avoid 
inducing pathology.
5.2 Evidence that a protective profile of cytokine production may be due to 
the absence of IFNy rather than increased IL-4 production.
If the immune response switches from a Thl-type in infected individuals to a Th2- 
type in uninfected individuals, it might be expected that a person with high levels of 
IFNy would also have low levels of IL-4 and vice versa. However no such 
dichotomous relationship was observed. This would suggest that the underlying 
mechanism of acquiring an appropriate protective immunity is not simply a switch
from the dominance of one T-cell subtype to another. Instead, I would suggest that
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the cytokine profile observed in adults in The Gambia, was not that of a positive 
Th2-type response, but was due rather, to the lack of a strong Thl-type response.
This hypothesis is supported by the observations that net IFNy production was 
significantly different between infected and uninfected individuals on stimulation 
with both WWH and SEA, whereas the difference in net IL-4 production was 
significant only as a result of stimulation with the non-specific mitogen PHA. If  this 
hypothesis is correct, then the induction of an artificially induced strong Thl-type 
response, although protective in mice, may have precisely the opposite effect in 
humans.
5.3 Is resistance to S. haematobium infection acquired as a result of age or 
experience of infection?
Evidence from new foci of schistosomiasis has indicated that the drop in intensity 
o f infection observed with adulthood, is due to resistance acquired as a result of 
age, rather than as a result of years of experience of infection (Gryseels et al, 
1989; Gryseels, 1991a; Gryseels et al, 1991b; Gryseels et al, 1994b). Other 
studies, however, have indicated that experience of infection is the dominant factor 
in the development of resistance (Kloetzel et al, 1967; Woolhouse, 1994) as 
previously discussed in section 1.2.
The study design in The Gambia did not differentiate between older people and 
those with more experience of infection, so it was not possible to address the 
question of age verses experience with that study. However, the Zimbabwean 
study did afford an opportunity to observe differences in the immune responses of
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children who had experienced S.haematobium for the same length of time, but in 
areas of differing transmission dynamics.
The place of residence of a child was the dominant factor in determining cytokine 
profile. More children resident in the low prevalence area produced IL-4 and they 
produced more IFNy and GM-CSF than children fi-om the high prevalence area. 
These results implied that children from the low prevalence area had a stronger 
ThO-type immune response than children from the high prevalence area. More 
children resident in the high prevalence area, however, produced GM-CSF and IL- 
10 (a Th2- or macrophage-type profile) on stimulation with SEA than children 
from the low prevalence area.
If it is assumed that a protective cytokine profile is Th2-like, a possible 
interpretation of these results is that children resident in the high prevalence area, 
were developing faster towards a protective type of immune response than children 
resident in the low prevalence area, and therefore that experience of infection was 
a dominant factor in altering the type of immune response that the children 
exhibited to S.haematobium infection.
Although age was not a significant explanatory variable of cytokine production in 
Zimbabwe, in The Gambian study, there was a distinct difference in immune 
response between children and adults. Possibly, the immune response of children 
gradually changes as they gain more experience of infection, as seen in the 
Zimbabwe study from a ThO-type response, to a Th2-type response (as defined by 
production of IL-10). IL-10, possibly derived from macrophages rather than T-
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cells, down-regulates the Thl-type responses, allowing what appears to be a 
predominant Th2 response to develop in adulthood, due to the relative lack of 
Thl-type cytokines such as IFNy, as observed in The Gambia. There could either 
be a sudden switch to Th2 (or from Thl), as might be expected given the sudden 
drop in age-related intensity of infection observed in many endemic areas, or a 
gradual shift from ThO to macrophage-induced suppression of Thl, resulting in a 
net Th2-type cytokine profile.
5.4 IL-4 and IL-5 are produced by separate cell populations.
IL-4 and IL-5 (both Th2-type cytokines) were rarely co-expressed in blood from 
the same child, when it was cultured for either 24 or 48 hours (section 4.4.6). One 
interpretation of these results is that IL-4 and IL-5 were expressed by separate cell 
populations. This hypothesis is supported by intra-cellular cytokine staining 
experiments (Jung et al, 1995). Jung and colleagues (1995) observed that IL-4 
and IL-5 were predominantly produced by different human peripheral T-cells, in 
blood fi-om healthy volunteers and in patients with hyper-IgE syndrome. IFNy and 
IL-2 (Th-1 type cytokines) were produced by the same cells.
Sewell and Mu (1996) have suggested that cytokines in micro-environments may 
mediate the development of ThO cells to one of four T-cell sub-types, rather than 
the conventional two. They discuss evidence that IL-12 and IFNy together, could 
mediate production of Thl cells, IL-4 alone may mediate production of Th2 cells 
that can produce both IL-4 and IL-5, IL-12 and IL-4 in the absence of IFNy could 
result in the development of IL-4 producing cells that do not produce IL-5, and
159
Chapters: General Discussion
that IL-2, with some other unknown co-factor may modulate the development of 
IL-5 producing cells that do not also produce IL-4.
After culture for 72 hours, blood from a significant proportion of Zimbabwean 
children produced both IL-4 and IL-5 on stimulation with WWH and PHA. This 
could be interpreted in two ways. Either, after 72 hours cells co-expressed both 
cytokines, or another cell population began to produce cytokine at this time. The 
experimental design was not capable of distinguishing between these two 
scenarios. However, intra-cellular cytokine staining has revealed that, unlike freshly 
sampled T-cells, T-cell clones are capable of co-expressing both IL-4 and IL-5 and 
further, that it is possible to induce co-expression in fresh human T-cells by 
multiple stimulation and culture for fourteen days (Jung et ah, 1995). One possible 
interpretation of the Zimbabwean results therefore could be that in blood from an 
individual, cells started by producing only IL-4 or only IL-5 and then later started 
to produce the other cytokine as a result of multiple stimulation of the cells in 
vitro.
IL-4 and IL-5 are independently regulated in several disease systems (Sewell et al, 
1996) including atopic dermatitis (Kagi et al, 1994), asthma (Walker et al, 1992) 
and psoriasis (Vollmer et al, 1994). IL-5 is generally associated with eosinophilia, 
whereas IL-4 is associated with IgE production. Where one of these cytokines was 
produced in the absence of the other, this was reflected in the resulting pathology 
(Sewell et al, 1996). It is possible that immunity to schistosomiasis could be 
mediated by either IL-4 or IL-5.
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It is interesting that almost no samples contained detectable IL-5 produced on 
stimulation with SEA or WWH in the Gambian study, and yet high levels of 
eosinophils were observed in children. IL-5, however, was detected in antigen- 
stimulated samples from the Zimbabwean study using the same ELISA protocol. A 
major difference between the two studies was the culture method. PBMC were 
utilised in The Gambia, whereas a whole blood stimulation method was used in 
Zimbabwe. It is possible that this difference between the two studies could be 
explained by eosinophils which, in The Gambia, because of their density, would 
have been pelleted with the red blood cells in the ficol-gradient centrifrigation 
method of separating PBMC from whole blood.
Other studies, however, have reported detectable IL-5 produced on stimulation of 
PBMC with schistosome antigens (Roberts et al, 1993; Grogan et al, 1996), 
suggesting that the other cell types may also produce IL-5 under some 
circumstances. These results not with standing, it would be interesting to compare 
levels of IL-5 produced by PBMC and whole blood taken from the same cohort of 
people from a schistosomiasis endemic area, and measured using the same 
protocol. A potentially more powerful method is intra-cellular cytokine staining. If 
the intra-cellular cytokine staining method could be developed further, such that 
cytokines produced by cell types other than T-cells could be investigated, it may be 
possible to better elucidate the actual, rather than simply the potential, source of 
many cytokines.
Grogan and colleagues (1996) observed that IL-4 secretion by PBMC from people 
(both children and adults) infected with S.haematobium increased five weeks after
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treatment, but there was no change in levels of IL-5. As previously discussed 
(sections 1.3.3 and 4.5), this could be due either to down-modulation of IL-4 
production by the live adult worm, or stimulation of IL-4 producing cells as a 
result of antigen release on treatment with praziquantel. Irrespective of which 
hypothesis is correct, these observations indicate that IL-4 and IL-5 are modulated 
independently in S.haematobium infection.
IL-5 produced on stimulation with PHA in Zimbabwe, one year post-treatment, 
was associated with pre-treatment infection status whereas, IL-4 produced on 
stimulation with SEA was associated with a lack of infection before treatment. 
These results could imply that antigen released on treatment resulted in an 
increased capacity to produce IL-5, but a decreased IL-4 response to stimulation 
with SEA (previously discussed in section 4.5).
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5.5 Summary of Conclusions
In summary, the major conclusions of this thesis are as follows. PBMC from 
children or infected individuals produced more net IFNy on stimulation with WWH 
and SEA compared to PBMC from adults or uninfected individuals. I would like to 
propose therefore, that the overriding immune response exhibited by children and 
infected individuals to schistosome antigens could be considered comparable to a 
murine Thl-type response. In children, experience is one factor in determining the 
type of immune response to S.haematobium, but this does not preclude the 
possibility that age is also an important factor. IL-4 and IL-5 are rarely co­
expressed in blood from children resident in an area endemic for S.haematobium 
supporting the hypothesis that they are expressed by separate cell populations.
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Figure 5.1. Modulation of T-cell subtype development.
Sewell and Mu (1996), suggested that different micro-environments, could result 
in ThO cells developing into one of four different Th-subtypes, instead of the 
conventional two.
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Appendices
Appendix la.
A comparison of Gambian children and adults: gross data
The population was split into children (<16 years) and adults (>25 years). 
Differences between the groups were tested with a Mann-Whitney U Rank 
comparison and accepted as statistically significant differences if p<0.05. Cell 
proliferation was measured using a colorimetric assay (Promega), according to the 
manufacturer’s instructions. Cell proliferation is expressed as ODsTOnm. IL-4, IL-5, 
TNFa and GM-CSF, were measured using sandwich ELISAs as described in 
section 2.3, which have a sensitivity of luml'^ and an accuracy of 0.01uml'\ IL-2 
was measured using a bioassay based on the proliferation of a CTLL cell line. 
Concentrations of IL-2, IL-4 (measured as described in section 2.3), IL-5, TNFa, 
GM-CSF are expressed as uml"\ IL-4 and IFNy were measured using Genzyme 
sandwich ELISA kits according to the manufacturer’s instructions. Results from 
Genzyme ELISAs are reported in pgml'\ PBMC were separated from blood taken 
before treatment and cultured at a concentration of 1 x 10^  in 0.1 ml aliquots for 5 
days for the proliferation assays and 1ml aliquots for 48 hours for the production 
of cytokine with lOfagml'  ^of either PHA, SEA or WWH.
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Appendix lb.
A comparison of children and adults: Net data.
The population was split into children (<16 years) and adults (>25 years). 
Differences between the groups were tested with a Mann-Whitney U Rank 
comparison and accepted as statistically significant differences if p<0.05. Cell 
proliferation was measured using a colorimetric assay (Promega), according to the 
manufacturer’s instructions. Cell proliferation is expressed as ODsvonm. IL-4, IL-5, 
TNFa and GM-CSF, were measured using sandwich ELISAs as described in 
section 2.3, which have a sensitivity of luml'^ and an accuracy of 0.01umf\ IL-4 
and IFNy were measured using Genzyme sandwich ELISA kits according to the 
manufacturer’s instructions. IL-2 was measured using a bioassay based on the 
proliferation of a CTLL cell line. Concentrations of IL-2, IL-4, IL-5, TNFa, GM- 
CSF and IFNy are expressed as um f\ PBMC were separated from blood taken 
before treatment and cultured at a concentration of 1 x 10  ^ in 0.1 ml aliquots for 5 
days for the proliferation assays and 1ml aliquots for 48 hours for the production 
of cytokine with lOpgml'^ of either PHA, SEA or WWH. All comparisons were 
made using net data. Net data are the amount of cytokine or cell proliferation 
produced by PBMC when cultured with stimulant minus levels produced by PBMC 
cultured without stimulant.
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Appendix le.
A comparison of infected and uninfected individuals from The Gambia: 
Gross data
The population was split into individuals either infected or uninfected with 
S.haematobium from The Gambia. Infection status was determined by the presence 
of S.haematobium eggs in urine. Differences between the groups were tested with 
a Mann-Whitney U Rank comparison and accepted as statistically significant 
differences if p<0.05. Cell proliferation was measured using a colorimetric assay 
(Promega), according to the manufacturer’s instructions. Cell proliferation is 
expressed as ODgvonm. IL-4, IL-5, TNFa and GM-CSF, were measured using 
sandwich ELIS As as described in section 2.3, which have a sensitivity of luml'^ 
and an accuracy of O.Oluml'^ IL-2 was measured using a bioassay based on the 
proliferation of a CTLL cell line. Concentrations of IL-2, IL-4 (measured as 
described in section 2.3), IL-5, TNFa, GM-CSF are expressed as uml'\ IL-4 and 
IFNy were measured using Genzyme sandwich ELISA kits according to the 
manufacturer’s instructions. Results from Genzyme ELIS As are reported in pgml"\ 
PBMC were separated from blood taken before treatment and cultured at a 
concentration of 1 x 10® in 0.1 ml aliquots for 5 days for the proliferation assays 
and 1ml aliquots for 48 hours for the production of cytokine with lOpgml'^ of 
either PHA, SEA or WWH.
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Appendices
Appendix Id.
A comparison of infected and uninfected individuals from The Gambia:
Net data.
The population was split into individuals either infected or uninfected with 
S.haematobium from The Gambia. Infection status was determined by the presence 
0 Ï S.haematobium eggs in urine. Differences between the groups were tested with 
a Mann-Whitney U Rank comparison and accepted as statistically significant 
differences if p<0.05. Cell proliferation was measured using a colorimetric assay 
(Promega), according to the manufacturer’s instructions. Cell proliferation is 
expressed as ODsvomn. IL-4, IL-5, TNFa and GM-CSF, were measured using 
sandwich ELISAs as described in section 2.3, which have a sensitivity of luml'^ 
and an accuracy of 0.01umf\ IL-4 and IFNy were measured using Genzyme 
sandwich ELISA kits according to the manufacturer’s instructions. IL-2 was 
measured using a bioassay based on the proliferation of a CTLL cell line. 
Concentrations of IL-2, IL-4, IL-5, TNFa, GM-CSF and IFNy are expressed as 
um f\ PBMC were separated from blood taken before treatment and cultured at a 
concentration of 1 x 10^  in 0.1 ml aliquots for 5 days for the proliferation assays 
and 1ml aliquots for 48 hours for the production of cytokine with lOpgmf^ of 
either PHA, SEA or WWH. All comparisons were made using net data. Net data 
are the amount of cytokine or cell proliferation produced by PBMC when cultured 
with stimulant minus levels produced by PBMC cultured without stimulant.
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Appendix 2a.
A frequency distribution of gross IL-4 produced by PBMC from Gambian 
children when cultured at a concentration of 1 x 10  ^ cellsmf* in 1ml aliquots, 
for 48 hours in the presence of lOpgml'^ of SEA. IL-4 concentration was 
determined using a sandwich ELISA as described in section 2.3 which had a 
sensitivity of luml^ and an accuracy of 0.01 uml \
i
%i
0 0.2 0.4 0.6
IL-4 produced by PBMC from children cultured with 
SEA (uml-’).
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Appendix 2b.
A frequency distribution of gross IL-4 produced by PBMC from Gambian adults 
when cultured at a concentration of 1 x 10* cellsml ‘ in 1ml aliquots, for 48 
hours in the presence of lOpgml ' of SEA. IL-4 concentration was determined 
using a using a sandwich ELISA as described in section 2.3 which had a 
sensitivity of luml * and an accuracy of 0.01 uml \
I
-0
0 0.1
IL-4 produced by PBMC from adults culturedwith SEA
(uml ').
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Appendix 2c.
A frequency distribution of net IL-4 produced by PBMC from infected Gambian 
individuals when cultured at a concentration of 1 x 10* cellsml’^  in 1ml aliquots, 
for 48 hours in the presence of lOpgml'^ of SEA. IL-4 concentration was 
determined using a using a sandwich ELISA as described in section 2.3 which 
had a sensitivity of luml'* and an accuracy of 0.01 uml \  Net IL-4 is IL-4 
produced by PBMC when cultured with SEA minus IL-4 produced by PBMC 
when cultured without stimulant.
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Net IL-4 produced by PBMC from infected Gambian 
individuals when cultured with SEA (uml ').
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Appendix 2d.
A frequency distribution of net IL-4 produced by PBMC from uninfected 
Gambian individuals when cultured at a concentration of 1 x 10* cellsml'^ in 1ml 
aliquots, for 48 hours in the presence of lOpgml^ of SEA. IL-4 concentration 
was determined using a using a sandwich ELISA as described in section 2.3 
which had a sensitivity of luml'^ and an accuracy of 0.01 uml \  Net IL-4 is IL-4 
produced by PBMC when cultured with SEA minus IL-4 produced by PBMC 
when cultured without stimulant.
I1
0 0.1 0.2 0.3 0.4 0.5 0.6
Net IL-4 produced by PBMC from uninfected Gambian 
individuals when cultured with SEA (umf^)
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